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Seaweeds are a large and diverse group of marine organisms that are commonly found 
in maritime regions. The term ‘seaweed’ itself does not have any taxonomic value, but 
is rather a popular term used to describe large attached (benthic) marine plants found 
in the groups that are referred to as the brown seaweeds (phylum Ochrophyta, class 
Phaeophyceae), the red seaweed (phylum Rhodophyta) and the green seaweeds 
(phylum Chlorophyta). To date, about 6000 species of seaweeds have been identified. 
Seaweeds are an excellent source of biologically active secondary metabolites and 
have been shown to exhibit a wide range of therapeutic properties, including anti-
cancer, anti-oxidant, anti-inflammatory and anti-diabetic activities, while also being a 
potential source of prebiotics. As such, seaweeds have been used to treat a wide variety 
of health conditions such as cancer, digestive problems, and renal disorders. Today, 
increasing numbers of people are adopting a “westernised lifestyle” characterised by 
low levels of physical exercise and excessive calorific and saturated fat intake. This 
has led to a rise in chronic non-communicable diseases (NCDs) such as cancer, 
cardiovascular disease, and diabetes mellitus, being reported. Recently, NCDs have 
replaced communicable infectious diseases as the number one cause of human 
mortality. Current medical treatments for NCDs rely mainly on drugs that have been 
obtained from the terrestrial regions of the world, with the oceans and seas remaining 
largely an untapped reservoir for exploration. The focus of Chapter 1 is the potential 
of using seaweed derived bioactives including polysaccharides, antioxidants and fatty 
acids, amongst others, to treat chronic NCDs such as cancer, cardiovascular disease 
and diabetes mellitus. The literature review presented here clearly demonstrates the 
plethora of novel bioactives that seaweed has to offer. While much of the research 
heralds the therapeutic effects from in vitro studies, the way is being laid to assess 
their efficacy in vivo through extensive animal trials and human clinical studies. 
Seaweeds are well regarded as source of dietary fibres and polysaccharides, that 
contain complex glycosidic linkages that the human hydrolytic degrading enzymes 
cannot break down. Seaweeds are a putative novel source of prebiotic compounds. A 
prebiotic is a selectively fermented food ingredient that promotes specific changes in 
the composition and/or activity of the gastrointestinal microbiota, thus conferring 





In Chapter 2, the bifidogenic potential of cold-water extracts from 15 Irish seaweed 
species was investigated using an anaerobic fermentation/ex vivo approach. A 
Bifidobacterium minimal growth media was prepared, containing all the required 
nutrient for bifidobacteria to grow except for the presence of a carbohydrate source. 
Five Bifidobacterium species (B. breve, B. lactis, B. longum, B. bifidum, B. infantis) 
were tested for their ability to use seaweed carbohydrates as their sole carbon source 
for growth. At a concentration of 2.5 mg/ml, 11 out of 15 seaweeds were observed to 
significantly (p<0.05) stimulate the growth of at least one of the Bifidobacterium 
species at both experiment time points (20 h and 28h). The greatest effect was found 
with the brown seaweeds, Fucus serratus and Pelvetia canaliculata, with F. serratus 
being chosen for further evaluation. Significant bifidogenic activity was detected with 
F. serratus at both 1.25 mg/ml and 0.625 mg/ml for B. breve, B. lactis and B. longum. 
It was also shown that, at 1.25 mg/ml, F. serratus had a significantly greater 
stimulatory effect on the growth of B. longum than the FOS prebiotic control. 
Interestingly, appreciable levels of phenolic compounds were observed in several of 
the seaweed extractions including F. serratus. High levels of such compounds are 
known to have antimicrobial activity and may explain an inhibitory effect observed 
with the F. serratus at 2.5 mg/ml. The results of this study indicate that seaweed 
extracts are good candidates for further prebiotic investigation, however a refined 
extraction process and experimental methodology should be utilised. 
 
In Chapter 3, a polysaccharide-rich extract was prepared from F. serratus (the Fse 
extract) and examined for prebiotic potential using an anaerobic ex vivo faecal 
fermentation. Samples were taken at 0 h, 5 h, 10 h, 24 h, 36 h and 48 h for DNA 
sequencing, enumeration of Bifidobacterium and Lactobacillus, short-chain fatty acid 
(SCFA) analysis and hydrogen sulphide production. SCFA production is a major 
indicator of prebiotic stimulation in the colon. Here, a 1.5-fold increase was observed 
in the production of SCFAs, particularly in the production of propionate (2.3-fold 
increase) and acetate (1.4-fold increase). There was also an associated significant 
increase (p<0.05) in the ratio of propionate production, rising from 15% in the control 
to 24%. There was no significant increase butyrate concentration. DNA sequencing 
analysis revealed that the Fse extract had no notable effect on the abundance of 





propionate producers such as the genus Parabacteroides, the family Veillonellaceae 
and the family Erysipelotrichaceae, which is peripherally related to the butyrate-
producing superfamily Lachnospiraceae. These results indicate that a crude 
polysaccharide extract from the seaweed F. serratus can significantly modulate the 
activity of the gut microbiota, and alter the SCFA production profile by stimulating 
propionate and acetate producing members of the microbiota. While the Fse extract 
did not exhibit all the expected prebiotic markers an increase in the production of 
SCFA, especially propionate, is a positive outcome in terms of promoting overall gut 
health and in combating obesity through enhancing satiety. Also, as the extract was 
shown to withstand gastric digestion, F. serratus would be an excellent source of 
dietary fibre as part of a healthy balanced diet. 
The proper function of dietary polysaccharides is greatly dependent on their 
molecular weight, with low molecular weight oligosaccharides often providing better 
sources of carbon and energy for bacteria than their parent sugars. The fibre content 
of seaweeds is typically high molecular weight and while some demonstrate 
fermentative capacity in the lower intestines most pass through the gut too quickly for 
the gut microbiota to utilize to any great extent. In Chapter 4, two similarly processed 
extracts from the brown seaweed L. digitata were prepared to study the effect of 
depolymerisation on prebiotic potential. The fermentation of both extracts brought 
about a significant increase (P>0.05) in total SCFA concentration and the production 
of the biologically significant SCFAs, butyrate (1.7-fold and 0.9-fold increases), 
propionate (3.3-fold and 3.1-fold increases) and acetate (1.76-fold and 1.9-fold 
increases). It was found that the depolymerisation of L. digitata with hydrogen 
peroxide significantly increased the production of propionate and significantly 
reduced the production of butyrate in comparison with the non-depolymerised extract. 
Modulation of polysaccharide chain length can bring about different fermentation 
profiles from the same seaweed raw material and starting faecal microbiota. This could 
potentially allow the production of ‘designer’ extracts whose impact on the gut 
microbiota can be predicted beforehand.   
 
Chondrus crispus is an economically and ecologically important red seaweed 





crispus, contain large quantities of complex polysaccharides such as carrageenans, 
agarans and xylans which also resist degradation in the gastrointestinal tract and reach 
the colon intact. As such they can be considered dietary fibre and a possible source of 
prebiotics. In Chapter 5, a depolymerised polysaccharide-rich extract from C. crispus 
was investigated for prebiotic potential using an anaerobic ex vivo faecal fermentation. 
Significant increases (p<0.05) in the production of total short-chain fatty acids, 
particularly the biologically important SCFAs propionate was recorded. However, 
there was no significant alteration in the molar ratio of SCFA production or impact on 
the production of butyrate. High-throughput DNA sequencing revealed that there was 
no notable impact on the relative abundance of the major probiotic genera of 
Bifidobacterium and Lactobacillus and had a minimum effect on the overall microbial 
population. Increases in propionate concentration, while statistically significant 
(p<0.05) at certain time points, fell short of the levels that would be expected from a 
putative prebiotic. The conclusion of this study is that polysaccharide extracts from C. 
crispus, as prepared here, are not an appropriate candidate for future prebiotic 
investigation as only a minimal stimulatory effect on the ex vivo microbial population 
was observed and limited changes in SCFA production. 
Food-borne illnesses are a major burden on health services throughout the world. 
A variety of antimicrobial agents have been used to prolong the shelf-life of processed 
goods and inhibit the growth of food-borne pathogens but resistance to traditional 
antimicrobials is spreading quickly. Listeria monocytogenes is among the most 
prevalent food-borne pathogen and is the causative agent of listeriosis. In Chapter 6, 
the antimicrobial activity of ten ethanol seaweed extracts was examined against a 
selection of food-borne pathogens including Listeria monocytogenes. Extracts from 
the seaweeds Fucus vesiculosus, F. serratus F. spiralis, Ascophyllum nodosum and 
Pelvetia canaliculata significantly inhibited (p<0.05) the growth of Listeria 
monocytogenes 5788 at 24 h. The F. vesiculosus extract was chosen for further 
evaluation. Molecular weight fractions of F. vesiculosus were tested against several 
listeria stains. It was found that the anti-listerial activity was concentrated in the 0-3.5 
kDa and the 3.5-100 kDa molecular weight subfractions, with the 3.5-100 kDa 
exhibiting the highest activity of all. Antimicrobial activity was found to be positively 
correlated with high levels of phenolic content. F. vesiculosus was found to have the 





GAE mg-1 and the most potent antimicrobial activity. Subfractions from F. vesiculosus 
that exhibited activity against L. monocytogenes were also found to contain large 
quantities of phenolic compounds. The results of this study indicate that the several 
Irish seaweeds display antimicrobial activity which is correlated to the presence of 
large concentration of phenolic compounds. F. vesiculosus had the highest levels of 
phenolic compounds of all the seaweeds investigated and demonstrated the most 
potent antimicrobial activity against the pathogen L. monocytogenes.  This is a 
promising outcome as to the potential of utilising such extracts from seaweeds in food 
products to serve as both biopreservation agent and antioxidants. 
Studies, like the one presented here, function to expand our knowledge seaweed 
as a resource and broaden our understanding of how its potential can be unlocked. The 
concept of prebiotics is an intriguing one. The delivery of non-digestible components 
to the gut, after having survived gastric transit, and then being utilised by certain 
beneficial members of the microbiota, namely Bifidobacterium and Lactobacillus. 
However, not all putative prebiotics are made equally and they vary considerably in 
their fermentability potential. We have shown that seaweed polysaccharides, 
especially those from brown seaweeds such as laminarin and fucoidan, have great 
potential. The definitive test of the prebiotic potential of a substrate is to transition 
from ex vivo to in vivo animal trials in small animals and subsequently in large 
animals/humans. However, several challenges exist in the upscaling of prebiotic 
studies. As the yield of polysaccharides can be very low following acid hydrolysis, 
large quantities of seaweed would need to be collected, stored and processed to 
produce sufficient extracts for further investigation. Additionally, the concentration 
and type of seaweed polysaccharide can vary greatly depending on the season of 
collection and the species of seaweed and must be taken into consideration in the 








(Published in Marine Drugs) 
Looking Beyond the Terrestrial: The Potential of Seaweed 











Kenneth G. Collins 1, Gerald F. Fitzgerald 2, Catherine Stanton 1,3, * and R. Paul 
Ross 1,3 
 
1 Teagasc Moorepark, Fermoy, Cork, Ireland ; kenneth.collins@teagasc.ie (K.G.C.) 
2 Department of Microbiology, University College Cork, Cork, Ireland ; 
g.fitzgerald@ucc.ie (G.G) 
3 APC Microbiome Institute, University College Cork, Cork, Ireland ; p.ross@ucc.ie 
(R.P.R.) 
* Correspondence: catherine.stanton@teagasc.ie (C.S); Tel: +353-25-42606 
Academic Editor: Keith B. Glaser 







1.1 Abstract.  
Seaweeds are a large and diverse group of marine organisms that are commonly found 
in maritime regions. They are an excellent source of biologically active secondary 
metabolites and have been shown to exhibit a wide range of therapeutic properties, 
including anti-cancer, anti-oxidant, anti-inflammatory and anti-diabetic activities. 
Several Asian cultures have a strong tradition of using different varieties of seaweed 
extensively in cooking as well as in herbal medicines preparations. As such, seaweeds 
have been used to treat a wide variety of health conditions such as cancer, digestive 
problems, and renal disorders. Today, increasing numbers of people are adopting a 
“westernized lifestyle” characterised by low levels of physical exercise and excessive 
calorific and saturated fat intake. This has led to an increase in the numbers of chronic 
Non-Communicable Diseases (NCDs) such as cancer, cardiovascular disease, and 
diabetes mellitus, being reported. Recently, NCDs have replaced communicable 
infectious diseases as the number one cause of human mortality. Current medical 
treatments for NCDs rely mainly on drugs that have been obtained from the terrestrial 
regions of the world, with the oceans and seas remaining largely an untapped reservoir 
for exploration. This review focuses on the potential of using seaweed derived 
bioactives including polysaccharides, antioxidants and fatty acids, amongst others, to 















Seaweeds are an extensive group of autotrophic organisms that have a long fossil 
history. They are globally distributed and can be found in every climatic zone ranging 
from warm tropical waters to  the freezing cold polar regions [1]. At present, more 
than 10,000 different species of seaweed are known [2]. The traditional division of the 
various seaweed species is one based largely on differences in pigmentations. The 
three main groupings are; the brown seaweeds (phylum Ochrophyta, class 
Phaeophyceae), the red seaweed (phylum Rhodophyta) and the green seaweeds 
(phylum Chlorophyta) (Figure 1) [3]. Seaweeds have been extensively used by 
mankind since the beginnings of recorded history in a wide assortment of ways. They 
are an important source of unique polysaccharides (agar, carrageenan, alginates, etc.) 
for the pharmaceutical and food industries and the use of seaweed extracts as gelling 
agents and thickeners goes back almost half a millennium. The practice of extracting 
agar from seaweed was first described in 1658 in China and agar is well known today 
as a common substrate in bacterial culture media, being first used by the pioneering 
German microbiologist Robert Koch [1]. Drift seaweed washed up on shore has been 
used as an organic agricultural fertiliser in coastal regions of the world for centuries. 
The application of seaweed as a fertiliser improves soil structure, provides trace 
elements and growth activators [4] as well as resulting in earlier seed germination, the 
enhancement of crop performance and yield and a better resistance to both biotic and 
abiotic stresses [5]. 
 
Figure 1.1 Seaweeds are divided into three main groupings based largely on their pigmentation. 



















Since ancient times, edible seaweed species have formed an important part of the 
culinary tradition in countries of the Far East, such as China, Korea and especially 
Japan[6]. Seaweed is a very healthy food source with some varieties containing higher 
levels of minerals and trace elements than terrestrial plants and animal products [7-
10]. For examples, a 100 g portion of seaweed can exceed the RDA value for vitamin 
A, B2 and B12 and two thirds of the vitamin C daily requirement [11]. The protein 
content of seaweed can vary greatly depending on many factors, such as the season 
when the plant is harvested and surrounding environmental conditions. Species of red 
seaweed can contain as much as 21–47 g/protein/100 g dry weight, while brown 
seaweeds have a comparatively low protein content of 7–16 g/100 g dry weight [12]. 
Seaweeds are also the best natural source of iodine and their addition to the diet could 
help people who are lacking in iodine to meet their daily iodine requirements [13]. In 
traditional Japanese cooking, edible seaweeds are extensively used as a sea vegetable 
and can also be used as condiments, seasonings and wrappings for sushi [14]. In such 
ways, they can account for as much as 25% of the daily food intake of some Japanese 
people [15]. Indeed, every year, over 1.6 kg of dry seaweed is consumed in Japan, on 
average per person [10]. Some of the more common seaweeds used in food preparation 
include the brown seaweed species, Laminaria (kombu), Undaria (wakame) and Hijiki 
(hiziki), and varieties of the red seaweed, Porphyra (nori). Edible seaweeds contribute 
few calories to the diet, owing to their low fat content and because seaweed derived 
carbohydrates and proteins cannot be fully digested in the gut by human intestinal 
enzymes [16]. As such, seaweeds are a good source of dietary fibre, which can 
positively affect satiety in between meals and glucose uptake from food [17]. 
Furthermore, soluble polysaccharide found in seaweeds may have a prebiotic effect, 
by stimulating the growth and/or activity of beneficial members of the microbiota such 
as the Bifidobacterium and Lactobacillus [18]. While seaweeds have undoubtedly 
been used extensively for thousands of years in Asia, South America and Oceania as 
a food source, the culinary use of seaweed has traditionally been very limited in both 
Europe and North America [1]. Despite this, the use of seaweed as sea vegetables has 
become more common in Western countries in recent decades [19] as a result of 
increasing globalization and improved accessibility of Asian cuisine to the rest the 
world. Furthermore, consumers in developed Western countries are increasingly 





Seaweeds are consistently exposed to both biotic and abiotic pressures in their 
natural marine environments. These pressures exert an influence on the plant’s 
physiology that leads to the production of metabolites in order for the plant to survive 
and thrive. Some of these metabolites may act as bioactive components, and thus have 
potential for use in the development of new functional ingredients and medical 
treatments. Indeed, secondary metabolites known to be produced by seaweeds have 
demonstrated therapeutic properties including anti-cancer, anti-oxidant, anti-
inflammatory, and anti-diabetic activities [16]. Historically, Asian civilizations have 
used seaweeds for various medicinal purposes by boiling the seaweed in water and 
using the decoction as a drug. Japanese and Chinese practitioners have been recorded 
using seaweeds in herbal medicines as far back as 300 BC. The range of ailments 
reported to have been treated with seaweed or seaweed derived products is much 
varied. They include treatments for cancer, digestive problems, dropsy, eczema, 
glandular problems, goitre, gout, hyper-throidisms, parasitic infection, swollen and 
painful scrotum and urination and renal disorders [21-23]. In this regard, these 
metabolites may potentially lead to useful leads in the development of new functional 
ingredients and medical treatments [16]. 
The aim of this review is to examine the literature regarding the use of seaweed 
derived bioactive metabolites in relation to the treatment/prevention of a particular set 
of diseases referred to as chronic non-communicable diseases (NCDs). NCDs are an 
extensive group of conditions that, unlike bacterial and viral infections, are not 
transmissible from person to person. NCDs are a leading cause of death and disability, 
and affect millions of people globally each year. These long-lasting conditions have a 
protracted duration and a generally slow rate of progression. The four main types of 
chronic NCDs are cardiovascular diseases (CVDs), cancer, diabetes mellitus and 
chronic respiratory ailments [24]. Chronic diseases typically begin to manifest in 
middle age, following long term exposure to a plethora of unhealthy activities, such 
as excessive alcohol consumption, primary and secondary smoke inhalation, low 
levels of physical activity, and the consumption of a diet with excess fat and red meat 
and low in fibre. The incidence of chronic diseases rises sharply as people start to age, 
with most people over the age of 65 having a chronic ailment of one sort or another. 
Today, NCDs are the leading cause of death and disability in the world (Figure 1.2) 





(including HIV/AIDS, TB and malaria), maternal and perinatal conditions and 
nutritional deficiencies [25]. Consequently, interventions to prevent and control NCDs 
are essential and since seaweed is an abundant and natural resource with proven 
therapeutic effects, its contribution to the alleviation of chronic diseases are evaluated 
henceforth. 
Figure 1.2 According to the World Health Organization (WHO) (a) cardiovascular diseases, 
cancers, respiratory diseases and diabetes account for 82% of all deaths attributed to non-
communicable diseases; (b) Each year, cardiovascular diseases account for 17.5 million deaths, 











1.3 Anticancer Activity of Seaweed Components. 
Cancer is a generic name given to a large group of clonal malignant diseases. The 
defining characteristic of cancer is the rapid creation of abnormal cells that proceed to 
grow beyond their normal boundaries, leading to the invasion of adjoining areas of the 
body culminating in the spread of the cancer in a process termed metastasis. Despite 
a better understanding of cancer biology in the last few decades, the treatment of most 
cancers has not progressed, with the reduction in cancer deaths mainly being attributed 
to early detection and preventive measures, rather than new cancer treatments coming 
on stream [26, 27]. The challenge of developing effective treatments for cancer has 
encouraged the development of new drugs from natural sources, with seaweeds and 
the marine environment as a whole expected to be a major frontier in both 
pharmaceutical and medical cancer research [28]. 
 
1.3.1 Seaweed-Derived Polysaccharides. 
Seaweeds, especially brown seaweeds, are rich in biologically active polysaccharides 
that exhibit a broad spectrum of biological activities. Examples of these 
polysaccharides include fucoidans, laminarins and alginic acids [29]. Fucoidans 
(fucans) are highly sulphated cell-wall polysaccharides found in species of brown 
seaweeds. Each different brown seaweed species produces its own array of fucans that 
have unique structural properties, which can be further altered by any number of biotic 
and abiotic factors to which the seaweed is exposed, as well as the extraction and 
purification method used to collect the fucan [30]. The biological activity of fucoidans 
is related to their molecular structure, which include fucose linkage, the sugar type, 
sulphate content, with molecular weight being the most important determinant. 
Fucoidan from Fucus vesiculosus (Phaeophyceae) is mainly composed of α-(1-3) 
linked sulphated L-fucose (Figure 3). In Ascophyllum nodosum (Phaeophyceae), α-(1-
3) linked fucose with low proportion of α-(1-4) linked fucose or a repeating α-(1-3) 
and α-(1-4), has been reported. Linkages of α-(1-3) found in other polysaccharides 
have a stronger anticoagulation ability than the α-(1-4) configuration. The sulphate 
content of fucoidan also influences the anti-cancer and anticoagulant activities. Over 
sulphated fucoidan has a better α-amylase inhibitory activity than native fucoidan. 





function of fucoidan. A molecular weight that is too high may result in low solubility 
and processability, resulting in poor penetration of the cell. Low molecular weight 
(LMW) fucoidan degraded by gamma-irradiation was shown to increase cell 
cytotoxicity in comparison to native fucoidan in cancer cell lines such as AGS, MCF-
7 and HepG-2. Gamma irradiated fucoidan also showed a higher level of cell 
transformation inhibition, resulting in higher anti-carcinogenic activity [31, 32] 
Evidence suggests that fucoidan can act as an anti-cancer agent through 
modulation of the human immune system. Fucoidan has been found to induce the 
maturation of dendritic cells and, in association with other cytokines, to shape the 
immune responses that are mediated by T-cells. For information of the proposed 
mechanism of fucoidan bioactivity see Figure 4. Dendritic cells are antigen-presenting 
cells that play a vital role in effectively stimulating the immune response as they are 
responsible for the initiation and polarization of adaptive immunity. Data suggest that 
fucoidan can modulate dendritic cell differentiation and drive it towards a Th1-
polarizing phenotype, which could possibly be used in dendritic cell based vaccines for 
cancer immunotherapy [33]. Polysaccharides isolated from plants and algae have been 
reported to enhance macrophage activation through specific membrane pattern 
recognition receptors. These receptors recognize foreign ligands such as those found 
on carbohydrates during the innate immune response. The major receptors reported 
for polysaccharide recognition in macrophages are Toll-like receptor 4 (TLR4), CD14, 
complement receptor type 3 (CR3) and scavenger receptor (SR). Acetyl fucoidan 
isolated from commercially cultured Cladosiphon okamuranus (Phaeophyceae) 
induced macrophage activation in the murine macrophage cell line, RAW 264.7 
through membrane receptors TLR4, CD14 and SRA (anti-scavenger receptor class A) 











Figure 1.3 Model for the average structure of fucoidan from Fucus vesiculosus. The core region of the 
fucan is composed primarily of a polymer of α (1-3) linked fucose with sulphate groups substituted at 
the 4 position on some of the fucose residues [35]. 
 
 
Fucoidan has also been shown to have cyto-protective properties. 
Chemotherapeutic anticancer drugs are effective against cancer cells but, because of a 
lack of selectivity, they also attack normal immune cells. It has been demonstrated that 
fucoidan can protect dendritic cells from the effect of 5-Fluorouracil (a representative 
cancer drug) [36]. Studies performed in vitro with crude fucoidan extracted from 
Sargassum sp. and F. vesiculosus demonstrated a reduction of the viable number of 
Lewis lung carcinoma cells and melanoma B16 cells in a dose dependent manner. 
Exposure to the fucoidan also caused morphological changes in the melanoma cells, 
which were indicative of apoptosis being induced. When male mice were challenged 
with daily i.p. injections of crude fucoidan from either seaweed over a 4 day period, 
the cytotoxic activity of their natural killer cells was enhanced [37]. Fucoidan 
extracted from the sporophyll of Undaria pinnatifida (Phaeophyceae) was reported to 
show anti-tumour activity against PC-3, HeLa, A549 and HepG2 cell lines, which was 
comparable to that of commercially obtained fucoidan [38]. Fucoidan from 
Saccharina cichorioides (Phaeophyceae), Fucus evanescens (Phaeophyceae), and U. 
pinnatifida was investigated for effects on proliferation, neoplastic formation, and 
colony formation of mouse epidemial cells (JB6 C141), human colon cancer cells 
(DLD-1), breast cancer cells (T-47D) and melanoma (RPMI-7951). These particular 
fucoidans specifically and significantly suppressed the proliferation of human cancer 
cells and exhibited less cytotoxicity towards normal mouse epidermal cells [39]. 
Another investigated the possibility of using acetylated fucoidan (AcFu) nanoparticles 
loaded with the chemotherapy drug doxorubicin for the treatment of cancer using the 
cell lines HCT-116 and HCT-8. The nanoparticles demonstrated first-order drug 
release for 5 days following treatment. Treated macrophages were found to 





particles were also resistant to the multidrug resistant characteristics of cancer cells 
[40].  
Figure 1.4 Proposed mechanism for fucoidan bioactivity (A) Macrophage activation by fucoidans as 
mediated through specific membrane receptor activation namely TLR-4, CD14, CR-3 and SR which 
induces intracellular signaling via mitogen-activation protein kinases (MAPKs); (B) Activation of 
macrophages leads to the production of cytokines such as IL-12, IL-2 and IFN-γ which enhance NK 
cell activation that may stimulate T-cell activation[41]. 
 
 
The laminarins are a group of water soluble polysaccharides produced by brown 
seaweeds. They consist of 1,3- and 1,6-linked β-D-glucose residues and normally have 
a molecular weight of 4–5 kDa. Laminarin isolated from Eisenia bicyclis 
(Phaeophyceae) was shown to inhibit human melanoma SK-MEL-28 and colon cancer 
DLD-1 cells. It was also demonstrated that decreasing the molecular weight of the 
laminarin (DP: 9–23) and increasing the ratio of 1–6 linked glucose residues increased 
the anticancer activity [29]. Rats fed a diet of 2% (w/w) laminarin suppressed indole, 
p-cresole and sulphide production significantly. Such compounds are produced from 
proteins by colonic bacteria and are putative risk markers for the development of colon 
cancer [42]. Other studies have also reported anti-cancer activity of laminarins and 
fucoidans [43]. One investigated the effectiveness of using polysaccharides from the 
edible Sargassum latifolium (Phaeophyceae) in chemoprevention. Fractions of water 
soluble polysaccharides from S. latifolium were tested for their chemopreventive 
efficacy revealing a range of chemopreventive properties, including anti-initiating, 
anti-promoting, and inhibition of NO, TNF-α and COX-2 [44]. A hot water-soluble 





inhibition of human cancer cells in a dose dependent manner. Treated cells exhibited 
a marked increase in caspase-3 activation, and decreases in both the expression of Bcl-
2 and the phosphorylation of insulin-like growth factor-I (IFG-1) receptor. Treatment 
with the polysaccharide extract also decreased the recruitment of p85 to IGF-1 
receptor and insulin receptor substrate-1 (IRS-1)[21]. Sulphated polysaccharides from 
the thallus of Sargassum plagiophyllum (Phaeophyceae) were shown to have anti-
cancer activity against HepG2 and A549 cell lines [45]. Porphyrans from Porphyra 
species induced cell death in human AGS gastric cancer cells in a dose dependent 
manner by decreasing cell proliferation and inducing apoptosis [46]. Carrageenan 
extracted from Solieria chordalis (Rhodophyta) showed no cytotoxicity towards 
human cancer cells lines but demonstrated immune-stimulating properties. Treatment 
resulted in enhancement of neutrophil phagocytosis, cytotoxicity by natural killer cells, 
antibody-dependent cell cytotoxicity and stimulation of lymphocyte proliferation, 
which points towards a use in cancer immunotherapeutic treatment [47]. A heterofucan 
isolated from Spatoglossum schröederi (Phaeophyceae), Fucan B, was found to inhibit 
the proliferation and migration of CHO-K1 when fibronectin was used as the substrate. 
Fucan B also promoted G1 cell cycle arrest [30]. A summary of recently reported 


















Table 1.1 A wide variety of biological activities have been reported from algal polysaccharides. 











































































Agar, alginates n/a 
Gelidium sp., 
Gracilaria sp., and 
A. nodosum 
Prebiotic [18] 











1.3.2 Fatty Acids. 
Fatty acids are commonly found in foods such as vegetable oils, meat, milk, and soy 
products. They play an important role in maintaining normal physiological functions. 
Docosahexaenoic acid (DHA) and arachidonic acid (AA) are both important parts of 
mammalian cell membranes and are crucial to brain and eye development in human 
infants. The intakes of omega-3 and omega-6 fatty acids have been linked to a 
reduction in cardiovascular mortality rates, suppression of arthritis-associated 
inflammation, and a decreased risk of cancer. Marine algae such as seaweed are a rich 
source of unsaturated fatty acids. An isolated diketosteroid, (E)-stigmasta-24(28)-en-
3,6-dione (Compound 1) along with three previously known steroids from Tydemania 
expeditionis (Chlorophyta), namely β-sitosterol (2), fucosterol (3) and saringosterol 
(4) collected from the China sea were evaluated for activity on prostate cancer cell 
lines DU145, PC3 and LNCaP. The diketosteroid termed (compound 1), showed 
moderate inhibitory activities while fucosterol proved to be most effective. Two 
unsaturated fatty acids isolated from a Fijian population of the T. expeditionis, were 
shown to have moderate inhibitory activity against a panel of tumour cell lines 
(including breast, colon, lung, prostrate and ovarian cells [59]. 
 
1.3.3 Carotenoids and Terpenes. 
Carotenoids are natural tetraterpenes which are produced by a wide variety of 
organisms ranging from single celled microbes to plants with more than 700 examples 
described so far [60]. The carotenoid β-carotene, which is found in large quantities in 
green and yellow fruit, and lycopene are both known for their anti-cancer activities 
[61]. Fucoxanthin is a carotenoid that is found in great abundance in Brown seaweeds 
[62]. Indeed, it is the most abundant of all carotenoids, accounting for more than 10% 
(approximately 10 million tonnes) of the estimated natural production of carotenoids 
each year [63]. Fucoxanthin is reported to be very effective in inducing cellular death 
in human leukaemia and colon cancer cells [64] and has been proven to suppress in 
vivo liver and skin carcinogenesis [61]. The ability to scavenge free radicals is thought 
to play an important role in the anti-mutagenic and anti-carcinogenic mechanisms of 
carotenoids, and as such, fucoxanthin displays potent scavenging abilities. To date, 





mainly on that of fucoxanthin. However, the exact mechanism by which fucoxanthin 
exerts it anti-cancer activity has not yet been fully defined. Fucoxanthin can strongly 
and concentration-dependently inhibit growth of human hepatoma cells and can 
facilitate growth of mouse embryonic cells. Fucoxanthin significantly enhanced gap 
junctional intercellular communication (GJIC) of the cancer cells without affecting 
noncancerous mouse cells. Treatment with fucoxanthin also resulted in an increase in 
both protein and mRNA expression. The upregulation of GJIC, coupled with increases 
in intracellular calcium levels may be responsible for cell cycle arrest and cellular 
death via apoptosis [63]. Fucoxanthin derived from seaweed Undaria pinnatifida 
(Phaeophyceae) was shown to markedly reduce the viability of different colon cancer 
cell lines in vitro. Treatment induced DNA fragmentation and reduced the level of the 
anti-apoptotic protein, Bcl-2. It was also noted that separate treatment of CaCo-2 cells 
with fucoxanthin and troglitazone recorded no decrease in cell viability, but when used 
in combination, cell viability was greatly reduced [62]. Fucoxanthin was shown to 
inhibit tumour cell growth in HepG2 cells by inducing G1 cell cycle arrest and/or 
inducing apoptosis [65]. In nature, most carotenoids occur predominately or entirely 
in the trans-form. The presence of a cis double bond garners greater steric hindrance 
between close-by hydrogen atoms and/or methyl groups, resulting in a bond that is 
less thermodynamically stable than the trans-form. The all-trans form of fucoxanthin 
was the major geometrical form found in the sample investigated. However, a mixture 
of 13-cis and 13′-cis isomers produced the strongest anti-proliferative activity of all 
the geometrical isomers [64]. Fucoxanthin from Saccharina japonica (formerly 
Laminaria japonica) (Phaeophyceae) has been shown to suppress the invasion of 
highly metastatic B16-F10 melanoma cells. This form of fucoxanthin inhibited the 
expression and secretion of MMP-9, which plays a critical role in tumour invasion and 
migration. Furthermore, the expression of cell surface glycoproteins that play an 
important role in migration, invasion and cancer-endothelial cell adhesion was 
diminished. In lung cancer metastasis models, fucoxanthin caused a significant 
reduction of tumour nodules [66]. 
Another carotenoid of interest is siphonaxanthin, which is a keto-carotenoid found 
in siphonaceous green algae. In comparison with other carotenoids such as 
fucoxanthin, siphonaxanthin is a potent inhibitor of HL-60 cells. Treatment with 





increase in TUNEL-positive cells and chromatin condensation in the HL-60 cells 
indicated apoptotic activity. The induction of apoptosis also reduced the expression of 
Bcl-2 and increased the expression of caspase-3 [67]. Halogenated monoterpenes are 
produced by marine algae of the families Plocamiaceae and Rhizophyllidaceae and 
have a well-established anticancer potential. Four halogenated monoterpenes isolated 
from Plocamium suhrii (Rhodophyta) exhibited greater cytotoxicity when compared 
to cisplatin, a known anticancer drug, when assayed against an esophageal cancer cell 
line [68]. Polyhalogenated monoterpenes from Plocamium corallorhiza (Rhodophyta) 
also showed moderate cytotoxicity towards esophageal cancer cells [69] Peyssonoic 
acids A-B and a novel sesquiterpene hydroquinnones isolated from Peyssonnelia sp. 
exhibited modest antiproliferative activity against ovarian cancer cells [70]. 
 
1.3.4 Seaweed Derived Antioxidants. 
Reactive oxygen species (ROS) are highly reactive molecules that are constantly 
produced by cellular enzymatic reactions. They are required to maintain cell 
homeostasis and the body’s antioxidant defense systems are designed to prevent 
harmful effects caused by increased levels of ROS. Cells in a normal healthy condition 
produce ROS at low levels. Free radical-mediated modification of DNA, proteins, 
lipids and small cellular molecules have been associated with such diseases as cancer, 
atherosclerosis and rheumatoid arthritis [71]. Antioxidants are secondary metabolites 
that scavenge ROS and free radicals by inhibiting initiation and breaking chain 
propagation or suppressing formation of free radicals by binding to the metal ions, 
reducing hydrogen peroxides and quenching superoxide and singlet oxygen [72]. 
Among marine organisms, seaweeds represent one of the richest sources of 
antioxidants [73]. In South East Asia, Eucheuma cottoni (Rhodophyta) is grown in 
abundance for human nutrition. A polyphenol rich extract from E. cottoni was shown 
to be anti-proliferative against oestrogen-dependent MCF-7 and oestrogen-
independent MB-MDA-231 human breast-cancer cells in vitro, but non-toxic to non-
cancerous cell lines. The extract was fed to female rats and following four weeks of 
dietary supplementation, mammary tumours were induced with carcinogenic agents. 
Tumour development and erythrocyte lipid peroxidation was inhibited in rats that had 





down-regulation of oestrogen biosynthesis and an improved antioxidant status [74]. 
Soluble fractions of Palmaria palmata (Rhodophyta), Laminaria setchellii 
(Phaeophyceae), Macrocystis integrifolia (Phaeophyceae) and Nereocystis leutkeana 
(Phaeophyceae) have been shown to inhibit the proliferation of HeLa cells. The anti-
proliferative effect of the seaweed extracts was positively linked to their total phenolic 
content [15]. One of the key antioxidant defense mechanisms in the cell is the NF E2-
related factor 2 (Nrf2)—antioxidant-response element (ARE) signaling pathway, 
which can be activated by a variety of small molecules. Fractionation of the edible 
seaweed Ulva lactuca (Chlorophyta) gave rise to multiple active fractions as measured 
by an ARE-luciferase reporter assay. A keto-type C18 fatty acid was shown to induce 
the expression of cytoprotective genes with its cellular activity requiring the presence 
of Nrf2 and PI3k function. Mice treated with a single dose of an U. latuca fraction that 
was enriched with the C18 fatty acid showed similar ARE-activating effects to those 
observed in in vitro studies. This observation could be due to the ability of the fraction 
to inhibit KEAP1-mediated Nrf2 ubiquitination and the subsequent accumulation and 
nuclear translocation of Nrf2. A significant increase in the transcript levels of Nqo1 
was also found in other mouse tissues such as the brain, stomach and lung [75]. 
Fucoidan has also been shown to exhibit antioxidant activity. When different 
sulphated polysaccharides from the seaweed Turbinaria conoides (Phaeophyceae) 
were evaluated for antioxidant activity, fucoidan showed the highest antioxidant 
potential followed by alginic acid and laminarin, respectively [71]. The anti-cancer 
properties of Laurencia obusta (Rhodophyta) were correlated with its total phenolic 
and flavonoid contents [76]. Polyphenol rich extracts from Ecklonia cava 
(Phaeophyceae) have shown strong anti-cancer activities. One study demonstrated 
significant suppression (p > 0.05) of migration and invasion of A549 cells in a dose-
dependent manner and down regulation of the matrix metalloproteinase (MMP)-2 
activity, which is essential in the degradation of the extracellular matrix [77]. Another 
poly-phenolic rich fraction from E. cava exhibited strong selective cell proliferation 
inhibition on all cancer cell lines tested (CT-26, THP-1, B-16 and U-937), which was 
attributed to induced apoptosis in CT-26. The extract also demonstrated strong radical 
scavenging activity and reducing power and at 5 µg/mL was found to be comparable 
to butylated hydroxytoluene at the same concentration [78]. Also, phloroglucinol 





triggered through NF-κB family and NF-κB dependent pathways [79]. Oxidative stress 
brought about by long term exposure to ultraviolet radiation from sunlight plays an 
important role in the development of skin cancer. Ultraviolet B radiation in particular 
(by having a longer wavelength 280–320 nm) is associated with a more harmful impact 
on the skin. Protective compounds against biotic factors such as UV radiation has been 
produced by Undaria crenata (Phaeophyceae), with ethanol extractions having 
demonstrated photoprotective activity against cell damage caused by exposure to UVB 
radiation in Human HaCaT keratinocytes. Analysis revealed a significant scavenging 
effect of the extract against superoxide anion and hydroxyl radical. UVB-induced 
apoptosis was reduced, resulting in recovery of cell viability. Treatment also decreased 
the level of UVB-induced oxidative stress to lipids, proteins, and DNA, as shown by 
a decrease in the level of 8-isoprostane, protein carbonylation and DNA tails [80]. 
 
1.3.5 Anti-Cancer Activity of Minor Seaweed Components. 
It is well documented that major seaweed components such as fucoidan and 
fucoxanthin have effective anti-cancer properties. However, the importance of 
screening crude seaweed extracts should not be overlooked, as minor components may 
also harbor potent biological activities. The sporophyll of U. pinnatifida is considered 
to have lower utility value compared to other parts of the plant and is usually discarded 
as waste. An ethanol extract of the sporophyll was prepared and shown to reduce the 
viability of colorectal cancer HCT116 cells [81]. A novel glycoprotein isolated from 
S. japonica (formerly L. japonica) (LJGP) was found to have anti-proliferative effects 
on numerous cancer cell lines in a dose-dependent manner. LJGP treatment of HT-29 
cancer cells caused them to display several apoptotic features such as DNA 
fragmentation, sub-G1 arrest, caspase-3 activation, and Poly (ADP-ribose) 
polymerase (PARP) degradation. It was also determined that LJGP-induced apoptosis 
led to the formation of a death-inducing signaling complex (DISC) of Fas, FADD and 
procapase-8. LJGP induced the reduction of mitochondrial membrane potential with 
the activation of the Bcl-2 family of proteins and caspase-9 [82]. The enzyme 
telomerase adds tandem arrays of TTAGGG repeats to the ends of telomeres. 
Telomerase activity is not usually detectable in normal cells, but high activity is found 





and much work has been performed on screening for telomerase inhibitors. Eitsuka et 
al., (2004) [83] confirmed the inhibitory effect of sulfoquinvosyldiacylglycerol 
(SQDG), a glyceroglycolipid, from Porphyra yezoensis on human telomerase in a cell-
free system, which acted in a dose-dependent manner. It was also confirmed that EPA, 
which is a component of SQDG, is a potent telomerase inhibitor. 
Three pigments isolated from an extract of Porphyra tenera (Rhodophyta) (β-
carotene, chlorophyll a and lutein) showed significant activity against mutagen-
induced umu C gene expression. Combined treatment with the pigments showed an 
additive effect compared with single treatment with each pigment [84]. The same 
authors later studied the in vivo anti-carcinogenic activity of the seaweed Ulva 
prolifera (formerly Enteromorpha prolifera) (Chlorophyta) using an initiator (7, 12-
dimethylbenz[a]anthracene) and promoter (12-O-tetradecanoylphorbol-13-acetate) 
model. The application of U. prolifera extract prior to initiator or promoter treatment 
caused a significant suppression of mouse skin tumourigenesis. The combined use of 
the extract before both treatments (with initiator and promoter) resulted in much 
stronger suppression against the same skin tumourigenesis. It was proposed that a 
chlorophyll-related compound, pheophytin-a was an antigenotoxic substance [85]. 
The anti-tumour effect of pepsin-digested Caulerpa microphysa extracts was 
demonstrated by their addition to HL-60 and WEHI-3 cell lines. Growth of both cell 
lines was significantly affected (p < 0.05) when incubated with the digested extract at 
concentrations of 25 µg/mL and above. A significant increase in DNA damage was 
also recorded at concentrations of 100 µg/mL and above in comparison with the 










1.4 Potential of Seaweed Components to Alleviate Cardiovascular 
Disease. 
Cardiovascular diseases (CVD), including heart disease and stroke are a diverse group 
of disorders that affect the mammalian circulatory system. Collectively, CVDs are the 
number one cause of human death worldwide. In 2008, 30% of all deaths were because 
of a CVD. Although many risk factors for CVDs are recognised, the most important are 
hypertension, hyperlipidemia, hyperglycemia and abdominal obesity [87]. The 
traditional Japanese diet, which is characterised by high consumption of fish, seaweed 
and other plant material and sodium, with an accompanying decrease in refined 
carbohydrates and animal fat has been associated with a reduced risk of mortality 
associated with CVD. Today, Japan enjoys one of the lowest rates of coronary heart 
disease of any country in the world [88]. 
 
1.4.1 Hypertension and Hyperlipidaemia. 
Hypertension or high blood pressure is a major modifiable risk factor of cardiovascular 
disease. Known as the “silent killer”, hypertension can be asymptomatic for years 
before the condition is diagnosed clinically [89]. Cases of hypertension are divided 
into those of essential, primary or idiopathic hypertension with essential hypertension 
accounting for 95% of all cases. Risk factors that contribute to the development of 
hypertension include differing concentrations of sodium and potassium in the body, 
obesity, resistance to insulin, high alcohol intake, low calcium intake, stress and 
ageing. Many of these factors, such as being obese and having a high alcohol intake 
are additive over time. Approximately 25% of the global adult population suffers from 
hypertension, with this percentage expected to reach 60% of the population by 2025 
[90, 91]. The prevalence of high blood pressure increases as people age. Indeed, in 
developed countries, 65% of those aged between 65 and 74 are affected by 
hypertension. Diet and lifestyle modifications are most often used to lower blood 
pressure levels [92]. 
Potassium alginate is a major polysaccharide present in brown seaweeds. 
Alginates are known to bind sodium, potassium and calcium ions and decrease the 





regard, dried seaweed flakes containing potassium alginate could be used as a 
replacement for table salt for people with high blood pressure [91, 93]. An 
epidemiological study performed in 25 countries spanning 15 years concluded that 
changes in dietary patterns such as cutting back on salt, increasing the consumption of 
fish oil, soybean protein and dietary fibre (including from seaweed) could reduce the 
risk of suffering a stroke [94]. Research into the effect of sulphated polysaccharides 
from S. japonica (formerly L. japonica) on rats with induced vascular endothelial 
damage after a psychological stress (PS) showed that adrenalin metabolites in plasma 
were significantly lowered in rats after administration of the seaweed extract. It was 
shown that the polysaccharide extract had a vascular endothelial cell-protective effect 
in stressed rats [95]. A low-molecular weight alginate extracted from L. japonica was 
shown to decrease systolic blood pressure in hypertensive rats. Rats that had high 
blood pressure displayed increased systolic blood pressure, sodium excretion, serum 
sodium and potassium levels, circulating plasma volume (CPV) and plasma atrial 
aldosterone (ALD) compared to a control group of non-induced rats. Treatment with 
the alginate extract normalised the induced changes. Furthermore, forms of potassium 
that do not contain chloride might offer better cellular entry in exchange for sodium 
and augment anti-hypertension activity [91]. Wakame powder from U. pinnatifida 
(5% w/w in a diet) significantly delayed signs of stroke and the survival rate of salt 
loaded, spontaneously hypertensive stroke-prone (SHRSP) rats [96]. In an early trial 
attempting to decrease sodium intake and increase potassium intake, a group of 
middle-aged patients suffering from mild hypertension were given a seaweed 
preparation (potassium loaded, ion-exchanging, sodium—adsorbing and potassium 
releasing). After four weeks of dietary intervention, there was a significant decrease 
in the mean blood pressure of those taking 12 and 24 g/day of the preparation [97]. 
While hypertension is mainly associated with adults, many studies have tracked blood 
pressure from childhood to adulthood with some showing that the process of 
atherosclerosis begins in childhood. Thus, monitoring blood pressure from an early 
age and appropriate intervention is important in preventing the development of CVD 
in later life. A study undertaken amongst Japanese preschool children examined the 
effect that seaweed intake had on blood pressure levels. Seaweed intake was 





related to diastolic blood pressure in boys suggesting that seaweed as part of the diet 
might have beneficial effects on blood pressure among children [98]. 
Hyperlipidaemia is a major cause of CVDs by bringing about sustained 
endothelial dysfunction and vascular inflammation [99]. A diet of restructured pork 
enriched with Himanthalia elongata fed to rats reduced plasma cholesterol levels in 
test subjects that were supplemented with dietary cholesterol [100]. 
 
1.4.2 The Renin-Angiotensin System. 
The renin-angiotensin system (RAS) is a major regulator of blood pressure and fluid 
homeostasis in the body. Disruption of the RAS system can lead to increased blood 
pressure and the development of cardiovascular disease, chronic kidney disease and 
diabetes [101]. The two key enzymes in the RAS system are renin and angiotensin 
converting enzyme 1 (ACE-1). The inhibition of ACE-1 is a favoured strategy in 
treating hypertension [102] and several synthetic ACE inhibitors (captopril, lisinopril, 
enalapril and fosinopril) are thus used for this reason in the treatment of hypertension 
[103] Despite their effectiveness, synthetic ACE inhibitors are responsible for a 
number of unpleasant side effects such as development of a cough, loss of taste, renal 
impairment, and angioneurotic oedema and as a consequence there has been a trend 
recently to explore and develop more natural inhibitors of ACE activity [89]. Several 
studies have investigated the ACE inhibitory potential of compounds isolated from U. 
pinnatifida. Administration of the U. pinnatifida peptide led to a significant decrease 
in blood pressure in spontaneously hypertensive rats [104, 105]. A cold-water protein 
extract derived from Porphyra columbina (Rhodophyta) has been shown to have 
antihypertensive properties (>35% of ACE inhibition) [106]. C. microphysa pepsin 
digested extracts were determined to have greater ACE inhibitory activity than 
extracts digested with Flavourzyme or Alcalase [86]. Using enzyme hydrolysis, highly 
functional antihypertensive peptides have been produced from Porphyra yezoensis 
(Rhodophyta) Peptides produced under optimal conditions (1.5% substrate, 5% 
alcalase, pH 9.0, temperature of 50 °C and hydrolysis time of 60 min) had high 
antihypertensive activity (55% of ACE inhibition and a low IC50 value of 1.6 g/L 
[107]. A protein hydrolysate from P. palmata with in vitro renin inhibitory properties 





bread to a large degree. The bread containing the hydrolysate also retained the renin 
inhibitory activity following preparation and could represent a new method for the 
delivery of renin inhibitory substances [102]. 
 
1.4.3 Heart Disease. 
Heart attack (myocardial infarction) is the leading cause of death for both sexes across 
the globe. It occurs when there is an insufficient blood supply to the myocardium 
leading to death of the myocardial muscle (ischemia). Prolonged ischemia leads to 
necrosis which is also termed myocardial infarction. Fucoidan from C. okamuranus 
was evaluated in rats where myocardial infarction was induced by isoproterenol, a 
synthetic catecholamine that has been known to cause severe stress in the myocardium. 
Fucoidan reduced the induced myocardial damage and improved the antioxidant 
defense system, reducing oxidative stress [108]. Similarly the pre-treatment of 
isoproterenol induced myocardial injured rats with fucoidan from T. conoides saw a 
significant normalization of the endogenous and exogenous antioxidant defense 
system [109]. Heparin is a widely-used anticoagulant that has unfortunate side effects 
such as bleeding and low platelet count (thrombocytopenia) as well as being 
potentially contaminated with prions and viruses from their animal sources. Fucoidans 
from algal sources are known to have anticoagulant activities and have been proposed 
as an alternative therapeutic treatment. Low and high molecular weight fucoidans were 
tested for their anti-aggregant, anti-coagulation and anti-thrombotic activities. When 
tested in the platelets of humans and rats, the high molecular-weight fucoidan showed 
pro-aggregation activity, whereas the low molecular-weight fucoidan demonstrated an 
inhibitory effect on thrombin induced aggregation, with an IC50 of 8 µg/mL, five-fold 
less than that of commercially available fucoidan or heparin. The inhibitory effects of 
low molecular-weight fucoidan and heparin on thrombin activity were greatly 
enhanced by either antithrombin or heparin cofactor II (HCII). Results indicated that 
low molecular weight fucoidan inhibits thrombin via activation of antithrombin and 
HCII, whereas commercial fucoidan mainly interacts directly with thrombin [110]. 
Other low molecular weight fractions of fucoidan from S. japonica (formerly L. 






1.4.4 Marine Derived Oils and Fatty Acids. 
Omega-3 oils are produced naturally by algae and phytoplankton which are then 
consumed by fish resulting in an accumulation of eicosapentaenoic acid (EPA) and 
docosahexaenoic acid (DHA) in their flesh [112]. Human populations with a high 
consumption of fish have an inverse relationship with coronary heart disease and 
breast cancer. This inverse relationship first came to light from epidemiological 
studies of Inuit and Japanese populations, both of whom have lower incidences of 
CVD and cancer. In their homelands, the traditional diet of both groups contained 
appreciable amounts of fish. As they migrate over time to other areas, they adopt local 
dietary patterns and the incidences of CVD and cancer among them increase to the 
level of the local native people [112]. Fish and marine derived oils such as those from 
seaweed are rich in the omega (ω)-3 oils, eicosapentaenoic acid (EPA; 20:5 ω-3) and 
docosahexaenoic acid (DHA; 22:6 ω-3). Nutritional compositional studies of 
Laminaria sp., U. pinnatifida, Sargassum fusiforme (formerly Hizikia fusiformis) 
(Phaeophyceae) and Porphyra varieties found that they contained high levels of these 
oils [113]. Essential fatty acids play an important role in many biological processes. 
Following absorption from the gut, fatty acids are incorporated into triglycerides, 
phospholipids and cholesterol esters. Phospholipids are needed for the formation of 
cell membranes in every cell in the body. Omega-3 oils are fatty acids that have a 
signature double bond at the third position from the methyl (omega) end of the 
molecule. Such fatty acids cannot be synthesised by humans as the required enzymes 
to introduce a double bond at the correct position are missing. Such oils must be 
ingested as part of the diet [114]. The fluidity of the cell membrane is of great 
importance for receptor function and signaling pathways. The level of fluidity is 
determined in part by the amounts of phospholipids and fatty acids in the membrane 
that have double bonds. Multiple double bonds increase the fluidity of cell membrane 
and may partially account for the health benefits of omega-3 oils in preventing cardiac 
arrhythmias, as well as maintaining neurological function. DHA comprises only 4% 
of the fatty acid contents in the bloodstream but is almost 30% of the fatty acids in the 
phospholipids in the brain and retina, implying an important role in neurological and 
visual function [114]. In the mammalian heart, both DHA and EPA are incorporated 
into the cell membrane of cardiomyocytes, the levels of which can be significantly 





released from myocardial membranes, exert anti-arrhythmic effects by prolonging the 
refractory periods of cardiac action potential. In a study of heart tissue from cadavers, 
levels of omega-3 and omega-6 fatty acids were found not to be associated with 
cardiac mortality. However, their presence in low levels (especially DHA and AA) 
were associated with high mortality in those with a history of coronary heart disease 
[115]. 
Ischemia-reperfusion injuries occur when tissues in the body are deprived of 
oxygen for a short period of time and the resumption of blood flow causes intense 
inflammation [116]. The intake of hydrogen gas has been shown to be an effective 
treatment for Ischemia-reperfusion injuries. Bacteria in the gut can produce hydrogen 
gas and it has been demonstrated that oral administration of mannitol to humans and 
animals can increase its production. Seaweed is a good source of mannitol and 
consumption can have a protective effect [117]. Seaweeds are also a good natural 
source of conjugated fatty acids (CFAs), isomers of PUFAs with a double bond in 
their structure. Dietary CFAs such as conjugated linoleic acids (CLAs) have been 
reported to prevent the onset of essential hypertension in non-obese hypertensive rats 
by regulating the production of physiologically active adipocytokines such as 














1.5 Potential of Seaweed Components to Alleviate Diabetes Mellitus 
and Obesity. 
Diabetes mellitus is a chronic disease where the pancreas does not produce enough 
insulin or when the body cannot use the insulin it produces effectively. Insulin is a 
hormone required for cells to take up glucose from the blood. People with diabetes 
exhibit an altered glucose metabolism [119] The inability to utilize glucose properly 
results in progressive complications in various bodily functions, and affects mineral 
levels in the body[120]. The vast majority of cases of diabetes mellitus present as 
either Type-1 diabetes or Type-2 diabetes, with Type-2 diabetes accounting for 90% 
of reported cases [121]. Since abnormally high or low blood glucose levels can lead 
to chronic cardiovascular problems, chronic renal failure, nerve damage, fainting and 
diabetic coma, people with diabetes must monitor and keep their condition under 
control at all times. Products obtained from nature have a long tradition of use in the 
treatment of diabetes. For example, plants that have high polyphenol content have the 
ability to inhibit the activity of carbohydrate hydrolysing enzymes such as α-amylase 
and α-glucosidase. This has the effect of lowering postprandial levels of glucose [122]. 
Seaweeds contain many components that are believed to be beneficial in the treatment 
of diabetes [123]. 
 
1.5.1 Seaweed-Derived Antioxidants in Treating Diabetes Mellitus. 
In humans, a balance exists between the production of ROS and their inactivation as 
previously discussed. Oxidative stress comes about under certain conditions, such as 
diabetes mellitus, when the balance between production and inactivation is disrupted 
and ROS overwhelms the cell’s antioxidant capabilities. Oxidative stress is reported 
to be the basal cause for the development of insulin resistance, β-cell dysfunction, 
impaired glucose intolerance and full blown type-2 diabetes [124, 125]. Several 
synthetic antioxidants, such as butylated hydroxyanisol (BHA), butylated hydroxytoluene 
(BHT) and tert-butylhydroquinone (TBHQ) are available commercially but their use 
is now being restricted due to adverse side effects, including the promotion of 
cancerous cells [126]. Because of this, interest in using naturally obtained antioxidants 





rich source of antioxidant compounds as previously discussed. Pigments such as 
fucoxanthin and astaxanthin, and polyphenolic compounds such as phenolic acid, 
flavonoid, and tannins have all exhibited antioxidant abilities [119]. Polyphenolic 
compounds can act as scavengers of ROS. However fundamental differences exist 
between the polyphenols produced by land plants and those produced by their marine 
counterpoints. This makes marine derived polyphenols a promising new target source 
for phenolic compounds that could be used as lead drugs in the pharmaceutical 
industry [124]. Edible seaweeds are a good source of polyphenols and by being able 
to modulate glucose-induced oxidative stress. Polyphenols are suggested to have anti-
diabetic activity. 
When extracting any potentially useful compound(s) from a source, it is important 
to remember that the profile of the extract is dependent on the profile of the solvent or 
solvents used. For example, ethanol and methanol can break down the plant cell walls 
more efficiently and are believed to be more effective at extracting antioxidant 
compounds from seaweeds than water [128]. The T. conoides showed higher total 
phenolic content (TPC) when developed as an extract in methanol, when compared to 
diethyl ether extract [129]. The brown seaweed Tubinaria ornata (Phaeophyceae) has 
demonstrated superoxide scavenging activity which may be effective in reducing the 
level of O2 that is elevated during oxidative stress in the body. The presence of 
phenolic compounds suggests that the antioxidant activity might be due to them [130]. 
Methanol extracts from E. cava containing high levels of polyphenol and strong ROS 
scavenging ability significantly reduced blood glucose levels and increased insulin 
concentration when fed to type-1 diabetic rats. Blood alanine transaminase (ALT) 
levels were dramatically reduced to near normal levels. Increased levels of ALT in 
serum are often associated with health problems such as diabetes and liver damage. 
The anti-diabetic effect appears to be at least partly mediated by the activation of both 
the AMP-activated protein kinase/ACC and the Pl-3 kinase/Akt signal pathways 
[131]. The addition of edible seaweeds to foodstuffs may provide a useful method of 
enhancing their anti-diabetic qualities. Added H. elongata, U. pinnatifida and Porhyra 
umbilicalis (Rhodophyta) served as a source of soluble polyphenolic compounds in 
low salt meat emulsion model systems and increased the antioxidant capacity of the 
meat. The increased antioxidant load of the samples leads to greater stability during 





found to contain high amounts of phenolic compounds and exhibited strong 
antioxidant activity, these include Sargassum swartzii (formerly Sargassum wightii) 
[126]; Fucus serratus (Phaeophyceae) and F. vesiculosus [133]. 
 
1.5.2 Controlling Glucose Levels in the Blood. 
High levels of glucose in the blood following carbohydrate ingestion have an 
important role in the development of type-2 diabetes as well as in complications that 
rise from the disease. The control of postprandial hyperglycemia is of great importance 
in the treatment of diabetes and the prevention of cardiovascular complications. One 
avenue of treatment is to prevent the absorption of glucose by inhibiting carbohydrate-
hydrolysing enzymes such as α-amylase and α-glucosidase. Synthetic inhibitors of α-
amylase and α-glucosidase such as miglitol, voglibose and acarbose are designed to 
sharply reduce the blood sugar level that spikes after meals. The use of these however 
has several undesirable side effects such as flatulence, abdominal cramps, vomiting 
and diarrhoea. It has been suggested that adverse side effects are caused by excessive 
inhibition of pancreatic α-amylase and the delay of carbohydrate digestion. When 
undigested carbohydrates and other matter enters the colon, they give rise to increased 
bacterial fermentation and subsequently [134]. 
Seaweeds are known to have the ability to inhibit starch digestive enzymes and 
are an underexplored source of enzymatic inhibitors for use in the treatment of diabetes 
[135, 136]. A study investigating the α-amylase and α-glucosidase inhibitory effects 
of fifteen Irish seaweeds found that cold-water and ethanol extracts of A. nodosum had 
a strong α-amylase inhibitory effect while extracts of F. vesiculosus exhibited potent 
inhibition of α-glucosidase. The recorded effects of the extracts were associated with 
phenolic content and antioxidant activity [137]. The phenol rich extracts of A. 
nodosum collected from UK waters have also been shown to inhibit α-amylase activity 
to some extent. In a study conducted with samples of A. nodosum, P. palmata and 
Alaria esculenta (Phaeophyceae), the A. nodosum extracts were found to be the most 
active of the three seaweeds. The same extracts were also able to inhibit the activity 
of α-glucosidase at low levels. Following fractionation of the A. nodosum extracts, it 
was found that the inhibitory activity was concentrated in the phlorotannin rich 





eaten by predatory species such as molluscs and they have been shown to potently 
inhibit the digestive glycosidases of marine snails [138]. Two bromophenols (2,4,6-
tribromophenol and 2,4-dibromophenol) isolated and purified from the red seaweed 
Grateloupia elliptica (Rhodophyta) were found to have high α-glucosidase inhibitory 
activity. In addition, both compounds mildly inhibited rat-intestinal sucrase and rat-
intestinal maltase. Both sucrase and maltase are similar in activity to α-glucosidase in 
so much as they break down sucrose and maltose to glucose. The authors of this study 
concluded that the bromophenols of G. elliptica have potential as natural 
nutraceuticals to manage diabetes mellitus [17]. Acetone crude extracts from S. 
schroederi and Caulerpa racemose (Chlorophyta) both inhibited α-amylase activity 
[139]. Dieckol isolated from E. cava showed pronounced α-amylase and α-glucosidase 
inhibition displaying higher activity than that of acarbose. Postprandial blood glucose 
levels in streptozotocin induced diabetic mice were also seen to be significantly 
suppressed [136]. Diphlorethohydroxyycarmalol (DPHC) isolated from Ishige 
okamurae (Phaeophyceae) showed strong inhibition of α-amylase and α-glucosidase 
without having any toxic effects on human umbilical vein endothelial cells (HUVECs) 
at various concentrations. In induced diabetic mice, extracts of Petalonia binghamiae 
(Phaeophyceae) (PBE) have been demonstrated to have anti-diabetic properties. 
Treatment with extract resulted in reduced blood glucose levels in diabetic mice and 
there was an improved tolerance to glucose [140]. Ethanol extracts from Ulva rigida 
(Chlorophyta) have been shown to have strong anti-hyperglycemic and antigenotoxic 
effects in diabetic mice [141]. 
 
1.5.3 Other Anti-Diabetic Activities. 
Numerous studies indicate that a diet enriched with whole, unprocessed plant foods 
that are abundant in phytochemicals may be of benefit for metabolic disorders such as 
diabetes. Obese mice supplemented with an U. pinnatifida ethanol extract showed 
significantly reduced amount of visceral fat, adipocyte size, fasting blood glucose 
concentration and plasma insulin after nine weeks compared to the high fat fed control 
group. Results indicated that insulin resistance and hepatic fat build-up can be 
prevented by modulating the hepatic glucose and lipid homeostasis in the high fat 





to have an improved blood glucose level and a lower level of blood glycosylated 
haemoglobin when compared to non-diabetic control mice. Data suggested that the I. 
okamurae extract lowered blood glucose levels by altering the activity of enzymes 
involved in glucose metabolism in the liver and by improving insulin resistance [143]. 
Dietary fibre present in seaweed such as alginates may reduce glycemic disturbances 
associated with obesity when included in the diet. A study involving forty self-
reporting healthy males looked at the glycemic response to a controlled test lunch of 
varied composition following ingestion of an ionic-gelling alginate drink. It was seen 
that the alginate drink was able to attenuate the glycemic response following 
consumption of the test lunch [144]. 
One severe consequence of diabetes is the development of hyperglycemia-
induced diabetic retinopathy (DR), a prevalent cause of blindness in many countries. 
LMWF from brown algae is known to demonstrate multiple biological activities (anti-
inflammation, anti-oxidation, and anti-aggregation) which could be of benefit in 
treating ischemic disorders such as diabetic retinopathy. Calcium dobesilate is a strong 
antioxidant that is a current treatment for this condition. Mice with streptozotocin-
induced diabetes were fed a diet containing LMWF (50, 100, or 200 mg/kg/day) or 
calcium dobesilate (50, 100, or, 200 mg/kg/day) for four months to examine the 
protective role of the LMWF against the development of diabetic retinopathy, the 
production of high glucose-promoted vascular endothelial growth factor (VEGF) and 
the proliferation of cells in microvascular endothelial cells. The LMWF alleviated 




Obesity is considered the gateway condition for several chronic diseases and is a major 
factor in the development of high blood pressure, type-2 diabetes, cardiovascular 
disease, and several types of cancer [146]. Obesity in children has been described as 
the most important health challenge of the 21st century, with the concern being that 
those individuals that are obese during their youth are likely to remain obese through 
to their adult life and as a result are more likely to develop cardiovascular diseases, 





reduce the amount of food and calories consumed. A reduction in casual snacking 
between meals and in portion size would have a major impact on obesity levels [148]. 
Satiety is an important factor in regulating the amount of food that people consume 
and has a great importance in public health as a means of controlling obesity. Satiety 
or the feeling of fullness implies that there is a cessation of hunger as a consequence 
of consuming food. This is due to many factors including energy density, weight and 
volume, macronutrient composition, particle size, appearance of the food, satisfaction 
upon eating it and palatability [149]. Dietary alginates can slow down the rate that 
nutrients are absorbed into the gut and promote satiety both of which are of 
consequence in controlling obesity and type-2 diabetes. Following ingestion, alginate 
formulations react with gastric acid and undergo ionic gelation in the stomach to 
produce a gel that can reduce the rate of gastric emptying, stimulate gastric stretch 
receptors, reduce the uptake of nutrients and influence the glycaemic response after 
meals [150]. A human intervention study, investigating different alginate solutions 
intended for use as dietary supplements to enhance satiety and limit energy intake in 
humans, found that consumption of a formulation with a low ratio of mannuronic acid 
to guluronic acid resulted in a decrease in self-perceived capacity for food intake and 
increased sensation of fullness [151]. Researchers in Korea found that the intake of 
oily foods and seaweed were among the factors associated with a higher risk of 
developing metabolic syndrome. However, data from animal studies have suggested 
that seaweed intake may be protective against weight gain. Another study by Maeda 
and colleagues found that mice fed a diet containing fucoxanthin resulted in 
significantly reduced (p>0.05) levels of abdominal white adipose tissue, blood glucose 
levels and insulin concentration [152]. Obesity can be characterised by an excessive 
deposition of fat with functional and morphological changes in adipocytes. The cell 
line 3T3-L1 is a preadipocyte cell line used in the study of adipogenesis. It has been 
shown that fucoxanthin enhances differentiation at an early stage but subsequently 
inhibits differentiation at the intermediate and late stages. Fucoxanthin also inhibited 
the uptake of glucose in mature 3T3-L1 adipocytes by reducing the phosphorylation 
of IRS-1 [131]. Fucoidan from the sporophyll of U. pinnatifida was investigated for 
anti-obesity potential through the inhibition of cytokines associated with 
inflammation. The presence of fucoidan significantly suppressed proliferator—





of inflammatory-related genes in 3T3-L1 adipocytes during adipogenesis. Fucoidan 
also reduced the synthesis of ROS and the build-up of lipids in the cells [153]. F. 
vesiculosus has been claimed to be a useful agent for the management of obesity. F. 
vesiculosus contains large amounts of iodine which is believed to stimulate the thyroid 
gland and have a subsequent effect on the metabolic rate. The presence of high levels 
























1.6 Dietary Fibre, Seaweed Polysaccharides and Prebiotics. 
 
1.6.1 Dietary Fibre. 
The main risk factors for NCDs for individuals are well known and are similar around 
the globe. Excess use of tobacco, harmful consumption of alcohol, low levels of 
physical activity and foods high in saturated trans fats, salts, and sugar account for 
two-thirds of all new cases of NCDs (Figure 5). In fact, the consumption of foods high 
in saturated and industrially produced trans fats, salt, and sugar is the cause of 40% of 
all deaths from NCDs [155]. A healthy diet coincides with lower incidence rates of 
CVD and other chronic diseases [156]. The dietary composition of humans has 
evolved greatly since the industrial revolution of the 18th and 19th centuries. Refined 
grains, meats, added fats and sugars have become more commonplace on the dinner 
table while the quantity of vegetables and fibre in our diets is reduced. This change in 
human nutrition, coupled with a more sedentary lifestyle is largely responsible for the 
increased level of obesity and other related chronic disease seen throughout the world 
today. Early humans had a predominantly plant based diet, similar to what modern 
apes live on today. This diet was high in fibre and low in sugar and, based on current 
dietary guidelines, would be expected to impart low serum cholesterol levels. Due to 
our close genetic relationship with modern apes, it is thought that the drastic changes 
in dietary habits that have taken place in the last two hundred years may help to explain 
our present day problems with chronic illnesses such as type 2-diabetes, obesity and 
heart disease [157]. Seaweeds are a good source of minerals and nutrients that are 
important for many biochemical reactions They are also rich in non-nutrient 
components such as dietary fibre and polyphenols [158]. Fibre is a generic term used 
to describe a broad family of carbohydrates found in plant cell walls. They are 
typically classified into three groups; soluble fibres (e.g., pectin and gums), insoluble 
fibres (e.g., cellulose) and mixed type fibre (e.g., brans). Generally, dietary fibres  
share the common characteristic that they are resistant to degradation by endogenous 
digestive tract enzymes, but can be broken down and fermented by the gut microbiota 
[159]. The definition of dietary fibre first appeared in 1953 in the context of describing 
the food components from plant cell walls. The current definition was suggested by 





ten or more monomeric units, which are not hydrolysed by the endogenous enzymes 
in the small intestine of humans and belongs to the following categories [160]. 
The chemical and physical properties of dietary fibre largely dictate its 
physiological effects. Soluble dietary fibres swell in the stomach and increase the 
density of the stomach content, hindering the absorption of nutrients in the intestinal 
mucosa. This effect can be beneficial in controlling non-insulin dependent diabetes as 
it causes a decrease in blood glucose and insulin responses after meals. Also an 
increased sense of satiety or fullness after eating may be useful in the treatment of 
obesity and the prevention of obesity-linked chronic diseases [161]. Seaweed 
polysaccharides are mainly found in their cell wall where they confer strength and 
flexibility to the plant as well as maintaining the cells internal ionic balance preventing 
desiccation [162]. The complexity of seaweed structural polysaccharides, such as agar 
(red seaweeds) and alginates (brown seaweeds) make them resistant to degradation by 
human digestive enzymes and therefore available for fermentation by the gut 
microbiota in the colon. As such they can be regarded as a source of dietary fibre. The 
dietary fibre content of seaweed can range from 33% to 75% with the soluble fraction 
consisting of as much as 50%–80% of total dietary fibre content [18]. In general, 
seaweed polysaccharides are hydrophilic, often water soluble and are known to 
establish intra-chain hydrogen bond networks making them rigid and stiff and ideal 
for use as thickeners. Seaweed polysaccharides also promote interactions with external 
ions and inter chain hydrogen bonding making them useful as gelling agents [162]. 
Dietary fibre obtained from seaweed differs in composition, chemical structure, 
physio-chemical properties and biological effects from terrestrially derived fibre 
sources [163]. In this regard, structural polysaccharides from brown seaweeds, such 
as laminarin and fucoidan could offer a dietary means to modulate the gut microbiota 










Figure 1.5 The major modifiable risk factors for the development of a chronic non-communicable 





There has been an increase in interest over the last two decades in the adjustment of 
the composition of the gut microbiota to confer a health benefit upon the host (human 
or animal). One such area of research is of prebiotics. The prebiotic definition is 
constantly evolving as more information comes forth concerning the role of the gut 
microbiota in maintaining and promoting good health. The most recent definition of a 
dietary prebiotic is: “A substrate that is selectively utilized by host microorganisms 
conferring a health benefit” [165]. To be classified as prebiotic, several characteristics 
must first be met. The putative prebiotic must be able to resist digestion in the upper 
GIT, be selective in its stimulation of beneficial bacteria in the gut resulting in change 
in the profile of the microbiota and it must induce luminal or systemic effects that are 
beneficial to the health of the host [162]. Among the postulated health benefits of 
prebiotics for chronic conditions are: anti-colon cancer properties, osteoporosis 
management, improved bowel function, lipid lowering action, beneficial for 
cardiovascular disease associated with dyslipidemia and insulin resistance, obesity and 
possible type-2 diabetes. Seaweed derived polysaccharides (hydrocolloids) are 
potentially an important new source of prebiotics [166]. 
Bifidobacterium are well known for their ability to degrade complex 
carbohydrates in the colon and they are a common target for prebiotic ingredients. As 
a result, their genomes contain a relatively high number of genes (~8% of total 





other commensal bacterial genomes [167]. For a recent review on carbohydrate 
metabolism of the Bifidobacteria see Pokusaeva et al. [168]. Prebiotics have been 
found to be of benefit in chronic inflammatory bowel disease in transgenic rats by 
preventing the development of colitis. The protective effect was seen in association 
with an increase in the number of intestinal Bifidobacterium and Lactobacillus [169]. 
An investigation by [170] looked at the effects of supplying diets containing seaweed 
derived laminarin and fucoidan to growing pigs. During their weaning phase, pigs are 
susceptible to carrying Salmonella typhimurium and other pathogens. It was found that 
such a supplemented diet resulted in an increase in Lactobacillus numbers in the 
caecum and an increase of butyric acid in the caecum and colon. Increased shedding 
of faecal S. typhimurium at selected time points during the experiment was also 
recorded. A recent study by Ramnani et al. [18], investigated the prebiotic and 
fermentation potential of low molecular weight polysaccharides (LMWP) derived 
from agar and alginate using pH and temperature controlled anaerobic batch cultures 
that were inoculated with human faecal matter. Fluorescent in-situ hybridization 
(FISH) was used to monitor changes in microbial composition and gas 
chromatography was utilised to monitor the fermentation end products, short chain 
fatty acids. It was found that the LWMP derived from Gelidium spp. showed a 
significant increase in bifidobacteria populations from log10 8.06 at 0 h to log10 8.55 
at 24 h. 
Alginates from seaweed have also been used as an encapsulation agent for the 
delivery of probiotics. Alginates are non-toxic, biocompatible, inexpensive to obtain 
and are easily solubilised in the human intestine facilitating the release of their 
entrapped cells [171]. Magnesium is in abundant supply in fibre-rich foods such as 
seaweed. In animal trials, the intake of magnesium supplements prevented a drop-in 
resistance to insulin or glucose intolerance and postponed the development of 
spontaneous diabetes mellitus. Results from human trials show that dietary fibre or 
fibre rich foods can improve the after meal glycemic response, most likely due to lower 
rates of glucose absorption and increased utilization of glucose in the gut. The effect 
of magnesium and fibre intake on the development of diabetes in 1604 healthy subjects 
aged above 30 was assessed [172]. A total of 141 diabetes incidents were recorded 
during the follow-up period and it was concluded from the dietary intake information 





both was associated with a higher risk of diabetes in the test population. The cell walls 
of some species of red seaweed contain the linear polymer agarose. The enzyme α-
agarase can hydrolyse the α-1,3 linkage to produce agaro-oligosaccharide (AOS) 
while β-agarase works on the β-1,4 linkage yielding neoagaro-oligosaccharide 
(NAOS). NAOS was seen to be highly resistant to the enzymes of the upper GIT. 
NAOS significantly stimulated the growth of bifidobacteria and lactobacilli in MRS 
medium, compared with fructooligosaccharide (FOS), 1% (w/v) NAOS significantly 
promoted the specific growth rate of beneficial bacteria by approximately 100%. In 
vivo, NAOS significantly increased the numbers of lactobacilli and bifidobacteria (p 
< 0.05) in fresh feces or cecal content while reducing putrefactive microorganisms. 
NAOS with higher degrees of polymerization (DP) showed better prebiotic activity 
[173]. 
 
1.6.3 Production of Short Chain Fatty Acids (SCFA) by Colonic Bacteria and 
Health Benefits in Chronic Diseases. 
Metabolites of bacterial metabolism are affected by the different types of food that we 
eat and by the subsequent production of bacterial enzymes such as β-glucuronidase, 
β-glucosidase, mucinase and urease. Through their action, the intestinal lumen can be 
exposed to detrimental toxic, carcinogenic or mutagenic substances. By changing the 
substrates that are made available in the gut, and favouring the production of beneficial 
metabolites such as short chain fatty acids (SCFA), a healthier environment can be 
established [174]. For example, the anaerobic microbial communities that inhabit the 
mammalian gastrointestinal tract produce SCFA (acetic acid (acetate), butyric acid 
(butyrate) and propionic acid (propionate)) as their main non-gaseous dietary fibre 
fermentation end products [175]. SCFAs can impart several health benefits on the host 
and the intake of seaweed can alter the SCFA production profile of the microbiota 
(Figure 6). Propionate has been shown to: lower the fatty acid content in the liver and 
in plasma, reduce the amount of food eaten at meals, demonstrate immunosuppressive 
activity and help tissue sensitivity to insulin, all of which can be of benefit in the 
treatment and prevention of obesity and type-2 diabetes [176]. Butyric acid is a 
preferred substrate for colonocytes and appears to promote a normal phenotype in 





for colorectal cancer[178] while acetate has been shown to increase colonic blood flow 
and enhance ileal motility [179]. 
When healthy Wister rats were fed the red seaweed Mastocarpus stellatus 
(Rhodophyta) (10% algal supplemented diet) an increase in the molar concentration 
of both acetate and propionate was seen while butyrate molar concentrations 
decreased. There was also a decrease in the total levels of SCFA produced between 
the algal treated group and the basal diet control group as well as an increase in caecal 
pH [180]. Work has been carried out to evaluate the effect of seaweed derived 
laminarin and fucoidan on different indices of GIT fermentation in newly weaned pigs. 
Regarding the production of the three main SCFAs, the addition of laminarin to pigs’ 
diet led to a significant increase in the concentration of acetic acid and a significant 
decrease in that of propionic acid in the caecum. The addition of fucoidan to their diet 
significantly increased acetic acid concentration and decreased the concentration of 
propionic acid in the same regions. Fucoidan also significantly increased butyric acid 
concentrations in both the caecum and the colon [170]. A study involving the in vitro 
fermentation of ten LMWP derived from agar and alginate from seaweed (Gracilaria 
spp. Gelidium corneum (formerly G. sesquipedale) (Rhodophyta) and A. nodosum) 
showed that the LMWPs caused a significant increase in total SCFA levels, especially 

















Figure 1.6 Putative health benefits of the main short chain fatty acids (SCFAs), acetic acid, 
propionic acid and N-butyric acid. SCFA are mainly produced by the endogenous gut 




1.6.4 Potential of Seaweed Components to Alleviate Respiratory Diseases and 
Allergies. 
Asthma is a complex inflammatory disease of the lungs characterised by variable 
airflow obstruction, airway hyper-responsiveness (AHR), and airway inflammation. 
The inflammatory response is characterised by infiltration of the airway wall by mast 
cells, lymphocytes and eosinophils and is associated with several inflammatory 
proteins, including cytokines, enzyme and adhesion molecules in the airway [181]. It 
is estimated that some 235 million people currently suffer from asthma, but it is likely 
that asthma is both under-diagnosed and undertreated worldwide. Asthma is the most 
common chronic disease affecting children. The fundamental cause of asthma is not 
completely known, but the use of medication and the avoidance of certain 
environments and triggers can reduce the severity of the condition. Triggers include 
indoor allergens such as dust mites, and pet dander; outdoor allergens like pollen and 
moulds; tobacco smoke; chemical irritants in the workplace and air pollution. 






Polyphenolic extracts from the edible Chondrophycus undulatus (formerly known 
as Laurencia undulata) (Rhodophyta) have been shown to possess therapeutic 
potential for combating bronchial asthma associated with allergic diseases. Mice 
sensitised and challenged with ovalbumin (OVA) showed typical asthma symptoms 
as follows: an increase in the number of eosinophils in the bronchoalveolar lavage 
(BAL) fluid; a marked influx of inflammatory cells into the lung around blood vessels 
and airways, and airway luminal narrowing; airway hyper-responsiveness; detection 
of TNF-α and TH2 cytokines in the BAL fluid; and detection of allergen specific IgE 
in the serum. Intraperitoneal treatment of L. undulata extracts before the last airway 
OVA challenge resulted in significant inhibition of all asthmatic reactions [181]. 
Previously, extracts from the E. cava were also seen to be effective in relieving asthma 
symptoms in sensitised mice challenged with OVA by inhibiting the TH2 response 
[183]. 
Allergic diseases affect approximately one third of the general population. They 
are caused by chemical or immunological activation of mast cells leading to massive 
release of endogenous mediators such as histamine and a wide variety of inflammatory 
mediators such as eicosanoids, proteoglycans, proteases and several pro-inflammatory 
and chemotactic cytokines such as TNF-α, interleukin (IL-6, IL-4, IL-13). Preventing 
immune cells from degranulating is one of the crucial steps in preventing an allergic 
disorder. Two phlorotannins isolated from E. cava, 6,6′-bieckol and 1-(3′,5′-
dihydroxyphenoxy)-7-(2″,4″,6-trihydroxyphenoxy)-2,4,9-trihydroxydibenzo-1, 4-
dioxin were found to exhibit anti-allergic activities. The proposed mechanism of 
activity was that the seaweed compounds prevented degranulation by suppressing the 
binding of IgE and the FcεR receptor [184]. Allergic rhinitis (hay fever) is an 
inflammatory nasal disorder that involves activation and tissue recruitment of both 
structural cells and infiltrating leukocytes [185]. In a study to investigate a possible 
protective effect of the traditional Japanese diet on allergic disorders, it was observed 
that a high dietary intake of seaweed may be associated with a decreased prevalence 
of allergic rhinitis (hay fever) [186]. A high serum IgE concentration is a defining 
characteristic of atopic diseases such as atopic asthma and allergic rhinitis, with levels 
correlating with the extent and severity of the disease. Fucoidan from seaweed has 













Dealing with a chronic illness on a day to day basis is a fact of life for an ever-
increasing proportion of the world’s population. This is an unfortunate knock-on effect 
of extended human longevity and a decrease in incidence rates of infectious disease. 
The most important preventive measure one can take to avoid developing a chronic, 
non-communicable disease is to modify diet and lifestyle factors. It is well 
documented that excessive use of tobacco and alcoholic beverages, not being 
physically active or eating unhealthily will greatly increase an individual’s chances of 
developing an NCD. However, for millions of people already suffering from chronic 
illness, simply avoiding risk factors is no longer an option. As the incidences of NCDs 
rise in the years to come, the burden on the world’s health care services will also 
increase. New therapies will be sought out to provide better care and more economical 
services for long term patients. The emphasis up until now has been in searching the 
terrestrial regions of the planet for new drugs and bioactives. However, to face the new 
challenges of the future, new environments must be explored. The surface of the Earth 
is over 70% water and within the marine environments (the oceans, seas, rivers and 
lakes) of the planet, there exists an immense quantity of biological diversity with 
untapped potential. Seaweeds are a common sight along the coastal regions of the 
world. These marine plants have a long tradition of diverse use by mankind having 
been used for centuries in food preparation and traditional medicine. It is only in 
relatively recent times that the scientific community has developed the capabilities to 
better understand the health benefits of seaweeds that our ancestors knew of 
anecdotally. Indeed, the literature presented here clearly demonstrates the plethora of 
novel bioactives that seaweeds have to offer. While much of the research heralds the 
therapeutic effects from in vitro studies, the way has been laid to assess their efficacy 
in vivo through extensive animal trials and human clinical studies. In conclusion, there 
is little doubt that the fight to control the rise of chronic, NCDs will be a major 
challenge in the 21st century, but it is not an insurmountable one. The further 
education of current and future generations in making positive healthy lifestyle 
choices along with increased scientific research into the underlying causes of chronic 
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Seaweeds represent an underutilized reservoir of bioactive compounds that can be 
used in several diverse industries. They are highly bioactive, rich in non-digestible 
polysaccharides and have high fibre content. In addition, seaweeds have been 
suggested as a possible source of prebiotics. A prebiotic is a substrate that is selectively 
utilized by host microorganisms conferring a health benefit. They are resistant to 
hydrolysis by mammalian gut enzymes and pass through to the gastrointestinal tract 
intact until they reach the colon. Here, they become available to the colonic microbiota 
as fermentable substrates. Among the known beneficial bacterial species of the 
microbiota is Bifidobacterium, which is a major target for prebiotics. The aim of this 
study was to investigate the bifidogenic potential of fifteen extracts derived from Irish 
seaweed species using an in vitro anaerobic fermentation approach as follows. An 
initial screen comprising five different Bifidobacterium species (B. breve APC 325 
NCBF 8807, B. animalis subspecies lactis Bb12 (APC 326), B. longum subspecies 
longum APC 422 DPC 6205, B. bifidum DPC 6034, B. longum subspecies infantis 
DPC 6036) representing the major Bifidobacterium species found in the mammalian 
gut, was used to test the ability of these beneficial microbes to utilise seaweed extracts 
as their sole carbon source for growth. In comparison with the control, an extract 
concentration of 2.5 mg/ml, eleven seaweeds (eight brown seaweeds and three red 
seaweeds) significantly (p<0.05) stimulated at least one of the Bifidobacterium strains 
at both time points (t= 20 h and 28 h), as measured through readings of optical density 
(OD600nm). One extract, Fucus serratus, significantly stimulated the growth of four 
of the five Bifidobacterium strains at both time points. Further evaluation of the F. 
serratus extract at concentrations of 1.25 mg/ml and 0.625 mg/ml respectively also 
showed significant (p<0.05) stimulation of growth of B. breve, B. lactis and B. longum. 
Furthermore, appreciable levels of phenolic compounds were observed in several of 
the seaweed extractions including F. serratus. High-levels of such compounds are 
known to have antimicrobial activity and may explain an inhibitory effect observed 
with the F. serratus extract at a concentration of 2.5 mg/ml. The results of this study 
indicate that seaweed extracts have potential as good candidates for further prebiotic 






Seaweeds belong to a rather ill-defined assemblage of marine plants known as algae. 
The term ‘seaweed’ itself does not have any taxonomic value, but is rather a popular 
term used to describe large attached (benthic) marine plants found in the groups that 
are referred to as the brown seaweeds (phylum Ochrophyta, class Phaeophyceae), the 
red seaweed (phylum Rhodophyta) and the green seaweeds (phylum Chlorophyta). To 
date, about 6000 species of seaweeds have been identified. [2]. The brown and red 
seaweeds are almost exclusively located in marine environments while most green 
seaweed species are found in freshwater systems or on land. The predominant 
colouring of brown seaweed species derives from the dominance of the xanthophyll 
pigment fucoxanthin which masks other pigments that might be present. Red seaweeds 
are so coloured because of the presence of phycoerythrin, a pigment which absorbs 
blue light and reflects red, while the presence of chlorophyll a and b gives green 
seaweeds their distinctive colouring. Seaweeds are well regarded as a healthy food 
option as they are rich in polysaccharides, vitamins, minerals and polyunsaturated 
fatty acids (PUFAs) while also having a low lipid content [3]. Several countries of the 
Far East, especially China, Japan and Korea, have a strong tradition of seaweed 
consumption that stretches back several centuries. In the west, seaweed usage has 
mainly been limited to be a source of hydrocolloids. Recently however, an increasing 
number of people in western countries have begun consuming different seaweeds for 
their health benefits and nutritive value. Ireland boasts a remarkably high proportion 
of the marine algae found in the entire Atlantic basin, considering the size of the island. 
Ireland and Great Britain are in the temperate zone of the NE Atlantic which is an 
important biogeographic transitional area. The littoral and shallow sublittoral regions 
of these islands support over 650 seaweed species. This represents approximately 50% 
of the North Atlantics and 7% of the world’s documented seaweed species [4]. Brown 
seaweed is reported as a major marine bio-resource in the north Atlantic waters around 
Ireland and the UK. Fermentative biomethane production from seaweed via anaerobic 
digestion may be exploited soon as an attractive alternative to current energy sources. 
Ireland is one of the largest producers of seaweed in Europe with 13% of the total 
European harvest being collected here. This harvest in dominated by Ascophyllum 
nodosum (ca. 30,000 tonnes per year) and is mainly collected along the north-west 





The microbiota of a healthy individual is a highly diverse, and relatively stable 
community of microorganisms that is comprised of tens of trillions of members with 
thousands of species-level phylogenetic-types [6]. The human microbiota is rich at the 
species phylogenetic level, but somewhat limited in terms of the phylum level of 
diversity. The most commonly represented bacterial phyla in healthy adults are 
Firmicutes and Bacteroidetes, with significant numbers of Actinobacteria and 
Proteobacteria members also present [7]. Numerically, members of the microbiota 
outnumber the eukaryotic cells of the body by a factor of ten.  Combined, they encode 
3.3 million genes which code for a large spectrum of enzymatic activities in the gut 
environment including catabolic enzymes necessary for complex carbohydrate 
breakdown [8]. The microbiota is established after birth, with facultative anaerobic 
bacteria such as E. coli being among the first colonisers of the gut. As initial oxygen 
levels diminish, a dynamic anaerobic ecosystem is created in the gut where 
Bifidobacterium and other strictly anaerobic microbes such as Clostridium and 
Bacteroides dominate [9]. The genus Bifidobacterium is a member of the family 
Bifidobacteriaceae and the phylum Actinobacteria. They were first isolated from the 
faeces of a breast-fed infant by Tissier in 1899, and were then named Bacillus bifidus 
[10]. They are one of the main beneficial species of the microbiota and are among the 
most frequently used microorganisms in functional foods and dietary supplements. As 
such, they are major targets for both prebiotic and probiotic studies [11]. 
Bifidobacteria dominate the gut bacterial population in healthy breast-fed babies, 
although levels decrease following weaning. For adults, bifidobacterial population 
levels stabilise at around 3-6% of the total gut microbial population. As people age 
(>65 years), bifidobacterial numbers usually decline [12]. They are anaerobic, Gram-
positive, non-motile, and nonsporulating irregular or branched fermentative rod 
bacteria. Traditionally, Bifidobacterium was considered a member of the lactic acid 
bacteria. However, as the mol% G+C content of its DNA is high and ranges between 
55% and 64% it is now included in the Actinobacteria phylum [13]. Bifidobacteria 
have the ability to utilise different types of complex carbohydrates found in the diet 
that are not hydrolysed in the gut by the endogenous enzymes present [14]. 
A prebiotic is a substrate that is selectively utilized by host microorganisms 
conferring a health benefit [15]. Prebiotics have emerged as food ingredients with 





(bifidobacteria/lactobacilli) and the production of the short-chain fatty acids, acetate, 
propionate and butyrate [16]. Prebiotics are commonly found in, or extracted from, 
fruits, cereal, and vegetables and are also present in human milk and colostrum. 
Candidate prebiotics include inulin-type fructans (ITF), fructooligosaccharide (FOS) 
and galactooligosaccharide (GOS). These compounds are predominately fermented in 
the proximal colon where the microbiota is known to have a saccharolytic metabolism 
[17]. It has been suggested that prebiotic intake may have numerous health benefits in 
humans such as: a reduction in the prevalence and duration of infectious and antibiotic-
associated diarrhea; a reduction in inflammation and symptoms associated with 
inflammatory bowel disease; exertion of a protective effect to prevent colon cancer; 
the enhancement of bioavailability and uptake of minerals; a reduction of some risk 
factors for cardiovascular disease and the promotion of satiety, weight loss and the 
prevention of obesity [18]. Linear chained ITF prebiotics have consistently shown 
stimulatory effects on bifidobacterial populations along with an associated increase in 
saccharolytic fermentations resulting in SCFAs in both human and animal studies.  
[16]. The ability to utilize complex dietary and host glycans is central to the survival 
of prominent members of the gut microbiota. Dietary fruit, vegetables and cereals 
serve to provide readily digestible carbohydrates as well as dietary fibres (DFs) that 
resist both degradation and absorption in the small intestine. The bulk of DF consists 
of plant cell wall polysaccharides and resistant starch. These polysaccharides comprise 
structurally diverse sugar moieties linked by glycosidic bonds that form chains and 
branches. Remarkably, the human genome encodes, at most, only 17 enzymes for the 
digestion of food glycans, specifically starch, sucrose and lactose [7]. In comparison, 
more than 8% of the bifidobacterial genome is dedicated to carbohydrate metabolism 
[19]. Complex carbohydrates (oligo and polysaccharides) can both be degraded by 
several different enzymes produced by bifidobacteria. The fermenting activity of β-
galactosidase, an example of a glycosyl hydrolase, is of high significance for 
bifidobacteria, as it ensures their growth in milk and dairy substrates containing β-
galactoside bonds, including lactose [20]. 
Seaweeds have been linked with several positive effects in the human body, 
such as decreasing ammonia absorption, immune modulation, possible anti-metastatic 
activity, and increased short chain fatty acid (SCFA) production, and it has been 





active components [17]. Seaweeds contain large quantities of complex carbohydrates 
that pass through the mammalian digestive system intact when ingested. Brown 
seaweeds mainly contain fucoidan, laminarin, cellulose, alginates and mannitol while 
red species of seaweed consist of starch, cellulose, xylan and mannan [21]. The cell 
walls of red seaweeds consists of polysaccharides such as agar, cellulose, xylan, 
mannan and carrageenan, while the cell walls of green seaweeds contain cellulose, 
mannose and xylan [22]. Different polysaccharides produced by seaweeds are used 
extensively in food, pharmaceuticals and other products for human consumption [23]. 
Most seaweed polysaccharides are non-digestible in the human gut given the absence 
of the required hydrolysing enzymes to break them down. As such, seaweed 
polysaccharides can be considered a source of DF and a potential source of novel 
prebiotics as they reach the colon intact where they may be fermented by the 
endogenous microbiota [24]. The seaweeds used in this study originated from along 
the Galway bay coastline, with two of the collection sites being in Co. Galway 
(Spiddal and Mweenish) and two in Co. Clare (Finnavara and New Quay). A great 
part of the Galway bay coastline is open to the full force of the Atlantic Ocean, 
especially in the northwest region where several of the bays are south-facing. Because 
of this south-facing direction, with relation to prevailing south-westerly winds and the 
coastal topography, rafts of seaweed uprooted by storms tend to be retained within the 
bay [25]. Irish coastal habitats vary considerably on spatial scales of kilometres with 
this being particularly true for the west coast of Ireland which has a highly indented 
topography [26]. These facts combine to make Ireland an ideal location for seaweed 
studies.  
The aim of this study was to assess the bifidogenic potential of fifteen different 
cold-water extracts derived from a variety of Irish seaweeds, using an anaerobic in 
vitro assay. Pure cultures of different members of bifidobacterial species were 






2.3 Materials and methods. 
 
2.3.1 Seaweed abbreviations. 
The different abbreviations used to denote the different seaweed species are as 
follows: AE - Alaria esculenta, AN - Ascophyllum nodosum, CC – Chondrus crispus, 
CF – Codium fragile FSE – Fucus serratus, FSP – F. spiralis, FV – F. vesiculosus, 
GG – Gracilaria gracilis, HE – Himanthalia elongata, LD – Laminaria digitata, LH 
– L. hyperborea, PC – Pelvetia canaliculata, PP – Palmaria palmata, SL – Saccharina 
latissima, UI – Ulva intestinalis. 
 
2.3.2 Material. 
All media and materials used in this study were obtained from Sigma-Aldrich, Dublin, 
Ireland unless otherwise stated.  
 
2.3.3 Experimental Bifidobacterium strains. 
All Bifidobacterium strains used in this study were obtained from the Teagasc 
Moorepark culture collection. The strains were as follows: Bifidobacterium breve 
APC 325 NCBF 8807 (B. breve), Bifidobacterium animalis subspecies lactis Bb12 
APC 326 (B. lactis), Bifidobacterium longum subspecies longum APC 422 DPC 6205 
(B. longum), Bifidobacterium bifidum DPC 6034 (B. bifidum), and Bifidobacterium 
longum subspecies infantis DPC 6036 (B. infantis). The strains were chosen to reflect 
the dominant species of Bifidobacterium found in the mammalian gastrointestinal 
tract, as well as the industrial important strain B. lactis Bb12. Each strain was grown 
on de Man, Rogosa, Sharpe (MRS) agar (Difco, Becton-Dickinson Ltd, Dublin, 
Ireland) supplemented with 0.05% (w/v) L-cysteine hydrochloride (MRScys). MRScys 
plates were incubated in an anaerobic jar (Merck KGaA, Darmstadt, Germany) with 
an AnaerocultA gas pack (Merck Millipore Ltd, Cork, Ireland) at 37 °C for 72 h. 
Stocks of all strains used in this study were stored at -80 °C with working stocks being 






2.3.4 Experimental controls. 
The control for the study was non-supplemented minimal media consisting of 
Tryptone (10 g/l), Yeast extract (2.5 g/l), Potassium phosphate dibasic (K2HPO4) 2 
g/l, L-cysteine hydrochloride and Tween® 80 (1 ml/l). The known prebiotic 
fructooligosaccharide (FOS) from chicory was also include as a prebiotic reference. 
The FOS was obtained from Sigma-Aldrich.  The positive control used in the growth 
study was the known prebiotic fructooligosaccharide (FOS) from chicory obtained 
from Sigma-Aldrich. The controls used in the Fucus serratus dose response assay was 
non-supplemented minimal media and FOS from chicory and. 
 
2.3.5 Seaweed collection. 
 The cold-water extracts used in this study were all derived from different species of 
brown, red and green seaweeds. All crude seaweed materials were harvested between 
April 2009 and February 2011 at four collection sites in the Clare/Galway region of 
Ireland. These sites were Finnavara, Co. Clare (F), New Quay, Co. Clare (NQ), 
Spiddal, Co. Galway (S) and Mweenish Island, Co. Galway (M). The seaweeds 
species used in this study were as follows: Alaria esculenta (Linnaeus) Greville (S), 
Ascophyllum nodosum (Linnaeus) Le Jolis (NQ), Chondrus crispus Stackhouse (F), 
Codium fragile subsp. fragile (Suringar) Hariot (F) Fucus serratus Linnaeus (S), 
Fucus spiralis Linnaeus (S), Fucus vesiculosus Linnaeus (S), Gracilaria gracilis 
(Stackhouse) M. Steentoft, L.M.Irvine & W.F. Farnham (F) Himanthalia elongata 
(Linnaeus) S.F. Gray (F), Laminaria digitata (Hudson) J.V. Lamouroux (S), 
Laminaria hyperborea (Gunnerus) Foslie (M), Pelvetia canaliculata (Linnaeus) 
Decaisne & Thuret (S), and Saccharina latissima (Linnaeus) C.E. Lane, C. Mayes, 
Druehl & G.W. Saunders (S) and Ulva intestinalis Linnaeus (S). As part of the Marine 
Functional Food Research Initiative, material from each of the collected seaweeds was 









2.3.6 Solid-liquid extractions. 
Following their collection, each of the seaweed was washed in cold water to remove 
any attached particulate matter such as sand and then frozen immediately. All seaweed 
samples were freeze-dried and ground into a fine powder for storage in vacuum-
packed bags at −80 °C. Solid liquid extractions, using cold-water as the solvent, were 
performed to extract bioactive compounds from the different seaweed samples. The 
seaweed extractions were performed in a large reaction vessel using an orbital shaker 
(MaxQ 6000 Shaker, Thermo Fisher Scientific, Ireland), with a ratio of seaweed 
material to cold-water of approximately 1:20. The reaction vessel was allowed to 
shake at 175 rpm for 3 h. The contents of the reaction vessel were then filtered through 
glass wool and concentrated using a rotary evaporator (Buchi Rotavapor R-220). Each 
extract obtained was freeze-dried to remove any remaining water and ground to a fine 
powder prior to storage at − 80 °C. 
 
2.3.7 Bifidogenic screening of Irish seaweed species. 
Each Bifidobacterium strain used in this study was routinely streaked out on de Man, 
Rogosa and Sharpe (MRS, Difco, Becton-Dickson ltd, Dublin Ireland) agar plates 
supplemented with 0.05% (w/v) L-cysteine hydrochloride (MRScys) and incubated 
anaerobically at 37 °C for 72 h. Single individual colonies were taken from the plates 
and cultured overnight in 5 ml MRScys broth and the following morning, the cell 
suspension was sub-cultured in 5 ml of fresh MRScys broth and allowed to reach an 
optical density (OD600nm) of 0.5 OD units. The extracts and controls were prepared 
in minimal media at an initial concentration of 2.5 mg/ml. Each extract was vortex-
mixed vigorously for 5 min to aid their solubilization in the minimal media. The 
prepared extracts and controls were filter-sterilized using 0.45 µm filters prior to use. 
Filtered extracts were dispensed into clean, sterile universal containers in duplicate. 
Sub-cultured bacterial cells (1 ml) were centrifuged at 15,000 g for 5 min, and washed 
in minimal media twice prior to use. A 1% inoculum of washed cells was added to 
each tube and vortex-mixed for 10 sec. The tubes were then incubated anaerobically 
in a Whitley A85 anaerobic workstation (DW Scientific, Shipley, United Kingdom) at 
37 °C. Readings of optical density were taken manually using a spectrophotometer at 





lower concentrations of 1.25 mg/ml and 0.625 mg/ml. Non-supplemented minimal 
media served as the control. FOS was used as positive a prebiotic reference for this 
analysis. As before, an extract concentration of 2.5 mg/ml was also included. The 
experimental procedure was as outlined above and carried out in duplicate. Readings 
of optical density were taken manually using a spectrophotometer at 0 h, 16 h, 20 h, 
24 h and 28 h. Serial dilutions were carried out in maximum recovery diluent (MRD, 
Oxoid, Fisher Scientific, Dublin) with the appropriate dilutions being plated on 
MRScys agar plates. The agar plates were incubated for 72 h under anaerobic 
conditions at 37 °C. For each strain, a minimum of three biological repeats were 
carried out, n = 3. 
 
2.3.8 Total carbohydrate and compositional analysis of seaweed extracts. 
The total carbohydrate concentration of each seaweed extract was determined by using 
the resorcinol (1, 3 –dihydroxybenzene) sulphuric acid micromethod [27], with 
modifications. The method was scaled up with readings of OD being taken manually 
in microtubes using a spectrophotometer. Briefly, a 6 mg/ml resorcinol stock solution, 
a 14M H2SO4 solution, and a glucose control solution of 200 µg/ml were prepared 
using fresh deionised water. Each of the cold-water seaweed extracts was prepared at 
a concentration of 1 mg/ml in deionised water. The experimental conditions in each 
microtube were as follows: To each microtube, 200 µl sample, 200 µl resorcinol 
solution, and 1 ml of the H2SO4 solution were added. Each microtube was covered in 
tin foil and vortexed for 30 sec. The samples were then incubated at 90 °C for 30 min. 
After the allotted period, the samples were placed at room temperature and allowed to 
cool. Readings at an optical density of 430nm and 480nm were taken and the average 
value of total carbohydrates was obtained. The concentrations of the monosaccharides 
glucose and galactose were subsequently determined using an Aminex HPX 87C 
fixed ion resin column. The temperature of the column was set at 60 °C and the eluent 
0.009N H2SO4 was run at 0.5 ml/min with.  Glucose and galactose were detected using 
a refractive index detector. Each extract sample was filtered through a 0.22 µm 
microfilter before subjecting them to HPLC. Calibration curves for both sugars were 







2.3.9 Determination of total phenols content of Irish seaweeds. 
The level of total phenolic compounds in the cold-water extracts was determined by 
using the Folin-Ciocalteu method and was externally calibrated using gallic acid. 
Briefly, 0.1 ml of extract solution (1 mg/ml), 0.1 ml of methanol and 0.1 ml of Folin-
Ciocalteu reagent were added and the contents mixed thoroughly. After 4 min, 0.7 ml 
of 20% Na2CO3 was added, and then the mixture was allowed to stand for 30 min at 
normal temperature. The absorbance was then measured at 735 nm using a 
spectrophotometer. The concentration of total phenolic compounds was calculated as 
mg of gallic acid equivalents. The determination of total phenolic compounds in the 
fraction was carried out in triplicate and the results were averaged plus/minus standard 
deviation.  
 
 2.3.10 Statistical analysis. 
This experiment was carried out at least in duplicate on three separate occasions. The 
results are presented as the mean value (± SE). Statistical analysis was carried out 
using GraphPad Prism version 5.01. An unpaired Student’s t-test was used to evaluate 


















2.4.1 Carbohydrate analysis of seaweed extractions. 
The total concentration of carbohydrates for each cold-water extract was determined 
using the resorcinol-sulphuric acid microplate method with modifications. Glucose 
was used as the control carbohydrate.  The highest recorded total carbohydrate content 
of the ten brown seaweed species (Fig. 2.1) was observed with S. latissima (62.0 ± 0.7 
GE mg-1) followed by F. serratus (44.9 ± 2.5 GE mg-1), and A. nodosum (44.6 ± 0.4 
GE mg-1). The recorded level of total carbohydrate content for the Himanthalia 
elongata cold-water extract was below the detectable range of the standard curve. Of 
the three red seaweed extracts (Fig. 2.1), the highest carbohydrate concentration was 
observed with C. crispus (49.2 ± 0.9 GE mg -1), followed by G. gracilis (25.6 ± 0.6 
GE mg-1) and P. palmata (9.9 ± 0.1 GE mg-1), while, of the two green seaweeds (Fig. 
2.1) evaluated, the highest total carbohydrate content was recorded with U. intestinalis 
(21.8 ± 0.1 GE mg-1) followed by C.  fragile (2.2 ± 0.5 GE mg-1)  
 The ten brown seaweed extracts were also analysed for their free glucose, and 
galactose content (Fig. 2.2) using HPLC. Notable concentrations of glucose were 
found with S. latissima (42.6 µg/ml), L. hyperborea (28.7 µg/ml), L. digitata (11.8 
µg/ml), and A. esculenta (7.3 µg/ml). No free glucose was observed with the H. 
elongata, F. serratus, F. vesiculosus, P. canaliculata extracts. No free galactose was 
present in any of the tested extracts. 
 
2.4.2 Determination of Total Phenolic Content. 
Total phenolic content was determined by using Folin-Ciocalteu reagent and external 
calibration with gallic acid (Fig 2.3) Of the brown seaweed extracts, the highest 
concentration of phenolic compounds was found in F. vesiculosus (132.5 ± 1.9 μg 
GAE mg−1), P. canaliculata (107.0 ± 0.9 μg GAE mg−1) and A. nodosum (89.3 ± 1.1 
μg GAE mg−1) (Fig 2.3 (a)). The highest concentration of phenolic compound found 
in extracts from red seaweed species (Fig 2.3 (b)) was that of P. palmata (8.4 ± 0.3 μg 
GAE mg−1), followed by C. crispus (6.3 ± 0.3 μg GAE mg−1) and G. gracilis (4.6 ± 





phenolic compounds was found highest in U. intestinalis (20.7 ± 0.6 GAE mg−1) 
followed by C. fragile (0.8 ± 0.1 GAE mg−1). 
 
2.4.3 Bifidogenic potential screen of cold-water extracts from ten brown Irish 
seaweeds species. 
Cold-water extracts at a concentration of 2.5 mg/ml from ten brown seaweeds were 
investigated for their bifidogenic potential using B. breve, B. lactis, B. longum, B. 
bifidum and B. infantis as indicator test strains. In comparison with the cellulose 
control, A. esculenta, A. nodosum, C. crispus, C. fragile, F. serratus, G. gracilis, H. 
elongata, L. digitata, L. hyperborea, P. canaliculata, and U. intestinalis all 
significantly increased (p<0.05) the relative OD at either 20 h or 28 h of at least one 
of the indicators strains. The greatest stimulatory activity observed amongst the brown 
seaweed extracts was observed for F. serratus. This extract significantly increased 
(p>0.05) the relative OD of four of the five indicator strains, B. breve (Fig 2.4), B. 
lactis (Fig. 2.6), B. longum (Fig 2.8), and B. infantis (Fig 2.12), at both time points (t 
= 20 h and 28 h), in comparison with the cellulose control. The second highest 
stimulatory activity was observed with the extract from S. latissima. This extract 
significantly increased (p>0.05) the relative optical density of three of the indicator 
strains, B. breve (Fig 2.4), B. longum (Fig. 2.6), B. bifidum (Fig 2.10), at both time 
points (t = 20 h and 28 h) in comparison with the cellulose control. The lowest overall 
level of stimulatory activity amongst the brown seaweeds was observed for the extract 
from F. vesiculosus and A. esculenta. The relative percentage change in OD600nm for 
the brown seaweed extracts for B. breve (Table 2.1), B. lactis (Table 2.3), B. longum 











2.4.4 Bifidogenic potential screen of cold-water extracts from red and green Irish 
seaweed species. 
Cold-water extracts at a concentration of 2.5 mg/ml from three red seaweeds and two 
green seaweeds were assessed for prebiotic potential. The bacterial strains used were 
as previously described. The greatest stimulatory activity amongst the red seaweed 
extracts was observed for G. gracilis. This extract significantly increased (p>0.05) the 
relative OD of B. longum (Fig. 2.9) at both time points (t = 20 h and 28 h) and for B. 
breve (Fig 2.5) at 28 h only, in comparison with the cellulose negative control. For the 
green seaweed species, the extract from U. intestinalis significantly increased the 
growth (p<0.05) of B. breve (Fig 2.5) and B. longum (Fig. 2.9) at both time points (t = 
20 h and 28 h) and the extract from C. fragile significantly increased the relative OD 
of B. longum (Fig 2.9) at 28 h only, in comparison with the cellulose control. Neither 
of the green seaweed extracts had a significant positive effect on the growth of B. 
lactis. The relative percentage change in OD600nm for the red and green seaweed 
extracts for B. breve (Table 2.2), B. lactis (Table 2.4), B. longum (Table 2.6), B. 
bifidum (Table 2.8) and B. infantis (Table 2.10) are detailed in below.  
 
2.4.5 Further analysis of the bifidogenic potential of the brown seaweed F. 
serratus. 
Further investigation of the bifidogenic stimulatory effect of the F. serratus extract 
was undertaken at 2.5 mg/ml, 1.25 mg/ml and 0.625 mg/ml. Readings of OD600nm were 
manually taken at 16 h, 20 h, 24 h, and 28 h. The indicator test strains were B. breve 
(2.14 (a), B. lactis (Fig.2.14 (b), and B. longum (Fig. 2.14 (c)). A notable inhibitory 
effect was observed for the F. serratus extract at a concentration of 2.5 mg/ml for B. 
breve and B. lactis. The greatest stimulatory effect of F. serratus extract was observed 
at a concentration of 1.25 mg/ml. At this concentration, the extract significantly 
increased (p>0.05) the relative OD of B. breve, B. lactis and B. longum at all time 
points (t = 16 h, 20 h, 24 h and 28 h), in comparison with the cellulose negative control 
(Fig. 2.14). Stimulation of B. longum by the F. serratus extract was significantly 
(p>0.05) increased over that observed with the FOS control at all time points (t= 16 h, 
20 h, 24 h, and 28 h), and for B. lactis at 28 h only. The lowest bifidogenic stimulatory 





The greatest bifidobacterial stimulatory effect for the FOS control was observed at a 
concentration of 2.5 mg/ml. At this concentration, significant increases in relative OD 
were observed for B. breve, B. lactis and B. longum at all time points (t= 16 h, 20 h, 
24 h, and 28 h). No inhibitory effect was observed with FOS. The relative percentage 
change in OD600nm for different concentrations of the F. serratus extract and FOS for 
B. breve, B. lactis, B. longum, B. bifidum, and B. infantis are detailed in below (Table 
2.11). 
Serial dilutions were prepared in maximum recovery diluent at 24 h and plated 
on to MRScys plates to quantify the recovery of viable Bifidobacterium colony forming 
units (CFUs) (Fig. 2.15). Significant increases (p<0.05) in recoverable bacterial CFUs 
were observed with the F. serratus extract for B. longum at 0.625 mg/ml and 1.25 
mg/ml but not at 2.5 mg/ml, in comparison with the negative control No significant 
changes in recoverable bacterial CFUs were observed with the F. serratus extract at 
this time-point for B. breve or for B. lactis at any concentration. A significant increase 
(p<0.05) in recoverable bacterial CFUs were observed with the FOS positive control 
for B. longum at a concentration of 0.625 mg/ml but not at 1.5 mg/ml or 2.5 mg/ml. 


















The main aim of this study was to ascertain whether different strains of bifidobacteria 
could utilize the complex assortment of monosaccharides, oligosaccharides and 
polysaccharides found in species of Irish brown, red and green seaweeds as their major 
energy source for growth. Improving host health, as well as reducing the threat of 
chronic disease, is among the driving forces for the development of functional foods 
for humans and animals. At present, there is both a scientific and commercial interest 
in the concept of prebiotics, which aims to beneficially modulate the composition of 
the gut microbiota and associated metabolic activities [19]. Any food ingredient that 
enters the large intestine has the potential to be a prebiotic compound and exhibit 
bifidogenic effects [29], however not all will. The genus Bifidobacterium is a major 
grouping of beneficial microorganisms and have been a major target for prebiotic 
compounds since the very beginning of prebiotic research. They are associated with 
many positive health benefits such as modulation of the intestinal barrier and of the 
immune response and the exclusion of pathogens [30]. The bifidobacteria used in this 
study are all prominent members of the healthy human gut microbiota. B. breve is the 
most common species of Bifidobacterium in breastfed and preterm infants and is the 
best-characterised of the bifidobacteria. This species appears to have an affinity for 
the immature bowel and colonisation is associated with fewer abnormal abdominal 
signs and better weight gain in very low birthweight infants [31, 32]. In 2006, B. 
infantis and B. longum, along with Bifidobacterium suis were unified into a single 
species, B. longum, based on DNA-DNA hybridization values. [33]. B. longum 
subspecies longum represents the most common subspecies [34]. B. longum 
subspecies infantis is unique for its ability to digest and consume many human milk 
oligosaccharides. This species of Bifidobacterium possesses a large repertoire of 
bacterial genes encoding for glycosidases and oligosaccharide transporters not found 
in other bacterial species. B. infantis  grows better in vitro than any other bacterial 
strain in the presence of human milk oligosaccharides [35]. Bifidobacterium animalis 
subspecies lactis Bb12 (B. lactis Bb12) is a commercially available probiotic strain 
used throughout the world in a variety of functional foods and dietary supplements. 
The health benefits of B. lactis Bb12 have been well-documented in several 
independent clinical trials [36]. Members of the taxon B. bifidum have been shown to 





as well as host-derived glycans [10]. The human genome is predicted to encode just 
eight glycosyl hydrolases (GHs) that are directly linked to carbohydrate metabolism. 
Accordingly, many complex dietary carbohydrates remain undigested and end up in 
the colon intact where they can serve as sources of fermentable substrates for the 
microbiota [12]. Carbohydrate metabolism in Bifidobacterium is adapted for life in the 
mammalian GIT environment as seen from the presence of genes for GHs, sugar ABC 
transporters, and phospohenolpyruvate-phosphotransferase (PEP-PTS), all of which 
are required for the breakdown of plant and host-derived carbohydrates. A large 
percentage of the genes in a given bifidobacterial genome is predicted to be involved 
in sugar metabolism with half of these devoted to carbohydrate uptake [37]. Key to 
carbohydrate metabolism in the bifidobacteria is phosphoketolase (PK), a prominent 
thiamine diphosphate-dependent (TPP) enzyme in microbial sugar metabolism. This 
enzyme is central to the fructose-6-phosphate phosphoketolase (F6PK) of 
bifidobacteria [38, 39]. Bifidobacteria are thought to degrade hexoses exclusively by 
F6PK pathway, which is also termed the ‘bifid’ shunt [40]. PK can catalyse the 
formation of acetyl phosphate and erythrose-4-phosphate from fructose-6-phosphate, 
or the formation of acetyl phosphate and glyceraldehyde-3-phosphate from xylose-5-
phosphate utilising inorganic phosphate as acceptor [39]. PK is a taxonomic marker 
for the family Bifidobacteriaceae. 
With this study, the initial step in investigating the prebiotic potential of Irish 
seaweeds was taken by using a targeted bifidogenic screen. Screening consisted of a 
panel of fifteen cold-water extracts, prepared from different Irish seaweed species, 
being tested against five bifidobacterial strains obtained from an in-house culture 
collection. To grow and multiply successfully, microorganisms need the right 
assortment of nutrients, a source of energy that they can metabolise and certain 
environmental conditions conducive to their survival. In the laboratory, these 
requirements must be met by a culture medium. A defined media is one that contains 
a simple sugar as a source of carbon and energy, an inorganic source of nitrogen as 
well as mineral salts and any required growth factors. In contrast, a minimal media 
provides only the exact essential nutrients needed for a particular organism to grow 
[41]. The media used in this study was a specifically designed ‘bifidogenic’ minimal 
media, containing all the required nutrients to promote bifidobacterial growth except 





would serve as the only major source of carbohydrates available to the bifidobacteria 
for growth. The primary control for the bifidogenic screen was minimal media without 
a supplementary source of carbon. A positive control, in the form of the known 
prebiotic FOS was also included. Growth/stimulatory activity was measured by taking 
optical density readings at a wavelength of 600 nm (OD600nm) at three different time-
points. The first step in accessing seaweed carbohydrates is to extract them in an 
inexpensive, environmentally friendly way. A variety of modern extraction methods, 
such as supercritical and subcritical-fluid extraction, microwave-assisted extraction 
and pressurised liquid extraction have been developed in recent years that improve on 
conventional extraction methods in terms of organic solvent consumption, extraction 
efficiency, selectivity and ease of automation for the extraction of natural compounds 
[42, 43]. Here, atmospheric pressure solid-liquid extraction was used for the extraction 
of bioactive components from the main biomass bulk. This method is relatively 
inexpensive in terms of capital costs and requires less state of the art knowledge and 
optimisation than other extraction methods. Solvents that can be used for extraction of 
seaweed bioactive compounds range from 100% water to mixtures of ethanol or 
acetone. The use of water as the solvent in previously reported extractions resulted in 
the highest yields. This reflects the hydrophilic nature of the majority of the 
components within seaweed and is in part explained by the high quantities of 
polysaccharides present [44].  
The supplementation of the minimal media with different seaweed extracts was 
generally met with positive stimulatory/growth outcomes. As the only major source 
of carbohydrates available, it was clear that the respective bifidobacteria were 
successfully able to utilize the seaweed extracts. Eight out of the ten brown seaweed 
extracts (F. serratus, S. latissima, L. hyperborea, P. canaliculata, A. nodosum, F. 
spiralis, H. elongata, and L. digitata) and all red seaweed extracts significantly 
increased (p<0.05) the growth of one or more of the test strains, as compared to the 
negative control. As expected, this result strongly corresponded with the total 
concentration of carbohydrates in the seaweed extracts, which was determined using 
a modified resorcinol-sulphuric acid microplate method. None of the tested seaweed 
extracts had a significant effect on all five of the test strains. It is important to note 
that the beneficial effect on a given strain of Bifidobacterium is strain specific [45]. 





brown seaweeds are especially rich in soluble fibre [3]. The cell walls of brown 
seaweeds contain large amounts of polysaccharides such as laminarin, a β-polymer of 
glucose that represents the main storage polysaccharide in algae, and fucoidan, a 
sulphated heteropolysaccharide which is mainly composed of L-fucose, and mediates 
a protective effect against desiccation [46]. Ten of the fifteen seaweed extracts were 
found to have a total carbohydrate content in excess of 20 GE mg-1. No free glucose 
or galactose were observed with the F. serratus and F. vesiculosus extract nor with 
the extracts from H. elongata and P. canaliculata. However, appreciable levels of free 
glucose were found with the A. esculenta, L. digitata, L. hyperborea, and S. latissima 
extracts.  Higher levels of total carbohydrate in general mirrored observed bifidogenic 
affects. The most evident bifidogenic stimulatory effect amongst the extracts was 
observed with the F. serratus cold-water extract. Supplementation with this extract at 
a concentration of 2.5 mg/ml significantly stimulated (P<0.05) four out of five test 
Bifidobacterium strains (B. breve, B. lactis, B. longum and B. infantis) at both 
experimental time-points. As such, the Fucus serratus extract was chosen for further 
analysis of bifidogenic potential. Readings of optical density at additional time-points 
were made (16 h, 20 h, 24 h and 28 h) with the extract concentration ranging from 2.5 
mg/ml to 0.625 mg/ml. The same positive and negative controls as the previous screen 
were used. An expected concentration dependent effect was observed with FOS for all 
three test strains, with the highest levels of stimulation being observed at a of 2.5 
mg/ml and the lowest at 0.625 mg/ml. Interestingly, at a concentration of 2.5 mg/ml 
an inhibitory effect was observed with the F. serratus extract affecting all test strains, 
but most notably B. breve and B. lactis. A significant reduction in OD readings 
(P<0.05) was recorded with B. lactis at this concentration for all time points in 
comparison with the F. serratus extract at a concentration of 1.25 mg/ml. A similar 
decrease was apparent for B. breve; however, there was no significant difference 
between results at 2.5 mg/ml and 1.25 mg/ml. This observation was also evident for 
B. longum. We propose that an inhibitory substance, naturally occurring within the 
seaweed, was the causative agent of the observed inhibition of Bifidobacterium 
growth. The results obtained for both FOS and the F. serratus extract at 2.5 mg/ml 
were comparable to that observed during the initial bifidogenic screen for all test 
strains, indicating that the effect is reproducible in vitro. The data from both the initial 





putative bifidogenic stimulatory activity observed with the seaweed extracts is strain 
dependent. This fact is supported by the plate count data obtained for the F. serratus 
extract. Significant increases in CFU/ml were only recorded for B. longum. No 
significant changes were observed with either B. breve nor B. lactis. This agreed with 
the optical density readings obtained. Differences in observations between readings of 
optical density and plate counts could be as a result of pipetting/serial dilution errors 
Utilisation of FOS by the bifidobacteria was varied and strain specific. Significant 
increases (P<0.05) in CFU/ml at were only observed for B. breve and B. longum at the 
two lower concentrations and not at 2.5 mg/ml. Differences in the fermentative ability 
of the different Bifidobacterium strains to use seaweed carbohydrates, such as 
fucoidan and laminarin, suggest that variations exist in their genomes with respect to 
complex carbohydrate utilisation.  
Dietary polyphenols are natural compounds occurring in plants and are 
characterized by hydroxylated phenyl moieties [47]. Polyphenols can affect human 
health because of their antioxidant and antimicrobial properties as well as free-radical 
scavenging activity [48]. A high proportion of polyphenols from our diet are not 
absorbed directly, so these compounds can directly reach the gut and modify the 
composition of the gut microbiota. Because of their ability to metabolise polyphenols, 
bacteria may play an important role in the production of new compounds in situ, which 
could have better bioavailability than their parent compounds. The transformation of 
these in the gut depends on microbial esterase and glucosidase as well as on 
demethylation, dehydroxylation and decarboxylation activities. In parallel to 
microbial catabolism, unabsorbed dietary polyphenols and their metabolites can 
behave as activators or inhibitors of bacterial growth depending on their chemical 
structure and concentration. These metabolites selectively inhibit pathogens and 
stimulate the growth of commensal bacteria, including some recognized probiotics 
[49]. A study carried out by Queipo-Ortuno et al. [50] showed that the daily 
consumption of red wine polyphenols significantly increased the numbers of several 
genera of beneficial bacteria including Bifidobacterium. There are many studies 
describing the influence of polyphenols on the growth and viability of lactic acid 
bacteria but mainly from the genus Lactobacillus. Gwiazdowska et al. [48] 
demonstrated that polyphenols exhibit both stimulatory and inhibitory effects on the 





the first hours of incubation. Most studies highlight the fact that the effect of 
polyphenols depends on the type of polyphenol, its structure, its concentration and 
also the susceptibility of the bacterial strain in question. High levels of phenolic 
compounds (< 50 GAE mg-1) were present in the brown seaweeds; F. vesiculosus, P. 
canaliculata, A. nodosum, F. spiralis and F. serratus. All other seaweed extracts tested 
had a level of phenolic compounds less than 25 GAE mg-1. Brown seaweeds 
accumulate a variety of phloroglucinol-based polyphenols (phlorotannins), formed 
from the polymerization of phloroglucinol monomer units resulting in compounds 
with different molecular weights. Phlorotannins are stored in special vesicles and are 
presumed to be defense compounds involved in protection against stress conditions 
and herbivores [51]. Phlorotannins are reported to act as inhibitory compounds for 
anaerobic digestion as they inhibit enzyme activity of various microbes [5]. Other 
polyphenolic compounds previously quantified in brown seaweeds include caffeic 
acid, chlorogenic acid, coumaric acid and catechins. Phlorotannins are unique to 
marine algae and are found at highest levels (2-10%) in brown algal species. [52]. 
Depending on the structure of the polyphenols contained in the extract, it is likely that 
portions of the phenolic content are the causative agent for the inhibition seen at a 
concentration of 2.5 mg/ml of F. serratus extract. 
 Fermentation in the gut can be considered in terms of a complex assortment of 
bacterial metabolic pathways, with each bacterium trying to garner the energy required 
for survival from the finite supply of carbon. In this system, fermentation end-products 
from one bacterial species can be utilised by another which lack the ability to ferment 
the original source. Further investigation of the bifidogenic or prebiotic potential of 
seaweeds would also require substantial refinement of the extract to be investigated. 
The extracts used in this study were obtained through a solid liquid extraction process 
with cold water being used as the solvent. It was shown that several of these extracts, 
following the extraction process, contained appreciable amounts of glucose as well as 
large concentrations of phenolic compounds. Simple monosaccharides are universally 
used by bacteria as a source of energy for growth. One of the key principles of the 
prebiotic concept is that of selective stimulation of beneficial bacteria. In experimental 
models, the presence of monosaccharides would serve to facilitate the growth of both 
beneficial bacteria such as Bifidobacterium and Lactobacillus but also potentially 





at high concentrations, are known to exhibit anti-microbial activity and could explain 
the inhibitory effect observed at the higher concentrations of F. stratus extract. As 
such, both simple sugars and phenolic compounds are to be regarded as undesirable in 
terms of the preparation of an extract to be used in bifidogenic/prebiotic trials. Any 
extraction process to be used in future prebiotic investigations of seaweeds should be 
designed in such a manner as to address these issues. Several techniques could be 
added to the extraction process to generate specific extracts for prebiotic investigation. 
To further increase the yield of total carbohydrates and to release bound 
polysaccharides from their cell wall matrices, a more vigorous and targeted extraction 
mechanism may be required for the preparation of extracts in the future. An example 
of this would be the use of a dilute hot acid extraction instead of using cold water as 
the extraction solvent. The introduction of an ethanol precipitation step immediately 
following the primary extraction would cause separation of seaweed monosaccharides, 
polysaccharides and dietary fibre from the non-carbohydrate contents of the seaweed. 
Further, size exclusion dialysis could also be employed to remove the seaweeds 
monosaccharide content, such as glucose, from the final extract. Based on the results 
obtained herein, the brown seaweed F. serratus proved to be the best candidate 
seaweed for further prebiotic investigation. Further use of this seaweed in prebiotic 
potential investigations is recommended. The adoption of a much-modified extraction 









In conclusion, the results presented here indicate that different bifidobacterial strains 
can successfully utilize the carbohydrate content of brown, red and green seaweed as 
their sole carbon source, as determined by an increase in optical density (OD600nm). 
All tested seaweeds (A. esculenta, A. nodosum, C. crispus, C. fragile, F. serratus, G. 
gracilis, H. elongata, L. digitata, L. hyperborea, P. canaliculata, and U. intestinalis) 
had a significant effect on the growth of one or more of the Bifidobacterium strain 
used in this study. The greatest effect was found with the brown seaweeds, F. serratus 
and S. latisima, with F. serratus being chosen for further evaluation. A dose response 
analysis was carried out with the F. serratus extract. Significant bifidogenic activity 
was detected with the F. serratus extract at all concentrations for B. breve, B. lactis 
and B. longum. The greatest bifidobacteria stimulatory effect was observed with the 
F. serratus extract at a concentration of 1.25 mg/ml. It was also shown that this 
concentration the F. serratus extract had a significantly greater stimulatory effect B. 
longum than the FOS prebiotic control. An unexpected inhibitory effect was observed 
at a concentration of 2.5 mg/ml for the F. serratus extract, most probably because of 
the presence of large quantities of phenolic compounds, which are known to possess 
antimicrobial activity. While the results presented here were positive in terms of 
bifidogenic potential, the effect was strain dependent. Further, information is lacking 
with regards to the effect of the extracts on mixed bacterial cultures. It is recommended 
that further investigation of the prebiotic potential of brown seaweeds be undertaken, 
with an emphasis on F. serratus, using an ex vivo faecal fermentation system and a 
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Figure 2.1 Total carbohydrate analysis using a resorcinol-sulphuric acid microplate method with 
modifications for (a) brown seaweed species and (b) red and green seaweed species. Data represent the 








































Figure 2.2 The concentration of the monosaccharides glucose and galactose was determined for the ten 
























Figure 2.3 Total Phenolic Content (TPC) of (a) the brown seaweed species and (b) the red and green 









































Figure 2.4 The effect of ten cold-water extracts from Irish brown seaweeds on the growth of 
Bifidobacterium breve APC 325 NCBF 8807. Growth was measured by readings of optical density 
(OD600nm). Data represent the mean (± SE). Significance was measured by independent t-test against 







Table 2.1 Percentage change in OD600nm readings for the ten Irish brown seaweed extracts in 
comparison with the cellulose control for Bifidobacterium breve APC 325 NCBF 8807. 
% Change 20 h 28 h 
FOS 10907.8 ± 3636.5 1590.2 ± 295.6 
A. esculenta 855 ± 408.4 63.5 ± 26.6 
A. nodosum 2957.4 ± 1555.3 464.4 ± 252.4 
F. serratus 3498.5 ± 1175.6 555.3 ± 194.4 
F. spiralis 894.7 ± 438.9 124.5 ± 68.3 
F. vesiculosus 1795.3 ± 253.6 342.8 ± 159 
H. elongata 405.8 ± 467.6 37.3 ± 59.5 
L. digitata 1420 ± 833.1 51.8 ± 33.3 
L. hyperborea 2115.6 ± 1018.7 114.7 ± 46.2 
P. canaliculata 4800.2 ± 2054.7 755.9 ± 323.5 


































Figure 2.5 The effect of cold-water extracts from Irish red and green seaweeds on the growth of 
Bifidobacterium breve APC 325 NCBF 8807. Growth was measured by readings of optical density 
(OD600nm). Data represent the mean (± SE). Significance was measured by independent t-test against 







Table 2.2 Percentage change in OD600nm readings for the Irish red and green seaweed extracts in 
comparison with the cellulose control for Bifidobacterium breve APC 325 NCBF 8807. 
% Change 20 h 28 h 
FOS 1762.1 ± 626.6 1828.8 ± 725.3 
C. crispus -88.8 ± 69.4 -13.9 ± 84.8 
C. fragile 68.7 ± 33.3 118.1 ± 72.4 
G. gracilis 337.1 ± 109.7 282.8 ± 55.9 
P. palmata 42.5 ± 34.5 43 ± 18.5 































Figure 2.6 The effect of ten cold-water extracts from Irish brown seaweeds on the growth of 
Bifidobacterium lactis Bb12 APC 326. Growth was measured by readings of optical density 
(OD600nm). Data represent the mean (± SE).  Significance was measured by independent t-test against 







Table 2.3 Percentage change in OD600nm readings for the ten Irish brown seaweed extracts in 
comparison with the cellulose control for Bifidobacterium lactis Bb12 APC 326. 
% Change 20 h 28 h 
FOS 836.2 ± 406.2 2659.9 ± 2395.3 
A. esculenta 181.2 ± 177.7 1001.5 ± 1036.8 
A. nodosum 107.9 ± 59 534.7 ± 582.7 
F. serratus 664.6 ± 307.4 1967.9 ± 1816.1 
F. spiralis 23.8 ± 43.8 1155.9 ± 1172.2 
F. vesiculosus 125.8 ± 55 430.2 ± 435 
H. elongata 417.5 ± 241.4 689.7 ± 706 
L. digitata 125.5 ± 20.7 678.1 ± 698.9 
L. hyperborea 289.5 ± 180.4 881.8 ± 835.1 
P. canaliculata 857.7 ± 314.8 3646 ± 3364.8 

































Figure 2.7 The effect of cold-water extracts from Irish red and green seaweeds on the growth of 
Bifidobacterium lactis Bb12 APC 326. Growth was measured by readings of optical density 
(OD600nm). Data represent the mean (± SE).  Significance was measured by independent t-test against 







Table 2.4 Percentage change in OD600nm readings for the Irish red and green seaweed extracts in 
comparison with the cellulose control for Bifidobacterium lactis Bb12 APC 326. 
% Change 20 h 28 h 
FOS 118.5 ± 25.5 113.1 ± 48.7 
C. crispus 83.6 ± 31.4 146.6 ± 45.6 
C. fragile -45.4 ± 42.5 -53.2 ± 18.2 
G. gracilis 76 ± 46.6 89.7 ± 56.6 
P. palmata 9.7 ± 34.7 -47.3 ± 32.8 




























Figure 2.8 The effect of ten cold-water extracts from Irish brown seaweeds on the growth of 
Bifidobacterium longum APC 422 DPC 6205. Growth measured by readings of optical density 
(OD600nm). Data represent the mean (± SE).  Significance was measured by independent t-test against 







Table 2.5 Percentage change in OD600nm readings for the ten Irish brown seaweed extracts in 
comparison with the cellulose control for Bifidobacterium longum APC 422 DPC 6205. 
% Change 20 h 28 h 
FOS 163.3 ± 51.9 60.3 ± 11 
A. esculenta 129.2 ± 77.2 33.1 ± 6.4 
A. nodosum 99.1 ± 11.8 40 ± 9 
F. serratus 676.5 ± 180.8 83.8 ± 4.3 
F. spiralis 128.7 ± 51.9 53.9 ± 10.7 
F. vesiculosus 154.6 ± 101.7 27.2 ± 10.7 
H. elongata 54.4 ± 31.1 29 ± 16.4 
L. digitata 256.7 ± 169.8 42.1 ± 20.5 
L. hyperborea 117.4 ± 6 48.2 ± 3.3 
P. canaliculata 373.1 ± 105.2 75.4 ± 4.9 

































Figure 2.9 The effect of ten cold-water extracts from Irish red and green seaweeds on the growth of 
Bifidobacterium longum APC 422 DPC 6205. Growth measured by readings of optical density 
(OD600nm). Data represent the mean (± SE).  Significance was measured by independent t-test against 







Table 2.6 Percentage change in OD600nm readings for the Irish red and green seaweed extracts in 
comparison with the cellulose control for Bifidobacterium longum APC 422 DPC 6205. 
% Change 20 h 28 h 
FOS 157.9 ± 31.4 361.8 ± 44.8 
C. crispus 91.8 ± 16.8 2.5 ± 0.3 
C. fragile -54.9 ± 14.9 0.9 ± 1.7 
G. gracilis 448.4 ± 46.1 6.2 ± 0.6 
P. palmata 89.2 ± 8.4 2.1 ± 0.3 































Figure 2.10 The effect of ten cold-water extracts from Irish brown seaweeds on the growth of 
Bifidobacterium bifidum DPC 6034. Growth measured by readings of optical density (OD600nm). Data 
represent the mean (± SE). Significance was measured by independent t-test against cellulose negative 






Table 2.7 Percentage change in OD600nm readings for the ten Irish brown seaweed extracts in 
comparison with the cellulose control for Bifidobacterium bifidum. 
% Change 20 h 28 h 
FOS 143.7 ± 25.5 2129.7 ± 771.7 
A. esculenta 34.7 ± 22.8 1163.3 ± 1039.9 
A. nodosum 18.8 ± 4.2 93.4 ± 11 
F. serratus 48.4 ± 20.8 1165.7 ± 981.8 
F. spiralis 16 ± 3.2 -54 ± 101.7 
F. vesiculosus 37.4 ± 30.3 1117.3 ± 1127.3 
H. elongata 6.9 ± 1.2 212.7 ± 86.6 
L. digitata 12 ± 5.7 506.2 ± 339.9 
L. hyperborea 68.5 ± 52.8 2563.1 ± 2312 
P. canaliculata 22.4 ± 14 544.5 ± 453 
































Figure 2.11 The effect of ten cold-water extracts from Irish red and green seaweeds on the growth of 
Bifidobacterium bifidum DPC 6034. Growth measured by readings of optical density (OD600nm). Data 
represent the mean (± SE). Significance was measured by independent t-test against cellulose negative 






Table 2.8. Percentage change in OD600nm readings for the Irish red and green seaweed extracts in 
comparison with the cellulose control for Bifidobacterium bifidum. 
% Change 20 h 28 h 
FOS 143.7 ± 25.5 2129.7 ± 771.7 
C. crispus 37.8 ± 1.5 599 ± 338.4 
C. fragile 57.7 ± 2 1096.4 ± 647.3 
G. gracilis 37.3 ± 4.7 757 ± 432.3 
P. palmata 37 ± 7.1 697.5 ± 337.1 

































Figure 2.12 The effect of ten cold-water extracts from Irish brown seaweeds on the growth of 
Bifidobacterium longum subspecies infantis DPC 6036. Growth measured by readings of optical density 
(OD600nm). Data represent the mean (± SE). Significance was measured by independent t-test cellulose 







Table 2.9 Percentage change in OD600nm readings for the ten Irish brown seaweed extracts in 
comparison with the cellulose control for Bifidobacterium longum subspecies infantis DPC 6036. 
% Change 20 h 28 h 
FOS 0.9 ± 12.6 70 ± 35.1 
A. esculenta 36.2 ± 24.7 50.9 ± 19.6 
A. nodosum 59.1 ± 18.9 28.1 ± 19.9 
F. serratus 50.7 ± 16.5 108.4 ± 25.3 
F. spiralis 46.6 ± 17.8 72.8 ± 28.9 
F. vesiculosus 15.7 ± 19.5 9.8 ± 16.9 
H. elongata -83.6 ± 3.3 -93.7 ± 9.2 
L. digitata -74 ± 5.4 -23.1 ± 33.6 
L. hyperborea -14.7 ± 9.7 -10.6 ± 30.7 
P. canaliculata -71.5 ± 9.1 -36.7 ± 19.9 



























Figure 2.13 The effect of ten cold-water extracts from Irish brown seaweeds on the growth of 
Bifidobacterium longum subspecies infantis DPC 6036. Growth measured by readings of optical 
density (OD600nm). Data represent the mean (± SE). Significance was measured by independent t-







Table 2.10 Percentage change in OD600nm readings for the Irish red and green seaweed extracts in 
comparison with the cellulose control for Bifidobacterium longum subspecies infantis DPC 6036. 
% Change 20 h 28 h 
FOS 0.9 ± 12.6 70 ± 35.1 
C. crispus -70.6 ± 9.9 -70.9 ± 12.3 
C. fragile 23.3 ± 23.5 -14.5 ± 7.8 
G. gracilis -76.1 ± 2.8 37.5 ± 16 
P. palmata -84.1 ± 5.2 -13.4 ± 33.4 
































Figure 2.14 Effect of different concentrations of the Fucus serratus extract on the growth of (a) 
Bifidobacterium breve APC 325 NCBF 8807, (b) Bifidobacterium lactis Bb12 APC 326 and (c) 
Bifidobacterium longum APC 422 DPC 6205. Data represent the mean (± SE). (a = P<0.05), b = 
































































































































































Table 2.11 Percentage change in OD600nm readings with the Fucus serratus extract and FOS control for 
(a) Bifidobacterium breve APC 325 NCBF 8807, (b) Bifidobacterium lactis Bb12 APC 326 and (c) 
Bifidobacterium longum APC 422 DPC 6205. Data represent the mean (± SE). 
 
(a) B. breve    
 
16 h 20 h 24 h 28 h 
FOS 0.625 mg/ml 687.944 ± 222.905 807.897 ± 321.081 1075.808 ± 643.569 233.543 ± 87.906 
FOS 1.25 mg/ml 1158.579 ± 133.257 1195.665 ± 186.74 1588.466 ± 627.371 1754.824 ± 1125.057 
FOS 2.5 mg/ml 1667.64 ± 147.84 1783.473 ± 111.598 2117.459 ± 438.388 2327.562 ± 1225.842 
FSE 0.625 mg/ml 223.782 ± 84.093 245.998 ± 49.941 240.33 ± 98.411 996.89 ± 859.376 
FSE 1.25 mg/ml 708.761 ± 190.698 646.473 ± 63.466 826.696 ± 276.343 681.568 ± 235.194 
FSE 2.5 mg/ml 444.172 ± 127.261 367.206 ± 58.911 427.322 ± 118.618 1056.881 ± 739.281 
     
(b) B. lactis    
 
16 h 20 h 24 h 28 h 
FOS 0.625 mg/ml 176.834 ± 64.669 165.104 ± 31.407 205.125 ± 109.77 130.192 ± 73.727 
FOS 1.25 mg/ml 287.35 ± 67.394 318.397 ± 117.751 398.013 ± 236.253 236.05 ± 59.31 
FOS 2.5 mg/ml 384.395 ± 104.006 513.198 ± 77.337 534.004 ± 241.2 356.429 ± 91.038 
FSE 0.625 mg/ml 194.24 ± 46.449 228.763 ± 30.447 300.455 ± 111.201 252.255 ± 51.693 
FSE 1.25 mg/ml 530.715 ± 138.713 573.332 ± 137.096 599.186 ± 191.161 622.702 ± 166.067 
FSE 2.5 mg/ml 45.375 ± 40.569 66.403 ± 42.506 112.022 ± 46.586 132.955 ± 31.693 
     
(c) B. longum    
 
16 h 20 h 24 h 28 h 
FOS 0.625 mg/ml 37.66 ± 45.347 -15.993 ± 26.866 -3.465 ± 33.844 18.3 ± 39.453 
FOS 1.25 mg/ml 84.902 ± 41.673 45.929 ± 34.826 16.812 ± 18.653 41.508 ± 24.274 
FOS 2.5 mg/ml 122.653 ± 7.419 219.339 ± 43.126 156.771 ± 49.489 251.994 ± 66.314 
FSE 0.625 mg/ml 156.731 ± 79.281 107.071 ± 45.314 114.414 ± 66.175 127.736 ± 52.458 
FSE 1.25 mg/ml 683.493 ± 65.157 589.14 ± 75.714 418.776 ± 125.342 475.115 ± 119.314 






Figure 2.15 Dose-response study plate counts of (a) Bifidobacterium breve APC 325 NCBF 8807, (b) 
Bifidobacterium lactis Bb12 APC 326 and (c) Bifidobacterium longum APC 422 DPC 6205. * = P<0.05, 
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Supplementary Table 2.1 Summary of the different brown, red and green seaweed extracts used in 








Phaeophyta Alaria esculenta 
Solid-liquid 
extraction 







Asco, Sea Whistle, Bladderwrack 



















































Irish Moss, Carragheen, 











































Supplementary Figure 2.1 Location of the four different collection points along Galway bay. Clockwise from top, 







Evaluation of the prebiotic potential of a polysaccharide-
rich extract from the brown seaweed Fucus serratus using 























Several seaweed polysaccharides (fucans and laminarins etc.) are resistant to 
degradation by human digestive enzymes.  They are recognised as dietary fibres and 
a possible new source of prebiotic compounds. As such, these polysaccharides pass 
through the GIT intact until they reach the colon, where they act as a source of 
fermentable substrates for components of the gut microbiota. This stimulates the 
production of the short-chain fatty acids (SCFAs) such as acetate, butyrate and 
propionate. SCFA production is a major indicator of prebiotic stimulation in the colon. 
Here a polysaccharide rich hot-acid extract prepared from the Irish seaweed Fucus 
serratus was investigated for prebiotic potential using ex vivo faecal batch 
fermentations. A 1.5-fold increase in the production of total SCFAs was observed, 
particularly in the production of propionate (2.3-fold increase) and acetate (1.4-fold 
increase). There was also an associated significant increase (p<0.05) in the proportion 
of propionate production, rising from 15% in the control to 24 %. There was no 
significant change in levels of butyrate production. High throughput DNA sequencing 
analysis revealed that the F. serratus extract had no notable effect on the abundance 
of members of the genera Bifidobacterium and Lactobacillus. However, there were 
notable increases in several propionate producing members of the microbiota such as 
the genus Parabacteroides, the family Veillonellaceae and the family 
Erysipelotrichaceae, which is peripherally related to the butyrate-producing 
superfamily Lachnospiraceae. These results indicate that a crude polysaccharide 
extract from the seaweed F. serratus can significantly modulate the activity of the gut 
microbiota, and alter the SCFA production profile by stimulating propionate 






Seaweeds are a ubiquitous sight along the coastlines and maritime regions of the 
world. They are plant-like multi-cellular organisms that generally live attached to 
rocks or other hard substrata in marine environments [1]. It is unsurprising that our 
ancestors made extensive use of seaweeds as they were both easily accessible and in 
plentiful supply. Traditionally, they are classified into three main groupings based 
primarily on the colour of their thallus or frond. These groupings are the phaeophyta 
(brown seaweeds), the rhodophyta (red seaweeds) and the chlorophyta (green 
seaweeds) [2]. Mankind's association with seaweeds stretches back many centuries 
and covers a wide range of activities that include their usage in cooking, herbal 
medicines as well as agriculture. Edible varieties of seaweed can be highly nutritious 
as they contain large amounts of vitamins and minerals, proteins, dietary fibre and 
essential fatty acids  [3]. Seaweeds have formed an integral part of the cooking process 
in countries of the Far East, such as Japan, China and the Republic of Korea [4]  where 
they are often used as an ingredient in soups and salads, as well as being used as a 
condiment [5]. Seaweed, as a staple ingredient in both the traditional and modern 
Japanese diet, can constitute between 10 and 25% of total food intake for some 
individuals, with an average of over 1.6 kg of dry seaweed being consumed per person 
per year [6, 7]. The seaweeds mainly used for human nutrition are of the brown 
(Phaeophyta) and the green (Chlorophyta) species [8].  The exploitation of seaweeds 
in Europe and North America has largely been confined to the manufacturing industry 
[9] where their polysaccharides are used as thickening and gelling agents in foods and 
for industrial applications [10]. Despite their abundance, seaweeds are an 
underutilized natural resource from a commercial and nutrition perspective  [11]. 
Although the production of seaweed has been increasing in recent years, use on an 
industrial scale has been largely confined to a limited number of commercially 
valuable species [12], such as Laminaria japonica, Undaria pinnitafida, Ascophyllum 
nodosum and Hizaki fusiformis  [13]. 
As well as being a nutrient rich food source, seaweeds produce a multitude of 
biologically-active secondary compounds that are associated with many health related 
attributes such as anti-oxidant, anti-inflammatory, anti-cancer, anti-diabetic, and anti-





especially soluble fibres and polysaccharides. Most seaweed-derived polysaccharides 
are non-digestible by the human digestive system. They contain complex glycosidic 
linkages that the natural human reservoir of hydrolytic degrading enzymes cannot 
break down. Seaweed DF differs in composition, chemical structure, physiochemical 
properties and biological effects from terrestrial plant DF [4]. The consumption of 
general DF is considered important in preventing conditions such as constipation, 
colon cancer, cardiovascular diseases, and obesity [11] and has been shown to 
positively influence satiety and glucose uptake from food, following meals [9]. DF 
from seaweeds has been shown to have cholesterol lowering and hypotensive effects 
[4]. In many cases, the fibre content found in seaweeds is higher than in most terrestrial 
fruits and vegetables with total dietary fibre ranging from 33-50 g/100g dry weight. 
Further, the main components of brown seaweeds differ from that of terrestrial 
biomass (cellulose, hemi-cellulose and lignin) with their main structural components 
being comprised of alginic acid, mannitol, laminarin and fucoidan.  
The main soluble polysaccharides in brown seaweeds are the fucoidans, 
laminarins and alginates. Fucoidans are a unique class of sulphated fucans whose 
composition varies with the species of seaweed [16, 17]. They have an α (1-3) 
backbone or repeating disaccharide units of α (1-3) and α (1-4) linked fucose residues 
with branches at the C2 positions. Besides fucose, fucoidans may also contain the 
monosaccharides, galactose, mannose, xylose, and rhamnose as well as uronic acid. 
Depending on the species of seaweed, and to a lesser degree the season, fucoidans may 
constitute 25-30% of the seaweed’s dry weight [18]. Sulphated polysaccharides can 
interact with many types of matrix and cellular proteins owing to their chemical 
structure, which is rich in polyanions [19]. Laminarins are composed of β-glucans and 
are the principle storage polysaccharides of brown seaweeds. They are short polymers 
of about 20-25 glucose residues linked by β (1-3) bonds and some β (1-6) bonds [20]. 
Alginates are the salts of alginic acid and are the main structural polysaccharide in 
brown seaweeds. They are composed of mannuronic and guluronic acid  [16]. Soluble 
polysaccharides from seaweed may also serve as a new source of novel prebiotics [21] 
as they escape digestion in the small intestine but undergo fermentation by the 





The term prebiotic was originally proposed in the mid 1990’s by Glenn Gibson 
and Marcel Roberfroid, when it was demonstrated that the fibrous oligosaccharide 
inulin reaches the colon intact and selectively stimulates the growth of bifidobacteria 
[23]. The most recent definition of a prebiotic is a substrate that is selectively utilized 
by host microorganisms conferring a health benefit [24]. The three main classes of 
carbohydrates typically classified as  prebiotics are inulin-type fructans, trans-galacto-
oligosaccharides, and lactulose [25]. Since the initial prebiotic publication, researches 
have robustly demonstrated a ‘prebiotic effect’ resulting from the consumption of 
certain fibre-containing foods, and animal studies have suggested that prebiotics 
influence factors such as gut and immune function, glucose tolerance, and metabolic 
regulation, as well as reducing the prevalence of colon cancer [23]. Prebiotic action 
can also lead to improvements in the integrity of the gut mucosal barrier which lessens 
the likelihood of developing diarrhoea [26].  
Beneficial microbes, such as Bifidobacterium, Lactobacillus and Eubacterium, 
usually ferment carbohydrates, do not produce harmful toxins and may cause a range 
of benefits for the host including enhancement of the immune system and competitive 
inhibition of pathogens [27]. Bifidobacterium are a major group of beneficial bacteria 
in the microbiota of healthy individuals and constitute a major target for prebiotics 
[28]. They improve the colonic environment by suppressing pathogens and the 
production of carcinogenic materials [29], while also being immunomodulatory. The 
bifidobacterial genomes reflect their adaptation to the human GIT environment in 
some cases by encoding for a variety of carbohydrate-modifying enzymes, such as 
glycosyl hydrolases, sugar ABC transporters, and PEP-PTS (phosphoenolpyruvate – 
phosphotransferase system) components. These are required for the metabolism of 
plant and host-derived carbohydrates. Members of the genus can utilize the complex 
carbohydrates that are otherwise non-digestible and reach the colon unabsorbed by the 
body. There the complex carbohydrates are degraded to low molecular weight 
oligosaccharides and in many cases to monosaccharides. The simple sugars are then 
converted by the microbiota to intermediates of the hexose fermentation pathway 
(fructose-6-phosphate shunt or ‘bifid’ shunt) and ultimately converted to short chain 
fatty acids (SCFAs) and other organic components [30]. Many non-digestible 





the growth of beneficial members of the microbiota. Two of the most studied NDOs 
are fructooligosaccharide (FOS) and galacto-oligosaccharide (GOS) [31].  
SCFAs are organic acids which consist of between 1 and 6 carbon atoms. Any 
dietary nutrients that survive gastric passage and reach the large intestine intact are 
potential substrates for bacterial metabolism. SCFAs are mainly produced from the 
fermentation of DF, resistant starch and non-digestible carbohydrates (prebiotics) by 
the microbiota in the colon. This leads principally to the production of butyrate, 
propionate and acetate, with minor amounts of the branched SCFAs, isobutyrate, 
valerate and isovalerate also being formed. In addition, some gasses, such as methane, 
carbon dioxide and hydrogen are generated. SCFAs enter cells through diffusion or by 
monocarboxylate transporters and solute transporters. They activate cells through cell-
surface G-protein-coupled (GPR) receptors [32]. Free fatty acid receptor 2 (FFAR2, 
also known as GPR43) and FFAR3 (GPR41) have been identified as endogenous 
receptors for SCFAs. FFAR2 expression mainly occurs in immune cells, but also in 
adipocytes, enterocytes and endocrine cells while FFAR3 displays a wide expression 
pattern (spleen, lymph nodes, bone marrow, adipose tissue and colon) [33]. Acetate 
preferentially activates FFAR2 ex vivo; propionate displays similar affinity for FFAR2 
and FFAR3; and butyrate preferentially activates FFAR3 [34]. The types and amounts 
of SCFA produced in the colon can vary depending on the composition of the 
microbiota and the types of undigested fibre reaching the colon. Bifidobacterium for 
example, produce both acetate and lactate which can be converted to butyrate and 
propionate through cross-feeding by other members of the microbiota. SCFAs 
produced in the gut can serve as a nutrient source for the colonic epithelium and may 
also act upon GIT diseases such as colon cancer, irritable bowel disease (IBD) and 
colitis. SCFA production also helps to lower the pH of the gut environment, inhibiting 
the growth of some GIT pathogens [35]. Supplementation with SCFAs has also been 
investigated as a treatment for ulcerative colitis, diversion colitis and short bowl 
syndrome [36].  
As the colonic microbiota play a key role on host health, a deep understanding 
of the fermentation dynamics of the bacterial populations is of significant importance. 
The investigation into the effects of prebiotics on gut health should not be just limited 





ecosystem. Only by monitoring total population shifts will we improve our 
understanding of the mode of action of prebiotics and our ability to determine their 
role in promoting health [27]. The aim of this study was to assess the prebiotic 
potential of a polysaccharide rich extract produced from the brown seaweed Fucus 
serratus by using an ex vivo faecal fermentation. F. serratus, also known as the 
serrated wrack, is a prominent canopy-forming species that has traditionally been 
found along the shores of Ireland and the UK as well as in other eastern Atlantic 






3.3 Materials and methods. 
 
 3.3.1 Materials. 
All chemicals were obtained from Sigma-Aldrich, Dublin, Ireland unless otherwise 
stated. 
 
 3.3.2 Seaweed origin. 
The seaweed material used in this study to produce the polysaccharide rich extract was 
from the brown seaweed species F. serratus. The seaweed sample was collected in the 
Galway bay region of the west coast of Ireland. 
 
3.3.3 Primary hot-acid extraction of F. serratus. 
Loose particulate matter from the collected seaweed was removed by washing with 
cold water. Afterwards the washed seaweed was stored at -20 °C before use. Prior to 
the extraction, the seaweed was removed from storage, mechanically blended to a fine 
powder and added to a reaction vessel before being re-suspended with deionised water 
(1:10 (w/v) seaweed/water solution). Hydrochloric acid (37%) was then added 
(8.25ml/L) to the seaweed/water solution to give a 0.1 M HCl solution. The vessel was 
allowed to shake at 75 RPM in an orbital shaker (MaxQ 6000 Shaker, Thermo Fisher 
Scientific, Ireland) for 3 h at 70 °C. After this, the vessel was removed from the shaker 
and allowed to cool. The seaweed solution was filtered through a muslin bag with the 
filtrate being transferred to a clean storage vessel. The remaining seaweed residue was 
returned to the reaction vessel with fresh reagents and a second extraction was 
performed under the same reaction conditions as above. Again, the contents were 
allowed to cool before being subsequently filtered using a muslin bag with the filtrate 
being added to the previously stored filtrate. The combined filtrate was neutralised 
using NaOH (pH 6-8) and centrifuged at 5000 x g for 5 min to remove remaining 
residual insoluble particulate matter prior to being blast-frozen and freeze-dried. The 






3.3.4 Ethanol precipitation of F. serratus extract. 
Ethanol precipitation was performed on the crude seaweed mass, immediately 
following the primary extraction to separate the carbohydrate content from the 
remaining non-carbohydrate bulk. The freeze-dried crude extract powder was re-
suspended in minimal deionised water and reacted with ethanol (100%) using a ratio 
of seaweed: ethanol of 1:5. The seaweed ethanol reaction mixture was then centrifuged 
for 5 min at 5000 x g. The supernatant was discarded and the precipitate pellet 
containing the seaweed sugars was collected. Fresh deionised water was then used to 
resuspend the pellet prior to being blast and freeze-dried 
 
 3.3.5 Size-exclusion dialysis and simulated digest of the F. serratus extract. 
Simple carbohydrates and other small compounds were removed using 1 kDa cut-off 
dialysis tubing (Spectrum Labs, Breda, The Netherlands). The freeze-dried extract was 
resuspended in minimal deionised water and dialysis tubing was cut into strips of 
approximately 15 cm in length. Each strip of tubing was rinsed gently with deionised 
water to remove traces of the sodium azide storage solution before use. The strips were 
filled with resuspended extract and sealed using clips. The tubing was positioned 
gently in a washed container filled with deionised water, covered with tin foil and 
placed in an orbital shaker at 25 °C at 40 rpm. The water in each container was replaced 
with fresh deionized water every day for three days. After the third day, the dialysis 
tubing was opened and the contents were collected. Following dialysis, a simulated 
digest was performed. Briefly, α-amylase (200 U) was dissolved in filter sterilized 
CaCl2 (1 mM, pH 7). This was added to the seaweed mixture and incubated while 
shaking (150 rpm) at 37 °C for 30 min. The pH was then adjusted to pH 2 using HCl. 
Pepsin (2.7 g) was prepared in 125 ml 0.1M HCl and added to the seaweed mixture 
which was then incubated under the same conditions as before for 2 h. The pH was 
then adjusted to pH 7.0 with NaOH. Bile (3.5 g) and pancreatin (560 mg) prepared in 
125 ml 0.5M NaHCO3 were added. The mixture placed in an orbital shaker (150 rpm) 
for a further 3 h. Subsequently, the seaweed digest underwent a second dialysis using 
tubing with a molecular cut-off point of 1 kDa to remove breakdown components from 






 3.3.6 Preparation of the experimental controls. 
The cellulose control for this study was processed in same manner as the F. serratus 
extract. The cellulose was subjected to a simulated gastric digestion followed by size 
exclusion dialysis with a molecular cut off point of 1 kDa, as previously outlined. 
Following size-exclusion dialysis, the cellulose was blast frozen and freeze-dried. The 
FOS control was not subjected to a simulated digestion or size exclusion dialysis 
before use. 
 
3.3.7 Carbohydrate analysis. 
The total concentration of carbohydrates in the Fse extract, FOS and cellulose control 
was determined by a resorcinol sulphuric acid method [38] with modifications. 
Briefly, a 6 mg/ml resorcinol stock solution, a 14 M H2SO4 solution and a glucose 
control solution of 200 µg/ml were prepared using fresh deionised water. Each sample 
was prepared at a concentration of 1 mg/ml. To each microtube, 200 µl of sample, 200 
µl of resorcinol solution, and 1 ml of the H2SO4 solution were added. Each microtube 
was covered in tin foil and vortexed for 30 sec. The samples were then incubated at 
90 °C for 30 min after which they were placed at room temperature and allowed to 
cool. Readings at an optical density of 430nm and 480nm were taken and an average 
value of total carbohydrates was obtained.  
To evaluate the types of polysaccharides contained within the Fse extract, the 
extract was degraded to its component monosaccharides in 2M trifluoroacetic acid 
(TFA). The Fse extract was prepared at a concentration of 1 mg/ml in the TFA and 
was reacted at 80 °C for 90 min with constant stirring. The concentrations of glucose 
and galactose in the degraded Fse extract were then determined using a HPLC method 
with an Aminex HPX 87C fixed ion resin column. The column was set at 60 °C and 
the eluent (0.009N H2SO4) was run at 0.5 ml/min. The sugars were detected using a 
refractive index detector attached to the system. Each extract sample was filtered 
through a 0.22 µm microfilter before subjecting them to HPLC. Calibration curves for 
the each sugar were generated using different concentrations 10, 20, 50, and 100 ug/ml 






 3.3.8 Ex vivo faecal fermentation distal colon model. 
The medium used for the faecal fermentations was prepared according to Fooks et al 
[40]. The Fooks media consisted of: tryptone water (2 g/l), yeast extract (2 g/l), NaCl 
(0.1 g/l), KH2PO4 (0.04 g/l), K2HPO4 (0.04 g/l), CaCl2.6H20 (0.04 g/l), MgSO4.7H2O 
(0.01 g/l), sodium bicarbonate (2 g/l), Tween 80 (2 ml/l), hemin (0.05 g/l), vitamin K1 
(10 µl/l), cysteine HCl (1 g/l) and bile salts (0.5 g/l). The medium (800 ml) was pH 
adjusted to 6.8 and autoclaved at 121 °C for 15 min. Prior to use, each vessel of the 
MultiFors fermentation system (Infors UK Ltd, Surrey, UK) was autoclaved at 121 °C 
for 15 min. On the morning of the experiment, 2 g (1% w/v) of either control or 
seaweed extract (Fse) were dissolved in 160 ml of Fooks medium and added 
aseptically to their respective fermentation vessel. The media was sparged with 
nitrogen gas for at least 120 min beforehand and throughout the experiment to ensure 
that an oxygen-free anaerobic environment was established in the system. A minimum 
of three freshly voided faecal samples were collected from volunteers on the morning 
of the fermentation. The donors were all healthy adults (age 22 to 50 y), had no history 
of bowl problems and had not taken antimicrobial agents in the previous six months. 
The samples were combined to form a composite faecal sample in order to increase 
the diversity of the microbial community present within. Equal amounts from each 
stool sample were weighted out into a sterile filter stomacher bag (Seward, VWR, 
Dublin, Ireland) and then adding an appropriate volume of maximum recovery diluent 
(Oxoid, Fisher Scientific, Dublin) containing 0.05% L-cysteine hydrochloride 
adjusted to pH 6.5 (which had been boiled after autoclaving and allowed to cool in the 
anaerobic cabinet (Whitley A85 anaerobic workstation (DW Scientific, Shipley, 
United Kingdom) to give a 20% composite faecal solution. The combined samples 
were placed in a stomacher and homogenized for 90 sec to create the composite slurry. 
Immediately after homogenization, 40 ml of the faecal slurry were added to the 
fermentation vessels at a final volume of 200 ml. Samples (1 ml aliquots) were taken 
at 0 h, 5 h, 10 h, 24 h, 36 h and 48 h for total SCFA analysis, pyrosequencing analysis 
and direct enumeration of Bifidobacterium and Lactobacillus species. Plate counts 
were carried out at 0 h, 5 h, 10 h, and 24 h to enumerate the main probiotic genera, 
Bifidobacterium and Lactobacillus. The negative control for this experiment was 





fermentation was repeated three times (n = 3) with samples being taken at each time 
point in duplicate. 
 
 3.3.9 Analysis of short-chain fatty acid production. 
Total short chain fatty acid analysis was performed using a Varian CP-3800 GC 
system incorporating a Flame Ionisation Detector (FID). The system was fitted with a 
Zebron ZB-FFAP capillary column (30m length x 0.32 mm internal diameter x 
0.32µm film thickness; Phenomenex, Cheshire, UK). Helium was supplied as the 
carrier gas at an initial flow rate of 1.3 ml/min. The initial oven temperature was 100 
°C, maintained for 30 sec, raised to 180 °C at 8 °C/min and held for 1 min, then 
increased to 200 °C at 20 °C/min, and finally held at 200 °C for 5 min. The 
temperatures of the detector and the injection port were set at 250 °C and 240 °C, 
respectively. Samples were taken for total SCFA analysis at 0 h, 5 h, 10 h, 36 h, and 
48 h in triplicate. Each sample was centrifuged immediately at 15,000 g for 15 min to 
remove bacteria and other solids with the supernatant being stored at -80 °C. Prior to 
processing, the SCFA samples were thawed on ice, centrifuged for a further 3 min at 
15,000 g and filter sterilized (0.22 µm). Samples were then diluted 1:5 with deionised 
water and 1 mM 2-ethylbutyric acid made up in formic acid was added to each sample 
as an internal control. A calibration curve was created using 10 mM, 8 mM, 4 mM, 2 
mM, 1 mM, and 0.5 mM concentrations of a seven SCFA standard mix. The injected 
sample volume was 0.5 μl. Peaks were integrated using Varian Star Chromatography 
Workstation version 6.0 software. Additional vials, containing standards were 
included in each run to maintain calibration and a cleaning injection of 1.2% formic 
acid was used before each analysis. The SCFAs investigated in this study were acetate, 
propionate, butyric acid, isobutyric acid, valerate, isovalerate and hexanoate. The 
internal standard used was 2 - ethylbutyric acid. 
 
 3.3.10 Enumeration of Bifidobacterium and Lactobacillus populations by plate 
count method. 
Culturable Bifidobacterium and Lactobacillus were enumerated using agar plates 
counts. Samples from each fermentation vessel were taken at 0 h, 5 h, 10 h, and 24 h 





modified de Man, Rogosa and Sharpe (MRS; Difco, Becton-Dickson ltd, Dublin, 
Ireland) agar plates supplemented with 0.05% (w/v) L-cysteine hydrochloride (Sigma-
Aldrich) and 100 µg/ml mupirocin (Oxoid). Mupirocin was prepared by adding 200 
mupirocin discs (200 µg/discs) to 10 ml of mMRS broth, which was then set gently 
shaking on an orbital shaker for 10 min and filter-sterilized (0.45 µm) before being 
added to 400 ml of molten modified MRS (mMRS) agar. The mMRS agar was allowed 
to cool to 48 °C before the addition of the mupirocin. Lactobacillus selective agar 
(LBS; Difco, Becton-Dickson ltd, Dublin, Ireland) plates with glacial acetic acid (1.32 
ml/L) were prepared for Lactobacillus enumeration. Serial dilutions of faecal aliquots 
(10-1 to 10-7) were carried out in maximum recovery diluent (MRD) (Oxoid). Plates 
were incubated anaerobically in a Whitley A85 anaerobic workstation (DW Scientific, 
Shipley, United Kingdom) at 37 °C for 3-5 days before counting. 
 
 3.3.11 Preparation of DNA for high-throughput pyrosequencing. 
Total bacterial genomic DNA was extracted from 1ml of fermentation sample that was 
collected at time points 0 h and 24 h and using the PowerFecal DNA Isolation Kit 
(MO BIO, San Diego, U.S.A). Extracted DNA was stored at - 20 °C following 
isolation. The microbiota composition of each sample was established by amplicon 
sequencing of the V4 region using universal 16S rRNA primers predicted to bind to 
94.6% of all 16S rRNA genes [41, 42]. A forward primer (5’- 
AYTGGGYDTAAAGNG) containing a distinct multiple identifier tag (MID) for each 
sample (Table 3.2) and a combination of 4 reverse primers, R1 (5’- 
TACNVGGGTATCTAATCC), R2 (5’- CTACDSRGGTMTCTAATC), R3 (5’- 
TACCAGAGTATCTAATTC) and R4 (5’- TACCRGGGTHTCTAAT.CC) were 
utilised. All the primers used in this study were synthesised by Eurofins Genomics, 
Ebersberg, Germany). PCRs were carried out using an Applied Biosystems 2720 
Thermo cycler (Applied Biosciences, Thermofisher, Ireland). A hot start step of 95 °C 
for 10 min preceded all PCR runs. Each PCR reaction was performed under the 
following experimental conditions: heated lid 110 °C, 94 °C for 2 min followed by 36 
cycles of 94 °C for 1 min, 52 °C for 1 min and 72 °C for 1 min. This was followed by 
a final temperature step of 72 °C for 2 min and a holding step at 4 °C. PCRs had a final 





Ireland), 1 ul forward primer (0.15 μM), 1 μl reverse primer (0.15 μM) (mix of 4), 5 
μl template DNA, and 18 μl sterile PCR water (BioLine, UK). All PCRs were carried 
out in triplicate. PCR products were analysed using agarose gel electrophoresis (1.5% 
in 1 x TAE buffer). The DNA products were subsequently cleaned using Agencourt 
AMPure XP (Beckman Coulter, California, U.S.A) and quantified using the Quant-
iT™ PicoGreen ® dsDNA Assay Kit (Invitrogen, Massachusetts, U.S.A). All samples 
were sequenced on a 454 Genome Sequencer FLX platform (Roche Diagnostics Ltd, 
West Sussex, U.K) per 454 protocols. 
 
 3.3.12 Analysis of sequencing data. 
Raw sequences were quality-trimmed using the Qiime Suite of programmes[43]; any 
reads not meeting the quality criteria (a minimum quality score of 25 and a sequence 
length <150bp for 16S amplicon reads) were discarded. OTUs were aligned using 
PyNAST [44] and taxonomy assigned using BLAST [45] against the SILVA SSURef 
[46] database release 111. Alpha (α) and β diversity indices and rarefaction curves 
were generated using Qiime. Principal coordinate analysis (PCoA) plots were 
visualised using EMPeror v0.9.3-dev. A phylogenetic tree was calculated using the 
FastTree [47] software and the resulting principal coordinate analysis was visualised 
within KiNG. 
 
 3.3.13 Statistical analysis. 
All results are presented as mean (± SE). Independent t-tests were used to measure 
significance (p<0.05). All statistical analysis was carried out using GraphPad Prism 
version 5.0 for Windows. Unpaired student t-tests were carried out on SCFA data and 











In this study, a polysaccharide extract from the brown seaweed F. serratus was 
investigated for prebiotic potential using an ex vivo faecal fermentation model. 
Samples were taken over a 48-hour period for total SCFA analysis, pyrosequencing 
analysis, and direct enumeration of Bifidobacterium and Lactobacillus species. 
 
3.4.1 Carbohydrate analysis of the Fse extract. 
The total concentration of carbohydrates for the Fse extract, FOS and cellulose control 
was quantified using a resorcinol sulphuric acid method with modifications. 
Carbohydrate concentration is presented in terms of Glucose equivalent (GE) per 
milligram. Total concentration of carbohydrates in the Fse extract was determined to 
be 50.432 ± 1.953 GE mg-1. Total concentration of carbohydrates in the cellulose 
control was 105.686 ± 6.332 GE mg-1 and in the FOS, was 272.052 ± 4.622 GE mg-1. 
The makeup of the Fse extract was examined by treating the extract with TFA to 
degrade the polysaccharides to their monosaccharide building blocks. Prior to 
treatment with TFA, no glucose or galactose was observed in the Fse extract prior to 
TFA degradation. Following treatment with TFA, the degraded extract was found to 
have a glucose concentration of 83.95 µg/ml, and a galactose concentration of 86.07 
µg/ml (Fig. 3.1). 
 
3.4.2 Effect on culturable Bifidobacterium and Lactobacillus. 
Culturable Bifidobacterium were selected for using MRScys agar plates supplemented 
with mupirocin. All values reported are minus the baseline values recorded at time 
point 0 h, and are ± the SEM. Bifidobacterial numbers attained their highest level at 
10 h for the Fse extract (2.04 x108 ± 1.6 x108), the cellulose control (1.163 x108 ± 9.0 
x107) and the FOS control (4.4 x108 ± 2.1 x108) (Fig. 3.2). A non-significant increase 
in Bifidobacterium numbers was observed for the Fse extract and FOS at 10 h in 
comparison with the cellulose control. A reduction in bifidobacterial numbers was 





difference in Bifidobacterium numbers was observed between the Fse extract and 
either control group. Culturable Lactobacillus were selected for using LBS agar plates 
with glacial acetic acid. A reduction in Lactobacillus numbers was recorded at every 
time point during the Fse fermentations. The number of Lactobacillus recovered 
reached their highest level after 5 h for the cellulose control (1.6 x106 ± 3.6 x106) and 
FOS control (1.2 x107 ± 5.4 x106). A reduction was recorded at each subsequent time 
point for cellulose and FOS (Fig. 3.2). 
 
 3.4.3 Short chain fatty acid analysis of fermentation samples. 
Samples were taken at all time points (t = 0 h, 5 h, 10 h, 24 h, 36 h and 48 h) for short-
chain fatty acids analysis. Analysis was carried out using Gas Chromatography – 
Flame Ion Detector (GC-FID) system. All mean values reported are minus the baseline 
values recorded at time 0 h, and are reported ± SE. For all fermentation conditions, 
approximately 90% of cumulative SCFA production took place during the initial 24 
hours. During this time, total SCFA production in the control cellulose fermentation 
remained relatively evenly distributed, with 38.7% ± 4.0% of SCFAs being produced 
between 0 - 5 h, 20.4% ± 4.3% between 5 – 10 h and 20.1% ± 3.1% between 10 – 24 
h. In contrast to this, more than half of total SCFA production (52.1% ± 7.5%) during 
the Fse extract fermentation occurred in the initial 5 h. A similar pattern was observed 
in the FOS fermentation, where 57.8% ± 5.2% of total SCFA were produced during 
the initial 0 - 5 h period (Fig 3.3, Fig 3.4). A significant increase (p<0.05) in total 
SCFA concentration was recorded for both the Fse extract and the FOS at all time 
points (t = 0 h, 5 h, 10 h, 24 h, 36 h and 48 h), in comparison with cellulose (Fig. 3.5). 
Total SCFA production was significantly increased (p<0.05) by 45.6% ± 12.7 with the 
FSE extract and 162.3% ± 5.1 with the FOS extract (Fig. 3.3). The primary SCFA 
produced was acetate, accounting for 47.8% ± 2.3 of Fse extract SCFA production, 
51.7 % ± 2.7 for FOS, and 49.1% ± 4.3 for cellulose. Acetate concentration was 
significantly increased (p<0.05) with the Fse extract at 5 h, 10 h, 24 h and 36 h, in 
comparison with cellulose. Acetate production was significantly (p<0.05) between 0 
– 5 h. (Fig. 3.6) Total acetate production for the Fse extract was increased by 41.9% ± 
6.6 %, in comparison with cellulose. The second major SCFA produced was 





propionate was observed for the Fse extract. Propionate production was increased by 
137.2% ± 49.0 in comparison with cellulose. Propionate production was significantly 
increased (p<0.05) between 0 – 5 h. Propionate concentration was seen to be 
significantly higher (p<0.05) at all time points with the Fse extract, in comparison with 
cellulose. The third major SCFA produced was butyrate (Fig. 3.8). No significant 
increase in butyrate concentration or production was observed with the Fse extract at 
any point. Total production of butyrate was increased by 25.2% ± 12.5. with the Fse 
extract. A trend towards a reduction in overall BCFA production was observed in both 
the Fse extract and FOS fermentations indicating a shift in fermentation profile away 
from the degradation of proteins and amino acids (Fig. 3.9). The fermentation of FOS 
resulted in significant increases (p<0.05) in total SCFA concentration and production 
and significant increases in concentration and production of acetate, propionate and 
butyrate. The Fse extract fermentation had a significant effect on the molar ratio of 
total SCFA production and on production of the major SCFAs (acetate, propionate, 
and butyrate). The proportion of propionate produced during the fermentation was 
significantly increased (p<0.05), rising from 15% to 24% (total SCFA production) and 
from 18% to 26% (acetate, propionate, butyrate) (Table 3.2). 
 
 3.4.4 High throughput DNA sequencing of the 16s rRNA gene variable V4 
region. 
High through-put DNA sequencing was used to investigate the composition of the 
microbiota in an ex vivo model. The data were normalised and differences in the 
relative abundance between the initial time point and were compared with the cellulose 
control. Seven bacterial phyla were identified across the various samples taken; 
Actinobacteria, Bacteroidetes, Firmicutes, Lentisphaerae, Proteobacteria, Tenericutes, 
and Verrucomicrobia. Of these, Firmicutes were the most abundant accounting for 
greater than 50% of reads in each sample, followed by Bacteroidetes and then 
Proteobacteria (Fig. 3.12). At the phylum level, there was no significant change in 
relative abundance between the Fse extract or FOS in comparison with the cellulose 
control. A significant increase (p<0.05) in relative abundance was observed between 





The major bacterial families present were Bacteroidaceae (Bacteroidetes), 
Lachnospiraceae (Firmicutes), Ruminococcaceae (Firmicutes), 
Porphyromonadaceae (Bacteroidetes), and Prevotellaceae (Bacteroidetes). At the 
family level, the Fse extract fermentation recorded a significant increase (p<0.05) in 
the relative abundance of Porphyromonadaceae (Fig. 3.14) in comparison with 
cellulose. For FOS, a significant increase in the relative abundance of the uncultured 
Bacteroidales family S24-7 (Fig 3.14) was observed in comparison with the cellulose 
control. There was no significant difference in changes of relative abundance at the 
family level between the Fse extract and FOS. There was no significant effect on the 
families Bifidobacteriaceae or Lactobacillaceae with any of the fermentations  
The dominant genera of bacteria present throughout the fermentations runs 
were Bacteroides, Lachnospiraceae incertae sedis and another uncultured 
Lachnospiraceae genus, Prevotella, and an uncultured Ruminococcacea genus. At the 
genus level, the Fse extract caused a significant increase (p<0.05) in the relative 
abundance of an uncultured Lachnospiraceae bacterium (Fig. 3.17). At the genus 
level, the FOS fermentation recorded a significant increase (p<0.05) in the relative 
abundance of Sutterella (Fig. 3.16), Christensenella (Fig. 3.17), and significant 
decrease in relative abundance (p>0.05) with Flavonifractor (Fig. 3.17). There was no 
significant effect on the genera Bifidobacterium (Fig. 3.15) or Lactobacillus (Fig 3.17) 
with any of the fermentations 
 
3.4.6 Measurement of Alpha (α) and Beta (β) diversity. 
Alpha (α)-diversity was measured using Chao1 richness estimation, Shannon’s index 
of diversity, Simpson index of diversity, observed species and phylogenetic diversity 
metrics were used to estimate α-diversity. Scatter plot analysis  of alpha diversity 
revealed that supplementation with cellulose had no notable impact on alpha diversity 
measurement. However, a slight trend towards greater diversity was observed with the 
Fse extract for two of the fermentation runs. Beta (β) diversity was measured using an 
unweighted Unifrac distance matrix and visualised in a principle coordinate analysis 
plot. This visualisation showed that the samples from each vessel were clustered 
together at T0 and that supplementation with either the Fse extract or the FOS control 







This study made use of an ex vivo faecal fermentation model to evaluate the prebiotic 
potential of a polysaccharide extract produced from F. serratus. This seaweed was 
chosen as data from a previous investigation (Chapter 2) indicated that an extract from 
this seaweed has bifidogenic properties. By consensus, the key characteristics that 
serve as the criteria for the classification of a compound as a prebiotic are the ability 
to resist gastric acidity and hydrolysis in the upper regions of the gastrointestinal tract 
and to be fermentable upon reaching the colon, leading to the selective growth and/or 
stimulation of a limited number of microbiota members [48, 49]. To satisfy the first 
of these conditions, it was important that the raw seaweed material was handled and 
treated in a way that would ensure an optimised prebiotic study. As such, the choice 
of the correct extraction method was of paramount importance. Solid-liquid 
extractions that use either hot/cold water and ethanol/methanol as solvents are 
commonly used for the collection of a variety of seaweed bioactive compounds [18] 
but sulphated polysaccharides from seaweeds are generally extracted using hot water 
or dilute acid/alkali [50]. While these methods allow for the extraction of seaweed 
polysaccharides, they also extract algal compounds that would not be desirable to have 
in a prebiotic candidate such as polyphenolic compounds that may exhibit 
antimicrobial activity [51], or simple monosaccharides such as glucose and fructose 
which could cause false positives. Previously utilised seaweed extracts were basic 
extracts where cold water was used as the extraction solvent. No post-extraction steps 
were taken to refine them and, thus, an extract containing a multitude of biological 
active components was produced. Here, the primary extraction was carried out using 
dilute hydrochloric (HCl) acid (0.1 M) at 70 °C. The use of hot dilute acid, rather than 
ethanol/methanol or cold water, aided in the extraction of the seaweed’s structural 
polysaccharides located in the algal cell wall. Protons from HCl interfere with the 
hydrogen bonds between the various polysaccharides, releasing them into solution 
resulting in an increased yield [50]. After the primary extraction, ethanol was used to 
precipitate the carbohydrate content out from the crude extract, while simultaneously 
removing large quantities of salts and non-polar materials. Soluble seaweed sugars 
and polysaccharides interact extensively with water molecules when in solution. The 





for the separation of the sugars and polysaccharides from the solutions. The higher the 
alcohol concentration the more the solubility of the polymers in the solution [52]. After 
centrifugation at high speed, the supernatant was removed and discarded and the 
pelleted precipitate, containing the seaweed sugars, was collected and stored after 
being freeze-dried. Although ethanol precipitation can effectively isolate 
carbohydrates from the non-carbohydrate bulk, simple sugars and other bioactive 
components can remain in the extraction mass. To remove these from the extract, 
several rounds of size exclusion dialysis, with a molecular cut off point of 1 kDa, were 
employed. The final post extraction step was an ex vivo simulated gastric digest, in 
order to mimic gastric transit. Breakdown products from the simulated digest were 
removed by a final size exclusion dialysis (1 kDa) step. The F. serratus polysaccharide 
extract, henceforth termed the Fse extract, was then blast frozen and freeze died before 
storage.  
The hydrolysis of polysaccharides to component sugar units is a common and 
crucial step in structural analysis. Soluble polysaccharides can be broken down to their 
component monosaccharides in TFA [53]. Seaweed polysaccharides are polymers of 
simple sugars linked together by glycosidic bonds [54] and thus, from knowing the 
basic monosaccharide building blocks, the parent polysaccharide can be reasoned. 
Prior to treatment with TFA, the Fse extract had no measurable concentration of the 
monosaccharides glucose or galactose. This was expected as free glucose and 
galactose, and other low molecular weight components, would have been removed 
following the 1 kDa size exclusion dialysis. Following treatment with TFA, 
appreciable amounts of both glucose (84.0 µg/ml) and galactose (86.1 µg/ml) were 
detected within the degraded Fse. Laminarin is a β-glucan, which mainly consists of 
β-1,3-D-glucopryanose residues [55]. Β-glucans are naturally occurring polymers of 
glucose that are produced by a variety of plants such as oats, barley and seaweed [56]. 
A fucoidan, described by Bilan et al. [57], consisting of L-fucose, sulfate and acetate 
with small amounts of xylose and galactose was previously isolated from F. serratus. 
As the levels of glucose and galactose detected in the degraded extract were at an 
approximately equal concentration and that galactose is a minor component of 
fucoidan, we hypothesize that the parent polysaccharides present in the Fse extract of 
prebiotic interest include fucoidan and laminarin with fucoidan being present at a 





demonstrated to be resistant to salivary, gastric, pancreatic and intestinal enzymes [58, 
59] 
The human proteome in the GIT has a limited range of the glycoside hydrolases 
for the digestion of complex dietary plant polysaccharides. It is the microbiota, which 
synthesise a large number of these enzymes, that allows us to convert dietary 
carbohydrates to short-chain fatty acids, principally acetate, propionate and butyrate 
[60]. Bacterial fermentation in the gut comprises several different metabolic pathways. 
The fermentation end-products of one species can serve as a growth substrate for 
another. In this manner, some microorganisms benefit from substrates which they are 
not able to utilize directly [61]. Fermentation of FOS resulted, as expected, in the 
largest increase in total SCFA production. The FOS was quickly fermented, by the ex 
vivo microbial populations, giving rise to significantly increased levels (p<0.05) of 
total SCFAs as well as significantly increased levels of total acetate, propionate and 
butyrate at all recorded time points in comparison with the cellulose control. This 
result indicates that the anaerobic faecal fermentation model was appropriately 
designed and implemented for short-chain fatty acid analysis and prebiotic 
investigation. Significant increases in SCFA production were also observed for the 
Fse fermentation but to a lesser extent than the FOS control. This observation agrees 
with a study by Deville et al.,  [20] in which laminarin isolated from Laminaria 
digitata exhibited an effect like the FOS control but in comparison with FOS, the Fse 
extract is a crude one containing carbohydrates of differing molecular weights, varying 
degrees of polymerisation and uncertain fermentation potential. The physical and 
chemical properties of carbohydrates affect which members of the microbiota will be 
involved in its fermentation. This in turn affects both the quantity and type of SCFAs 
produced. Most SCFA production took place early in the fermentation indicating that 
the polysaccharides (fucoidan, laminarin,) contained within Fse extract were readily 
fermented by the ex vivo microbiota. As cellulose is poorly metabolised by the 
microbiota, and no additional carbohydrate source was supplied during the 
fermentation, observed increases in SCFA production in the control vessels can 
principally be attributed to the fermentation of dietary substances carried over from 
the composite faecal sample. The three principal SCFAs (acetate, propionate and 
butyrate) alone accounted for more than 85% of the total SCFAs produced in the 





Significant increases (p<0.05) in the production of both acetate (1.4-fold increase) and 
propionate (2.4-fold increase) were observed with the Fse fermentation. Non-
significant increases in butyrate concentrations were also observed for the Fse 
fermentation.   The results of this investigation also broadly agree with a similar study 
involving batch fermentations with low molecular weight polysaccharide derivatives 
of alginate and agar as the test compounds. There, significant increases of acetate 
and/or propionate were recorded, while all seaweeds produced very low or negligible 
levels of butyrate [10]. While it is understood that all dietary fermentable 
carbohydrates that reach the colon have the potential to produce butyrate, not all 
fermentable substrates are equally butyrogenic. Resistant starch and oligofructose, for 
example, are associated with greater production rates of butyrate as a proportion of the 
total SCFA produced than pectin or alginate, which is a major polysaccharide in brown 
seaweed. [62].  
Chemical and physical properties also influence which members of the 
microbiota will be involved in its fermentation. Studies have shown that SCFA 
production in the proximal and distal colon is in the order of acetate > propionate = 
butyrate, in a molar ratio of approximately 60:20:20 [63] with the ratio varying among 
individuals because of difference in their microbiota and in types and amounts of 
carbohydrates consumed in the diet. Forty-eight hours after inoculation of the 
fermentation vessels, the acetate/propionate/butyrate ratio of the cellulose control 
(without the supplementation of any carbohydrate) was 57:18:26 in approximate 
agreement with other reported values. The acetate: propionate: butyrate ratio of the 
Fse containing fermentation was observed to be 53:26:21, indicating a significant 
alteration (P<0.05) of the relative amount of propionate produced as well as a 
corresponding decrease in the relative production of both acetate and butyrate. Studies 
dealing with the fermentation of brown seaweeds are contentious [64]. A fermentation 
study involving laminarin reported significantly increased levels of both butyrate and 
propionate in comparison to glucose, which was used as a non-prebiotic control [58]. 
The microbial fermentation of indigestible carbohydrates in the gut is the main source 
of propionate available in the body [65]. Propionate production is associated with the 
presence of greater amounts of β-glycosidic bonds as demonstrated by the 
fermentation of polysaccharides such as laminarin [58]. Propionate is a precursor for 





that include anti-lipogenic, cholesterol-lowering, anti-inflammatory and anti-
carcinogenic activities [66]. Furthermore, as obesity levels continue to rise worldwide, 
there has been much interest recently in the role that propionate has in enhancing 
satiety. The selective increase of colonic propionate levels in humans, through the 
consumption of inulin propionate ester, has been shown to regulate appetite, reduce 
hepatic and intra-abdominal visceral fat deposits and reduce body weight in 
overweight adults [67]. Recent proteomic research indicates that some of the effects 
of propionate at the cellular level differ from the action of butyrate. In human colon 
cancer cells and neutrophils, the anti-proliferation capability of SCFA has been 
associated with the inhibition of histone deacetylase. Butyrate is viewed as the most 
effective inhibitor, with propionate being regarded as less potent. Acetate was seen 
not to harbor inhibitory activity [68]. The SCFA receptors FFAR2 and FFAR 3 are 
likely to mediate some of the actions of propionate. In a study carried out with mice 
transplanted with Bcr-Abl-transfected BaF3 cells, who received inulin-type fibres in 
their drinking water, both acetate and propionate were shown to reduce BaF3 cell 
proliferation. Propionate is one of the most potent endogenous FFAR2 ligands and 
FFAR2 is highly expressed by BaF3 cells [33, 69]. Further, both FFAR2 and FFAR3 
are expressed in the intestine and colocalise with a subset of enteroendocrine cells in 
the mucosal epithelium that express Peptide YY (PYY). PYY and other peptide 
hormones secreted by enteroendocrine cells, such as Glucagon-like peptide 1 (GLP-
1) and Glucose dependent insulinotropic polypeptide (GIP), are key modulators of 
energy homeostasis and glucose metabolism. Propionate is believed to be the most 
potent endogenous agonist for both FFAR2 and FFAR3.  A study by Chambers et al. 
[67] demonstrated that propionate significantly stimulated the release of PYY and 
GLP-1 from human colonic cells. An increase in propionate levels in the colon could 
lead to an anti-obesity effect on humans. Even a small habitual increase in energy 
intake of just 50-100 kcal/day can lead to gradual long-term weight gain, with the 
reported average weight gain for an adult being 0.3-0.8 kg/year. A major challenge for 
public health agencies is the development of effective strategies that can prevent the 
increased prevalence of obesity.  Interventions, that can be safely applied at the 
population level to reverse this minor energy imbalance and prevent weight gain 
throughout life, would therefore have substantial benefits for public health. Increasing 





be an attractive prospect in preventing overeating, increasing post prandial satiety and 
maintaining good general health. 
DNA sequencing and other culture-independent technologies do not rely on 
cultivation in the laboratory but target nucleic acids directly to better study changes in 
the microbial populations present in specific niche environments [70]. The sequencing 
analysis of the 16s rRNA gene amplicon is a widely used technique for studying 
microbial communities in samples taken from a variety of different sources such as 
soil, blood and food [71]. The nine variable 16s rRNA gene regions are flanked by 
conserved regions in most bacteria and can be used as targets of PCR primers with 
near-universal bacterial specificity [72]. In this study, the V4 region of the 16s rRNA 
gene was targeted to examine the effect that the Fse extract had on the ex vivo 
microbial community. This variable region has been shown to be most efficient in 
identifying microbial populations in samples with high levels of sequence diversity 
[73].. The production timeline for SCFAs is also indicative of how well the Fse extract 
and the experimental controls were fermented by the ex vivo microbiota. Both the Fse 
extract and the FOS control were quickly and efficiently utilised by the endogenous 
microbiota with 57.002% ± 5.453 and 61.548% ± 4.668 of total SCFA, respectively 
produced after the first five hours of the fermentation. This implies that the Fse extract 
has prebiotic potential, however, three biological repeats lack the statistical power to 
provide a definitive analysis on the effect of seaweed polysaccharides, this is the first 
time that a processed polysaccharide-rich extract from F. serratus has been 
investigated in this manner. 
Global stimulation of the gut microbiota would be detrimental to host gut 
health as it would allow for the proliferation of pathogenic species and a corresponding 
build-up of toxic metabolites. A putative prebiotic would need to have a selective 
effect on only the beneficial members of the gut microbiota. Culture independent 16s 
rRNA analysis has indicated that the two most abundant phyla in adults are the 
Bacteroidetes (normally between 10-50%) and the Firmicutes (up to around 75%). The 
dominant Firmicutes species mainly belong to the families Lachnospiraceae and 
Ruminococcaceae. Members of the phylum Actinobacteria, especially the genus 
Bifidobacterium can also be present in large numbers in the normal healthy adult colon 
(normally up to 10%), but have often been underestimated by 16s rRNA analysis if 





its fermentation in the gut would result in the stimulation of Bifidobacterium, 
Lactobacillus and a few other beneficial members of the microbiota.  
Supplementation of the fermentation vessels with the Fse extract did not have 
a widespread effect on the microbiota in the ex vivo model. An apparent selective 
stimulation of certain propionate and acetate producers, in agreement with observed 
trends in SCFA production, was observed. To understand and control SCFA formation 
by the colonic bacteria, knowledge of the phylogenetic groups and pathways which 
have roles in the formation of each acid is needed. The three phyla Bacteroidetes, 
Firmicutes and Actinobacteria are the most abundant in the intestine. The phylum 
Bacteroidetes mainly produces acetate and propionate, whereas the Firmicutes phylum 
has butyrate as its primary metabolic end product [75]. This information is currently 
available for butyrate but is lacking for propionate. Three different biochemical 
pathways are known for propionate production by the microbiota; the succinate 
pathway, the acrylate pathway, and the propanediol pathway. The most common 
metabolic pathway for propionate biosynthesis amongst the microbiota (Bacteroides, 
Phascolarctobacterium, Dialister, Veillonella) is the succinate pathway. Through this 
pathway, pyruvate is converted to oxaloacetate from pyruvate which in turn is 
converted into succinate, succinyl-CoA, propionyl-CoA and finally into propionate. 
Propionibacterium spp. is another common propionate producer that uses the 
succinate pathway. The acrylate pathway for propionate production has been 
characterised in the soil bacterium Clostridium propionicum, and the corresponding 
genes have been recently described. It is possible to distinguish the succinate pathway 
from the acrylate by incubation with stable isotope-labelled substances.  
Finally, several bacteria are known to produce 1,2-propanediol from deoxy 
sugars such as fucose and rhamnose, or via different pathways from 
dihydroxyacetonephosphate or lactate. In some bacteria, 1,2-propanediol can be 
further metabolised to propionate or propanol [65, 69, 76]. There was a marked 
increase in the relative abundance of the propionate-producing family  Veillonellaceae 
[77], the genus Parabacteroides that is known to produce both propionate and acetate 
and the family Erysipelotrichaceae which is peripherally related to the butyrate-
producing superfamily Lachnospiraceae. Members of the family Veillonellaceae have 
an interesting metabolism in that they are unable to ferment carbohydrates including 





the relative abundance of this family would likely be because of bacterial cross-
feeding. Megasphaera, a member of the family Veillonellaceae, can utilize lactate and 
convert D-Lactate to propionate [79]. A member of the family Alcaligenaceae, 
Parasutterella excrementhihominis, isolated from human faeces was shown to 
produce trace amounts of propionate as an end product of metabolism [80]. 
Interestingly, both the Fse extract and the FOS control had a negative effect on levels 
of Bacteroides and Prevotella, (two major propionate producers), Faecalibacterium 
and the previously mentioned family Lachnospiraceae which belong to the major 
butyrate producing Clostridial cluster IV of the Firmicutes [81, 82]. In agreement with 
the plate count data for the probiotic bacteria, the Fse extract had no positive impact 
on the relative abundance of bifidobacteria or lactobacillus populations. A substantial 
increase in the mean relative abundance of bifidobacteria was seen with the FOS 
fermentation although no impact was seen on the abundance of lactobacilli.  
Scatter plot analysis of Alpha diversity indicated a slight trend towards greater 
diversity of species for the F. serratus fermentation. This infers that the extract had a 
wider stimulatory effect than either the FOS or cellulose control. This could be 
because of the presence, in the F. serratus extract, of a wider spectrum of oligo – and 
polysaccharides that have different glycosidic linkages which more bacterial species 
can degrade. Unifrac β-diversity analysis indicates the extent of similarity between 
microbial communities [83]. Unweighted PCoA (Principle co-ordinate Analysis) plots 
indicated a clear separation between the fermentation communities based on run rather 
than treatment condition. Supplementation with either the Fse extract or the FOS 
control had no notable effect on the similarity between their respective ex vivo 
populations and that of the cellulose control.  
Most intestinal bacteria are saccharolytic which means that, in general, they 
hydrolyse dietary polysaccharide, first to oligosaccharides of a lower molecular 
weight and then to monosaccharides using a diverse range of carbohydrate modifying 
enzymes and transportation systems. Bifidobacteria, for example, are able to use a 
diverse range of dietary carbohydrates that are not digested in the upper regions of the 
GIT and reach the colon intact [28]. As cellulose is poorly metabolised by the gut 
microbiota [84], substantial bacterial proliferation would not be expected in a 
fermentation vessel where cellulose was the only available carbohydrate source. The 





would be from the inevitable crossover of small amounts of unused carbohydrates in 
the added composite faecal slurry. In contrast, both the polysaccharide rich Fse extract 
and the FOS control contain complex carbohydrates that are available for the microbial 
community to use as an energy source for growth. Serial dilutions of collected 
fermentation sample were carried out at 0 h, 5 h, 10 h, and 24 h in maximum recovery 
diluent to determine Bifidobacterium and Lactobacillus numbers (Log10 CFU/ml). The 
respective agar plate data for the enumeration of bifidobacteria and lactobacilli showed 
that the Fse extract had no significant impact (p-value <0.05) on the numbers (Log10 
CFU/ml) of either. However, a noteworthy, non-significant, effect on bifidobacteria 
numbers was observed with FOS between 0 h and 10 h.  
The ability of bifidobacteria to metabolise complex carbohydrates has allowed 
them to inhabit a unique ecological niche. From this, the host gains energy by 
absorbing SCFAs while the bifidobacteria are protected in a safe, anaerobic 
environment and are supplied with large quantities of glycans. Analysis of the genome 
of B. breve UCC2003 revealed the presence of a fos operon that encodes for a putative 
permease, a conserved hypothetical protein and a β-fructo-furanosidase, all of which 
have involved in the metabolism of short-chain FOS [85]. Despite this, FOS had little 
or no observed effect on numbers of bifidobacteria. The ability to stimulate the growth 
of beneficial members of the gut microbiota is an important part of the prebiotic 
definition as currently understood. In the years to come, it is likely that new subclasses, 
with tightly defined criteria of activity, will be established. 
The apparent difficulty that intestinal bacteria had in fermenting the Fse extract 
was not completely unexpected. While alginate and laminarin are fermented by some 
strains of Bacteroides and Clostridium, most intestinal strains of microflora cannot 
ferment fucoidan. The breakdown of the α- (1-3) bonds in fucoidan is done by 
fucoidanases, enzymes that are only found in marine bacteria and mollusks. Although 
Bifidobacterium cannot utilise laminarin it is reported that degraded products from 
laminarin produced by Clostridium ramosum, a general human intestinal bacteria, are 
utilised by Bifidobacterium strains [59, 86]. The FOS fermentation resulted in large 
increases in production of all three biologically important SCFAs and in 
Bifidobacterium populations indicating that the experimental design for this prebiotic 





F. serratus polysaccharides, as well as seaweed derived polysaccharides in general, 
should be carried out by fractionating the algal polysaccharides into different 
molecular weight bands and then testing each M.W. fraction separately or in 
combination for prebiotic activity. Currently, prebiotics have been tested to stimulate 
Bifidobacterium, Lactobacillus and a small number of other organisms such as 
Eubacteria and Faecalibacteria. While stimulating the actual growth of select 
members of the microbiota is clearly important in terms of being a prebiotic, it is only 
one part of the prebiotic definition, as currently stated, coupled with the stimulation of 
bacterial activity. The definition, as quoted in the introduction, is an ever evolving one 
as more and more knowledge becomes available regarding the inner workings of our 
gut and the complex relationships that exist amongst its resident microbiota and their 
environs. In time, new classes or subcategories of prebiotic may be established that 
have well-defined modes of action and may supersede our current definitions of 






3.6 Conclusion.  
In this chapter, we have demonstrated that the Fse extract was successfully able to 
tolerate a simulated gastric digestion where it was subjected to both salivary and 
gastric digestive enzymes as well as acidic conditions mimicking the stomach 
environment. When the Fse extract was added to an ex vivo faecal fermentation 
system, the representative microbiota successfully used the algal polysaccharides as 
fermentation substrates as indicated by noticeable increases in SCFA production 
especially propionate and acetate. Fermentation of the extract also resulted in non-
significant increases in butyrate concentration. Fermentation of the Fse extract did not 
stimulate increased growth of Bifidobacterium or Lactobacillus or significantly alter 
their relative abundance within the representative microbiota. The results indicate that 
the fermentation of the Fse extract did not bring about a desired prebiotic effect as 
outlined previously, possible because of the low fermentability of F. serratus 
fucoidan. Interestingly, a similar result was obtained for the known prebiotic FOS. 
During the FOS fermentation, there was also no significant effect on Bifidobacterium 
or Lactobacillus in terms of relative abundance or in recovery of culturable strains. 
This could simply be because the extract concentration used in the study was too low 
for a prebiotic effect to be evident, or that the absence of the required enzymes for the 
breakdown of seaweed polysaccharides such as fucoidan (fucoidanases), reduced the 
overall fermentability of the Fse extract. Further, it is known that brown seaweeds 
possess components, such a phlorotannins, that have potent anti-microbial properties. 
The carryover of such compounds from the extraction may have reduced the overall 
effectiveness of the extract from a prebiotic point of view.  
While the Fse extract, prepared as part of this study did not exhibit all the 
prebiotic markers an expected increase in the production of SCFA, especially 
propionate, is a positive outcome in terms of promoting overall gut health and in 
combating obesity through enhancing satiety. Also, as the extract was shown to 
withstand gastric digestion, F. serratus would be an excellent source of dietary fibre 
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Figure 3.1 Carbohydrate analysis of the F. serratus polysaccharide extract pre-treatment and post-


























Figure 3.2 Effect on culturable (a) Bifidobacterium and (b) Lactobacillus recovered. Data represent the 
mean (±SE). (a = P<0.05), b = P<0.005, c = P<0.0005 relative to cellulose, d = P<0.05, e = P<0.005, f 










































Figure 3.3 SCFA production timeline. The timeline of SCFA production for (a) cellulose, (b) FOS and 
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Figure 3.4 The percentage breakdown of total SCFA production. Breakdown of SCFA production (a) 
total, (b) between 0-24 h and (c) between 24-48 h. Date represents mean values. 
 
(a) Total SCFA production 
 
(b) SCFA production 0 – 24 h 
 
(c) SCFA production 24 – 48 h 
 
































































Figure 3.5 The effect of the F. serratus extract and FOS on (a) total SCFA concentration and (b) total 
SCFA production per time point. Data represent the mean (±SE). (a = P<0.05), b = P<0.005, c = 
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Figure 3.6 Acetate production. The effect of the F. serratus extract and FOS on (a) acetate 
concentration and (b) acetate production. Baseline values obtained at 0 h were subtracted from each 
time point. Data represent the mean (±SE). (a = P<0.05), b = P<0.005, c = P<0.0005 relative to cellulose, 
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Figure 3.7 Propionate production. The effect of the F. serratus extract and FOS on (a) propionate 
concentration and (b) propionate production. Baseline values obtained at 0 h were subtracted from each 
time point. Data represent the mean (±SE). (a = P<0.05), b = P<0.005, c = P<0.0005 relative to cellulose, 
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Figure 3.8 Butyrate production. The effect of the F. serratus extract and FOS on (a) butyrate 
concentration and (b) butyrate production. Baseline values obtained at 0 h were subtracted from each 
time point. Data represent the mean (±SE). (a = P<0.05), b = P<0.005, c = P<0.0005 relative to cellulose, 
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Figure 3.9 Branched-chain fatty acid production. The effect of the F. serratus extract and FOS on (a) 
BCFA concentration (b) BCFA production. Baseline values obtained at 0 h were subtracted from each 
time point. Data represent the mean (±SE). (a = P<0.05), b = P<0.005, c = P<0.0005 relative to cellulose, 
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Table 3.1. The fermentation of the F. serratus extract resulted in significant changes in (a) the molar 
ratio of acetate: propionate: butyrate: BCFAs, and (b) the molar ratio of acetate: propionate: butyrate. 






Acetate: Propionate: Butyrate: BCFAs: 
Production total SCFA 
 
   
Cellulose 49 15 22 14 
FOS 52 21 21 6 
F. serratus extract 48 24a 19 9 
SCFA Production 0 – 24 h     
Cellulose 52 16 21 11 
FOS 54 21 20 4 
F. serratus extract 51 25a 18 6 
SCFA Production 24 - 48 h     
Cellulose 25 12 28 34 
FOS 34 16 31 30 





Acetate: Propionate: Butyrate: 
Production total SCFA 
 
  
Cellulose 57 18 26 
FOS 55 23 23 
F. serratus extract 53 26a 21 
SCFA Production 0 – 24 h    
Cellulose 58 17 24 
FOS 56 23 21 
F. serratus extract 55 27a 19 
SCFA Production 24 - 48 h    
Cellulose 39 18 43 
FOS 42 20 38 





Table 3.2 To generate 16s rRNA bacterial gene amplicons (V4), a different version of the same forward 
primer was used for each fermentation sample. (a) Each version contained a unique a distinct multiple 
identifier (MID) barcode allowing for distinction between the different samples. (b) A mixture of four 
different reverse primers in conjunction with a single forward primer was used to generate16s rRNA 





Sample ID Primer name Clamp Barcode Oligo 








































































































Table 3.3 Rarefaction curve for each group at 97% similarities levels. The amount of taxonomical units 























































































































































































Figure 3.10 Alpha diversity was measured by several different metrics. (a) Shannon’s index of diversity, 
observed species, Chao1 richness estimation, Simpson index of diversity, and phylogenetic diversity metrics 








Figure 3.11 Beta diversity. Principle coordinate analysis of unweighted Unifrac reveals separation by 
fermentation run. Purple (light) - Run 1 0 h, Yellow (light) - Run 2 0 h, Green (light) - R3 0 h, Purple 










































Figure 3.13 (a) Increase/decrease in relative abundance at the phylum level. (b) Percentage change in 
relative abundance at the phylum level. Data represent the mean (±SE). 
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Figure 3.14. (a) Increase/decrease in relative abundance at the family level . (b) Percentage changes in 
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Figure 3.15 (a) Increase/decrease in relative abundance of genera in the phyla Actinobacteria, 
Fibrobacteres, Lentisphaerae, Tenericutes, and Verrocomicrobia. (b) Percentage change in the relative 
abundance of genera in the phyla Actinobacteria, Fibroacteres, Lentisphaerae, Proteobacteria, 
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Figure 3.16. (a) Increase/decrease in relative abundance of the genera in the phylum Proteobacteria. 
(b) Percentage change in the relative abundance of genera in the phylum Proteobacteria. Values 
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Figure 3.17 (a) Increase/decrease in relative abundance of genera in the phylum Firmicutes. (b) 
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Supplementary Figure 3.1 Summary of the extraction process and post extraction processing carried 







•Primary extraction of the F. serratus using hot dilute HCl (0.1M)
•Filtered and centrifuged to remove particular matter
Ethanol precipitation
• Carbohydrates separated out and collected following centrifugation
Size exclusion dialysis
•Monosaccharides and other compounds with a molecular weight of less 
than 1 kDa are removed
Simulated digestion
•simulated digestion mimics passage through the mammalian digestive 
system.





Supplementary Figure 3.2 Overview of the ex vivo faecal fermentation model used to assess the 




Vessel A: Negative control 
(cellulose)
Vessel B: Positive control 
(FOS)
Vessel C: Fucus serratus 
polysaccharide extract
Temp: 37°C 
pH:  6.8 




1% w/v extract or control 
+ 

















Supplementary Table 3.1. Alpha diversity., Shannon’s index of diversity, observed species, Chao1 
richness estimation, Simpson index of diversity, and phylogenetic diversity metrics were used to  










Species        
Control run 1 0 h 1,465.43 0.97 6.77 42.74 770.00 
Control run 2 0 h 1,072.83 0.96 6.59 38.17 620.00 
Control run 3 0 h 989.06 0.96 6.40 32.14 556.00 
FOS run 1 0 h 1,295.62 0.96 6.54 40.69 688.00 
FOS run 2 0 h 1,048.61 0.96 6.43 39.70 639.00 
FOS run 3 0 h 903.48 0.96 6.31 30.18 505.00 
Fse extract run 1 
Fse extract run 1 
0 h 920.47 0.98 6.83 33.18 548.00 
Fse extract run 2 0 h 1,004.17 0.95 6.13 34.47 522.00 
Fse extract run 3 0 h 1,169.14 0.96 6.49 37.23 649.00 
Control run 1 
Control run 1 
24 h 1,485.28 0.97 6.98 45.99 828.00 
Control run 2 24 h 979.45 0.96 6.65 37.03 611.00 
Control run 3 24 h 1,101.78 0.97 6.79 36.14 631.00 
FOS run 1 
FOS run 1 
24 h 1,031.50 0.97 6.57 36.09 619.00 
FOS run 2 24 h 1,359.05 0.98 7.31 44.53 759.00 
FOS run 3 24 h 1,014.92 0.96 6.08 35.91 561.00 
Fse extract run 1 
Fse extract run 1 
24 h 1,234.12 0.98 6.67 40.77 722.00 
Fse extract run 2 24 h 784.16 0.97 6.64 30.28 485.00 















A comparison of prebiotic properties between low 
molecular weight and high molecular weight polysaccharide 
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Jointly performed all experiments relating to: 
• The faecal fermentation using an ex vivo colonic model 
• Analysis of SCFA production by GC-FID 
• Extraction and purification of DNA from faecal pellets 






The proper functioning of dietary polysaccharides is greatly dependent on their 
molecular weight. These molecules are often chemically transformed into lower 
molecular oligosaccharides via depolymerisation processes. Lower molecular weight 
oligosaccharides can be better sources of carbon and energy for bacteria than their 
parent sugars. Seaweeds such as the brown seaweed Laminaria digitata, amongst 
others, are naturally rich in polysaccharides making them suitable candidates for 
prebiotic investigation. However, the fibre content of seaweeds is typically high 
molecular weight and while some demonstrate fermentative capacity in the lower 
intestines most pass through the gut too quickly for the gut microbiota to utilize them 
to any great extent. Molecular weight is an important factor for the correct functioning 
of polysaccharides. Lower weight oligosaccharides can be better sources of carbon 
and energy than their parent molecule. Here, two similarly processed extracts L 
digitata were used to access the effect of depolymerisation on prebiotic potential. Both 
extracts, the L. digitata polysaccharide extract (crude extract) and the L. digitata 
depolymerised polysaccharide extract (depolymerised extract), were subjected to an 
ex vivo faecal fermentation model where samples were taken at 0 h, 5 h, 10 h, 24 h, 36 
h and 48 h for DNA sequencing, enumeration of Bifidobacterium and Lactobacillus, 
and SCFA analysis The fermentation of both extracts brought about a significant 
increase (P<0.05) in total SCFA production (1.8-fold and 1.7-fold increases) and the 
production of the biologically significant SCFAs, butyrate (1.7-fold and 0.9-fold 
increases), propionate (3.3-fold and 3.1-fold increases) and acetate (1.8-fold and 1.9-
fold increases) in comparison with a cellulose control. It was found that 
depolymerisation of L. digitata polysaccharides significantly (p<0.05) increased 
propionate production and significantly (P<0.05) reduced butyrate production relative 
to the non-depolymerised L. digitata extract. Neither L. digitata extract had a 









The functionality of dietary polysaccharides is closely related to their molecular 
weight. Biopolymeric substrates, specifically polysaccharides, are often chemically 
transformed into lower molecular weight oligosaccharides or monosaccharides via 
depolymerisation processes, which can be hydrolytic, thermal or oxidative in nature. 
Depolymerised products can be better sources of carbon and energy for growing 
bacterial cells [1, 2]. There is emerging evidence that low-molecular weight 
polysaccharides and oligosaccharides derived from hydrocolloids can act as a source 
of soluble fibre and may also have prebiotic activity. Seaweeds such as L. digitata, 
amongst others, are naturally rich in polysaccharides making them suitable candidates 
for prebiotic investigation. However, the fibre content of seaweeds is typically high-
molecular weight and, while some demonstrate a degree of fermentative capacity in 
the lower intestines, most pass through the gut too quickly for the microbiota to use 
them to any significant degree. The inclusion of fibre in the diet is known to increase 
the feeling of satiety following meals and improve digestive transit through increased 
faecal bulking [3]. Both Bifidobacterium and Lactobacillus have been observed to 
more selectively ferment lower molecular weight oligosaccharides than their parent 
carbohydrate with a higher molecular weight. An example of this is the degree of 
polymerisation (dp) of fructans, which has a major impact on their fermentation by 
probiotic bacteria, and thus has an influence on their beneficial effect on host health. 
Different dp of fructans can also influence the production profile of short chain fatty 
acids (SCFAs). For most probiotic strains, inulin-type fructans with a lower dp lead to 
earlier growth of bifidobacteria and lactobacilli than those with a higher dp. Longer 
chain inulins, however, show a more pronounced prebiotic effect affecting probiotic 
strains in the proximal and distal colon. The dp of gluco-oligosaccharides is also 
known to influence bifidobacterial selectivity, with a dp of 3 to 7 giving highest 
prebiotic activity. Gluco-oligosaccharides with a dp of greater than 7 were found to be 
selective for bifidobacteria in a non pH-controlled fermentation experiment [4, 5].  
 Fucoidans are high-molecular weight sulphated fucose rich polysaccharides 
which are extracted from brown seaweeds. Low-molecular weight fucoidan (< 30 
kDa) can be obtained through acid hydrolysis or free radical depolymerisation. A study 





bioactivities than high-molecular weight fucoidan [6]. Low molecular weight fucoidan 
in combination with high stability fucoxanthin has also been found to exert a prebiotic 
effect and anti-inflammatory activity in Caco-2 cells by enhancing intestinal epithelial 
barrier and immune function [7]. In a study carried out by Tsai et al. low-molecular 
weight chitosan, a marine polysaccharide found in the shells of crustaceans, exhibited 
a significantly higher activity for promoting the growth of Bifidobacterium and 
mediating higher levels of total anaerobes than a fructooligosaccharide (FOS) control 
using a hamster model [8]. For the preparation of low molecular weight extracts, acid, 
radical and enzymatic methods have been widely described in literature. For the acid 
method, the higher temperatures or acidity can lead to lower molecular weight 
products as well as a lower sulphated group content. However, the sulphated group 
has been associated with many polysaccharide bioactivates. Enzymes prepared from 
bacteria and the digestive glands of marine invertebrates are highly specific for 
cleaving glycosidic bonds in the polysaccharide chain, though, the commercial 
preparation and usage of these enzymes is still not feasible. The radical method 
typically uses hydrogen peroxide. The presence of 0.1 – 10 mM hydrogen peroxide 
has been shown to hydrolyse polysaccharides such as xylan, galacturonan, 
arabinogalactan and cellulose [9]. 
Seaweeds and seaweed extracts have been shown to demonstrate prebiotic and 
immune modulatory activities. The approval of some seaweeds for human 
consumption has led, in part, to a renewal of interest in them as sources of dietary fibre 
and in their biological properties. In these seaweeds, soluble fibre consists of laminarin 
(β1–3, β1-6-glucan), fucans and alginates. The non-soluble fibre content is essentially 
cellulose. The human gastrointestinal tract (GIT) produces a limit array of enzymes 
that can catalyse the hydrolysis of various disaccharides and a few specific 
polysaccharides (starches). Most complex polysaccharides, such as FOS, however, 
cannot be degraded by human digestive enzymes [10, 11]. Laminarin is a glucose 
polymer consisting of a (1, 3), -β-D-glucan backbone with β (1, 6) branches while 
mannitol is a sugar alcohol. Alginate is a linear copolymer composed of (1, 4)-β-D-
mannuronic acid and (1, 4)-α-L-guluronic acid. Laminarin and mannitol are storage 
carbohydrates that accumulate in the seaweed during the light season, while alginate 
is a structural component with little annual variation. The biomass composition of 





conditions and the harvesting time [12]. Laminarin concentration varies with habitat 
and season, and can reach up to 32% of dry weight and is to be found mainly in the 
fronds of the different Laminaria species [13]. Laminarin contains two types of 
polymeric chains, the G-chain (glucose is attached to the end of the chain) and the M-
chain (has mannitol as the terminal reducing chain). Fucoidan extracted from L. 
digitata is reported to contain fucose and sulphates as well as xylose, mannose, 
glucose, galactose and uronic acid in minor amounts [14]. Laminaria digitata is a 
brown seaweed generally found in the sub littoral zone of the northern Atlantic Ocean 
but can also be cultivated on ropes. The leaves of this species are known to grow up 
to 6m in length. Traditionally this seaweed has been used a fertilizer and for the 
extraction of iodine. In more modern times, L. digitata has been used as a source of 
alginic acid, which is used in the manufacture of toothpastes and cosmetics, and in the 
food industry as a binding, thickening and molding agent. The major structural 
component of the cell wall of brown seaweeds is alginate, which is composed of 
mannuronic and guluronic acids that are covalently linked in sequence together. The 
main storage carbohydrates of brown seaweeds are laminarin, which consists of a β-
(1,3) glucan chain with small amounts of β-(1,6) branches, and mannitol. Other 
compounds of importance include fucoidan, proteins and minerals [15, 16].  
Prebiotics are a class of food ingredients that are resistant to gastric acidity, 
hydrolysis by mammalian digestive enzymes and absorption in the GIT. They are 
fermentable in the gut and stimulate the growth and/or activity of intestinal bacteria 
associated with health and wellbeing. Carbohydrates such as FOS, inulin and 
galactooligosaccharides (GOS) are well accepted examples of prebiotics [17]. The 
most effective way to assess fermentation in vitro is through the incubation of a 
representative microbiota in an anaerobic fermentation chamber in the presence of 
potential prebiotic compounds [18]. Only a few studies have been carried out  
examining the impact that seaweed polysaccharides have on gut microbial 
communities, especially employing methodologies that allow for the analysis of most 
bacteria in the community rather than pre-determined groups [19]. The main aim of 
this study was to assess the effect of depolymerisation on the prebiotic potential of two 
similarly processed polysaccharide extracts, from the brown seaweed Laminaria 





extracts were termed the L. digitata polysaccharide extract (crude extract) and the 























4.3 Materials and methods.  
 
4.3.1 Materials. 
The seaweed material used in this study to produce this polysaccharide rich extract 
was from the brown seaweed species L. digitata. The L. digitata raw material 
originated from a collection site in the Clare/Galway region of Ireland. All laboratory 
materials were obtained from Sigma-Aldrich, Dublin, Ireland unless otherwise stated. 
All plastic consumables were obtained from Sarstedt Ltd, Wexford, Ireland. 
 
4.3.2 The primary extraction of L. digitata using a hot-acid extraction method. 
The seaweed sample was washed with cold water to remove any attached particulate 
matter and afterwards stored at -20 °C. Prior to extraction, the seaweed was removed 
from cold storage and blended to a fine powder, which was then added to the reaction 
vessel and resuspended with deionised water (1:10 (w/v) seaweed/water solution). 
Hydrochloric acid (37%) was added (8.25 ml/L) to the seaweed/water solution to give 
a final concentration of 0.1 M. The vessel was allowed to shake at 75 rpm in an orbital 
shaker (MaxQ 6000 Shaker, Thermo Fisher Scientific, Ireland) for 3 h at 70 °C. 
Afterwards, the vessel was removed from the shaker and allowed to cool. The seaweed 
solution was filtered through a muslin bag with the filtrate being transferred to a clean 
storage vessel. The remaining seaweed residue was returned to the reaction vessel with 
fresh reagents and a second extraction was performed under the same reaction 
conditions as above. Again, the contents were allowed to cool and were filtered once 
more, with the new filtrate being added to that which had previously been obtained. 
The combined filtrate was neutralised using NaOH (pH 6 - 8) and centrifuged at 5000 
g for 5 min to remove remaining insoluble particulate matter prior to being blast-frozen 








4.3.3 Ethanol precipitation of L. digitata extracts. 
Algal sugars and polysaccharides were separated from the main seaweed bulk by 
ethanol precipitation. The freeze-dried crude extract powder was resuspended in 
minimal deionised water and reacted with ethanol (100%) using a ratio of seaweed: 
ethanol of 1:5. The seaweed ethanol mixture was then centrifuged for 5 min at 5000 
g. The supernatant was discarded and the precipitate pellet containing the seaweed 
sugars was collected. Fresh deionised water was used to resuspend the pellet prior to 
being blast and freeze-dried 
 
4.3.4 Size-exclusion dialysis and simulated digest of the L. digitata extract. 
Simple sugars and other compounds were removed from the extract using size 
exclusion dialysis tubing with a molecular cut-off point of 1 kDa (Spectrum Labs, 
Breda, The Netherlands). The freeze-dried extract was resuspended in minimal 
deionised water with the 1 kDa dialysis tubing being cut into strips of approximately 
15 cm in length. Each strip of tubing was rinsed gently with deionised water to remove 
traces of the sodium azide storage solution before use. The strips were filled with 
resuspended extract and sealed using clips. The tubing was positioned gently in a 
washed container filled with deionised water, covered with tin foil and placed in an 
orbital shaker at 25 °C at 40 rpm. The water in each container was replaced with fresh 
deionized water every day for three days. After the third day, the dialysis tubing was 
opened and the contents were collected. Following dialysis, a simulated digest as 
described by Connolly et al. [20] was performed with modifications. Briefly, α-
amylase (200 U) was dissolved in filter sterilized CaCl2 (1 mM, pH 7). This was added 
to the seaweed mixture and incubated while shaking (150 rpm) at 37 °C for 30 min. 
The pH was adjusted to pH 2 using HCl. Pepsin (2.7 g) was prepared in 125 ml 0.1 M 
HCl and added to the seaweed mixture which was then incubated under the same 
conditions as before for 2h. The pH was adjusted to pH 7 with NaOH. Bile (3.5 g) and 
pancreatin (560 mg) prepared in 125 ml 0.5M NaHCO3 were added. The mixture was 
set shaking (150 rpm) for a further 3h. Subsequently, the seaweed digest underwent a 
second 1 kDa size-exclusion dialysis step to remove breakdown components from the 





4.3.5 Depolymerisation of L. digitata polysaccharides using hydrogen peroxide. 
A low molecular weight depolymerised L. digitata extract was prepared as described 
by Ramnani et al., with modification [21]. Following the ethanol precipitation step, L. 
digitata extract was dissolved in 0.04% FeSO4 (1:5 w/v) solution to which hydrogen 
peroxide (30% puriss grade) was added (1:40 v/v) using a ratio of extract to hydrogen 
peroxide of 1:25. The mixture was allowed to shake at 150 rpm in a water bath at 80 
°C for 15 min. Following the depolymerisation reaction, the extract was blast-frozen 
and freeze-dried prior to storage. The effect of depolymerisation on molecular weight 
was not determined.  
 
4.3.6 Preparation of the cellulose control. 
The cellulose control for the study was processed in a similar manner to the final crude 
extract. Firstly, the cellulose was subjected to a simulated gastric digestion followed 
by size exclusion dialysis with a molecular cut off point of 1 kDa, as previously 
outlined. Secondly, the cellulose (post dialysis) was blast frozen and freeze-dried. 
 
 4.3.7 Ex vivo faecal fermentation distal colon model. 
The medium used for the faecal fermentations was prepared according to Fooks et al 
[22]. The Fooks media consisted of: tryptone water (2 g/l), yeast extract (2 g/l), NaCl 
(0.1 g/l), KH2PO4 (0.04 g/l), K2HPO4 (0.04 g/l), CaCl2.6H2O (0.04 g/l), MgSO4.7H2O 
(0.01 g/l), sodium bicarbonate (2 g/l), tween 80 (2 ml/l), hemin (0.05 g/l), vitamin K1 
(10 µl/l), cysteine HCl (1 g/l) and bile salts (0.5 g/l). The medium (800 ml) was pH 
adjusted to 6.8 and autoclaved at 121 °C for 15 min. On the morning of the experiment, 
2 g (1% w/v) of either control or seaweed extract (crude extract or depolymerised 
extract) were dissolved in 160 ml of Fooks medium and added aseptically to their 
respective vessels in the MultiFors fermentation system (Infors UK Ltd, Surrey, UK). 
The media was sparged with nitrogen gas for at least 120 min beforehand and 
throughout the experiment to ensure that an oxygen-free anaerobic environment was 
established in the system. A minimum of three freshly voided faecal samples were 





healthy adults (age 22 to 50 y), had no history of bowl problems and had not taken 
antimicrobial agents in the previous six months. The samples were combined to form 
a composite faecal sample by weighting out equal amounts from each stool sample 
into a sterile filter stomacher bag (Seward, VWR, Dublin, Ireland) and then adding an 
appropriate volume of maximum recovery diluent (Oxoid, Fisher Scientific, Dublin) 
containing 0.05% L-cysteine hydrochloride adjusted to pH 6.5 (which had been boiled 
after autoclaving and allowed to cool in the anaerobic cabinet (Whitley A85 anaerobic 
workstation, DW Scientific, Shipley, United Kingdom) to give a 20% composite 
faecal solution. The combined samples were placed in a stomacher and homogenized 
for 90 sec to create the composite slurry. Immediately after homogenization, 40 ml of 
the faecal slurry were added to the fermentation vessels at a final volume of 200 ml. 
Samples (1ml aliquots) were taken at 0 h, 5 h, 10 h, 24 h, 36 h and 48 h for total short-
chain fatty acid analysis, pyrosequencing and hydrogen sulphide production analysis. 
Plate counts were carried out at 0 h, 5 h, 10 h and 24 h to enumerate the main probiotic 
genera, Bifidobacterium and Lactobacillus. The negative control for this experiment 
was cellulose and the positive control was fructooligosaccharide (FOS). The faecal 
fermentation was repeated three times (n = 3) with samples being taken at each time 
point in duplicate. 
 
4.3.8 Analysis of short-chain fatty acid production. 
Fermentation output was determined by measuring changes in SCFA concentration in 
collected supernatant fractions. The analysis was performed using a Varian CP-3800 
GC system incorporating a Flame Ionisation Detector (FID). The system was fitted 
with a Zebron ZB-FFAP capillary column (30m length x 0.32 mm internal diameter x 
0.32 µm film thickness; Phenomenex, Cheshire, UK). Helium was supplied as the 
carrier gas at an initial flow rate of 1.3 ml/min. The initial oven temperature was 100 
°C, maintained for 30 sec, raised to 180 °C at 8 °C/min and held for 1 minute, then 
increased to 200 °C at 20 °C/min, and finally held at 200 °C for 5 min. The 
temperatures of the detector and the injection port were set at 250 °C and 240 °C 
respectively. Samples were taken for total SCFA analysis at 0 h, 5 h, 10 h, 24 h, 36 h, 
and 48 h in triplicate. Each sample was centrifuged immediately at 15000 g for 15 min 





to processing, the SCFA samples were thawed on ice, centrifuged for a further 3 min 
at 15000 g and filtered sterilized (0.22 µm). Samples were then diluted 1:5 with 
deionised water and 1 mM 2-ethylbutyric acid, made up in formic acid, was added to 
each sample as an internal control. A calibration curve was created using 10.0 mM, 
8.0 mM, 4.0 mM, 2.0 mM, 1.0 mM and 0.5 mM concentrations of a seven SCFA 
standard mix. The injected sample volume was 0.5 μl. Peaks were integrated using 
Varian Star Chromatography Workstation version 6.0 software. Additional vials 
containing standards were included in each run to maintain calibration and a cleaning 
injection of 1.2% formic acid was used before each analysis. The SCFAs investigated 
in this study were acetate, propionate, butyric acid, isobutyric acid, valerate, 
isovalerate and hexanoate. The internal standard used was 2 - ethylbutyric acid. 
 
4.3.9 Enumeration of Bifidobacterium and Lactobacillus bacterial populations by 
plate count method. 
Numbers of bifidobacteria and lactobacilli were enumerated using agar plates counts. 
Samples from each fermentation vessel were taken at 0 h, 5 h, 10 h, and 24 h for 
bacterial plate counts. The media used for bifidobacteria enumeration was modified 
de Man, Rogosa and Sharpe (mMRS) agar plates supplemented with 0.05% (w/v) L-
cysteine hydrochloride and 100 µg/ml mupirocin (Oxoid, Fisher Scientific, Dublin). 
The mupirocin was prepared by adding 200 mupirocin discs (200 µg/discs) to 10 ml 
of mMRS broth, which was then set gently shaking on an orbital shaker for 10 min 
and filter sterilized (0.45 µm) before being added to 400 ml of molten mMRS agar. 
The mMRS agar was allowed to cool to 48 °C before the addition of the mupirocin. 
Lactobacillus selective agar (LBS; Difco, Becton-Dickson ltd, Dublin, Ireland) plates 
with glacial acetic acid (1.32 ml/L) were prepared for Lactobacillus enumeration. 
Serial dilutions of faecal aliquots (10-1 to 10-7) were carried out in maximum recovery 









4.3.10 Preparation of DNA for high-throughput pyrosequencing. 
Total bacterial genomic DNA was extracted from 1ml of fermentation sample that was 
collected at time points 0 h and 24 h using the PowerFecal DNA Isolation Kit (MO 
BIO, San Diego, USA) per the manufacturers’ instructions. Extracted DNA was stored 
at -20 °C following extraction. With a view to using high throughput DNA sequencing 
and microbiota compositional analysis, 16s rRNA bacterial gene amplicons (V4) were 
generated using universal 16S rRNA primers predicted to bind to 94.6% of all 16S 
rRNA genes [23, 24]. A forward primer (5’- AYTGGGYDTAAAGNG) and a 
combination of 4 reverse primers, R1 (5’- TACNVGGGTATCTAATCC), R2 (5’- 
CTACDSRGGTMTCTAATC), R3 (5’- TACCAGAGTATCTAATTC) and R4 (5’- 
TACCRGGGTHTCTAAT.CC) were utilised. Different versions of the same forward 
primer. each containing a distinct multiple identifier (MID, were used for each 
fermentation sample. All the primers used in this study were synthesised by Eurofins 
Genomics. PCRs were carried out using an Applied Biosystems® 2720 Thermo 
cycler. A hot start step of 95 °C for 10 min preceded all PCR runs. Each PCR reaction 
was performed under the following experimental conditions: heated lid 110 °C, 94 °C 
for 2 min followed by 36 cycles of 94 °C for 1 min, 52° C for 1 min and 72 °C for 1 
min. This was followed by a final temperature step of 72 °C for 2 min and a holding 
step at 4 °C. PCRs had a final volume of 50 μl comprising 25 μl of BioMix Red (MSC, 
Ireland), 1 µl forward primer (0.15 μM), 1 μl reverse primer (0.15 μM) (mix of 4), 5 
μl template DNA, and 18 μl sterile PCR water. All PCRs were carried out in triplicate. 
PCR products were analysed using agarose gel electrophoresis (1.5% in 1x TAE 
buffer). The DNA products were subsequently cleaned using Agencourt AMPure XP 
(Beckman Coulter, California, USA) and quantified using the Quant-iT™ PicoGreen 
® dsDNA Assay Kit (Invitrogen, Massachusetts, USA). All samples were sequenced 
on a 454 Genome Sequencer FLX platform (Roche Diagnostics Ltd, West Sussex, 
UK) per 454 protocols. 
 
4.3.11 Analysis of sequencing data. 
Raw sequences were quality-trimmed using the Qiime Suite of programmes [25]; any 





length <150bp for 16S amplicon reads) were discarded. Operational taxonomic units 
(OTUs) were aligned using PyNAST [26] and taxonomy assigned using BLAST [27] 
against the SILVA SSURef [28] database release 111. Alpha and beta diversity 
diversities were generated using Qiime. Principal coordinate analysis (PCoA) plots 
were visualised using EMPeror v0.9.3-dev. A phylogenetic tree was calculated using 
the FastTree [29] software and the resulting principal coordinate analysis was 
visualised within KiNG. 
 
4.3.12 Statistical analysis. 
All results are presented as mean value (± SE). Independent t-tests were used to 
measure significance (p<0.05). All statistical analysis was carried out using GraphPad 
Prism version 5.0 for Windows. Unpaired student t-tests were carried out on SCFA 





4.4 Results.  
The differences in prebiotic potential between low molecular weight and high 
molecular weight polysaccharide extracts derived from Irish Laminaria digitata were 
assessed through the enumeration of culturable bifidobacteria and lactobacilli on 
appropriate media, the analysis of short-chain fatty acid production using a GC-FID 
system and the high through-put sequencing analysis of fermentation samples taken at 
0 h and 24 h.  
 
4.4.1 Effect of crude and depolymerised L. digitata extracts on culturable 
Bifidobacterium and Lactobacillus. 
Neither L. digitata extract had a positive impact on the growth of culturable 
bifidobacteria during the first 24 h of the fermentation (Fig 4.1). Further, no 
noteworthy significant increases (p<0.05) in numbers of bifidobacteria were seen with 
either extract at any time-point. With the FOS fermentation, a non-significant increase 
in Bifidobacterium numbers was recorded at 5 h and a significant increase (P<0.005) 
was recorded at 10 h. A decrease in numbers was observed at 24 h. The highest 
recorded level of bifidobacteria in the FOS fermentation was at 5 h. Similarly, neither 
extract had a positive effect on culturable lactobacilli in the first 24 h. Decreases in the 
number of lactobacilli during both extract fermentations recorded decreases in 
Lactobacillus numbers (Fig 4.1). Non-significant increases of culturable lactobacilli 
were observed during the FOS fermentation at both 5 h and 10 h, with the highest level 
of recoverable lactobacilli being recorded at 10 h. Between 10 h and 24 h, a large 
decrease in Lactobacillus numbers was recorded. No significant differences (p<0.05) 
were observed between the initial level at 0 h of culturable bifidobacteria in each of 









4.4.2 Effect of fermentation of L. digitata extracts on the production of short-
chain fatty acids (SCFAs). 
SCFA production was measured using a Varian CP-3800 GC system incorporating a 
Flame Ionisation Detector (FID). All values reported are minus the baseline values 
recorded at time point 0 h, and are the mean value (±SE). The highest levels of total 
SCFA production through microbial fermentation occurred in the FOS positive control 
vessels (112.0 ± 2.8 mm/ml), followed closely by the crude (109.9 ± 17.7 mm/ml) and 
the depolymerised (106.7 ± 16.5 mm/ml) extracts. Total SCFA production in the 
cellulose control vessels was determined to be 39.1 ± 2.1 mm/ml. (Fig. 4.2). Total 
SCFA concentration with the FOS fermentation was significantly (p<0.05) increased 
at all time-points (t = 0 h, 5 h, 10 h, 24 h, 36 h and 48 h). Total concentration of SCFAs 
for both extracts was significantly increased at 10 h, 24 h, 36 h, and 48 h. No 
significant difference in total SCFA production was found between the crude extract 
and the depolymerised L. digitata extract (Fig 4.2). SCFA production was significantly 
increased during the FOS fermentation (p<0.05) between 0-5 h, 5-10 h and 10-24 h, 
during the crude extract fermentation 5-10 h and 10-24 h and during the depolymerised 
extract fermentation between 5-10 h, 10-24 h and 24-36 h (Fig 4.2) 
 
4.4.3 Effect of fermentation of L. digitata extracts on acetate, propionate and 
butyrate production. 
For all fermentation conditions, the combined production of acetate, butyrate and 
propionate accounted for more than 85% of total SCFAs produced; Cellulose control 
(87.1% ± 2.2, FOS (94.6% ± 1.2), crude extract (91.4% ± 8.6) and depolymerised 
extract (93.9% ± 1.5). Acetate was the major SCFA produced under all fermentations 
conditions. Acetate production accounted for 51.4% ± 0.7 of total SCFA production 
with the cellulose control fermentation, 49.9% ± 4.0 with the FOS control 
fermentation, 49.8% ± 2.3 with the crude extract fermentation, and 55.1% ± 0.4 with 
the depolymerised extract respectively (Fig. 4.3). Total production of acetate was 
significantly increased (P<0.05) for the FOS fermentation (+ 177.5% ± 19.2), the 
crude extract (+ 176.1% ± 55.9), and the depolymerised extract (+ 191.0% ± 32.5), in 





acetate production observed between the crude and depolymerised extract. The 
concentration of acetate was significantly higher (P<0.05) than the cellulose control 
with the FOS fermentation at all time points (t = 5 h, 10 h, 24 h, 36 h and 48 h) and 
for both extract fermentations at 10 h, 24 h, 36 h and 48 h.  
Acetate production was observed to be significantly increased for the FOS 
fermentation (P<0.005) between 0 – 5 h and 0 – 10 h, and (P<0.05) between 10 – 24 
h, for the crude extract (P<0.05) between 5 – 10 h and 10 – 24 h and the depolymerised 
extract (P<0.005) between 5 – 10 h. There was no significant difference in total acetate 
production between the FOS control, the crude extract and depolymerised extracts. No 
significant difference was observed between acetate production for the crude extract 
and the depolymerised. at any timepoint (Fig. 4.4) 
The second major SCFA produced during all fermentations was butyrate. This 
SCFA accounted for 21.8% ± 1.1 of total SCFAs production for the cellulose control, 
27.5% ± 3.3 for the FOS fermentation, 22.0% ± 2.7 for the crude extract, and 15.4% 
± 2.6 for the depolymerised fermentation (Fig. 4.3). Total production of butyrate was 
significantly higher (p<0.005) for the FOS fermentation (+ 259.8% ± 27.1), for the 
crude extract fermentation (+ 174.0% ± 8.8) and for the depolymerised extract 
fermentation (+ 87.3% ± 18.1), than the cellulose control. Butyrate concentration was 
significantly higher for the FOS fermentation at all time points (t = 5, 10, 24, 36, and 
48 hours) and for both L. digitata extracts at 10 h, 24 h, 36 h and 48 h (Fig. 4.5). 
Significant increases of butyrate during the FOS fermentation occurred between 
(p<0.05) for all time intervals for the crude extract (P<0.005) between 0 – 5 h), 
(P<0.05) between 5 – 10 h and (P<0.005) between 10 – 24 h and for the depolymerised 
extract P<0.05) between 0 – 5 h, 0 – 10 h, 5 – 10 h (+ 204.0% ± 43.3) and 24 – 36 h. 
(Fig.4.5). Production of butyrate was significantly higher (P<0.05) with the crude 
extract than the depolymerised extract between 10 – 24 h, Overall production of 
butyrate was also significantly increased (P<0.05) with the crude extract over the 
depolymerised extract (+ 50.3% ± 20.6). There was no significant difference in overall 
butyrate production between the crude extract and the FOS control, however the FOS 
control did generate significantly higher levels (P<0.05) of butyrate than the 





The third major SCFA produced was propionate. Production of propionate 
accounted for 13.9% ± 1.0 of all SCFAs produced during the cellulose fermentation, 
17.2% ± 2.8 with the FOS fermentation, 19.6% ± 1.8 with the crude L. digitata extract, 
and finally 23.4% ± 1.6 for the depolymerised extract fermentation (Fig. 4.3). Total 
production of propionate was significantly increased (P<0.05) for FOS fermentation 
(+ 224.0% ± 55.3), for the crude extract, (+ 333.7 % ± 57.4), and for the depolymerised 
extract (+ 313.6% ± 23.8), in comparison with cellulose. Propionate levels were 
significantly higher (P<.0.05) than the cellulose control for FOS fermentation at 10 h, 
24 h, 36 h, and 48 h, while propionate levels for both extract fermentations were 
significantly higher at all time points (t = 5 h, 10 h, 24 h, 36 h, and 48 h) (Fig 4.6). A 
significant increase in propionate production was observed for the FOS fermentation 
(P<0.05) between 5 – 10 h and 10 – 24 h, with the crude extract (P<0.005) between 0 
– 5 h, (P<0.05) 5 – 10 h, 10 – 24 h and 24 – 36 h and for the depolymerised extract 
(p<0.005) between 0 – 5 h, and 5 – 10 h. Production of propionate was significantly 
(P<0.05) higher with the depolymerised extract than the crude extract between 0-5 h. 
Total production of propionate was observed to be significantly increased (p<0.05) for 
the depolymerised extract over the crude L. digitata extract (+ 33.3% ± 6.9), between 
0 – 5 h. 
 
4.4.4 Effect of fermentation of L. digitata extracts on branched chain fatty acid 
production. 
Accumulated BCFA production accounted for 12.9% ± 2.2 of total SCFA production 
for the cellulose fermentation, 5.4 % ± 1.2 for the FOS fermentation, 8.6 % ± 1.3 for 
the crude extract and 6.075 % ±1.495 for the depolymerised extract (Fig. 4.3). Total 
production of BCFAs, in comparison with the cellulose control, was significantly 
(P<0.05) increased in the presence of the crude extract (Fig. 4.7). A significant 
increase in production occurred for this extract between 36-48 h. No significant 
differences were observed between the crude and depolymerised extracts. 
Furthermore, no significant difference in BCFA production was observed between the 






4.4.5 High throughput DNA sequencing of the 16s rRNA gene variable V4 region. 
Values are only given for bacterial phyla, family and genera that were present in all 
samples. 
 
4.4.6 Sequencing reads at the phylum level. 
The dominant phyla present were Firmicutes, Bacteroidetes, Proteobacteria and 
Actinobacteria. These four phyla accounted for 98.5% ± 0.505 of all assigned 
sequencing reads at 0 h. For the cellulose control, there was an average increase in the 
relative amount of Proteobacteria (+ 266.0% ± 64.7), Actinobacteria (+ 33.1% ± 8.6) 
and Bacteroidetes (+ 7.5% ± 36.0), and an average decrease in the relative abundance 
of Firmicutes (- 12.4% ± 8.0) during the fermentation (Fig.4.8), in comparison with 
the cellulose control. 
The FOS fermentation revealed a significant reduction (P<0.05) in the relative 
abundance of Proteobacteria (Fig. 4.8), in comparison to cellulose. For the crude 
extract, there was a significant decrease (P<0.05) in relative abundance of 
Fibrobacteres in comparison with the cellulose control (Fig. 4.8). For the 
depolymerised extract, there was a significant reduction (P<0.05) in relative 
abundance of Actinobacteria in comparison with cellulose. No significant differences 
were observed between the crude extract and the depolymerised extract for any 
measurable bacterial phyla. In comparison with the FOS control, a significant increase 
(P<0.05) in the change of relative abundance of Proteobacteria was observed with the 
crude extract. There were no significant differences in relative abundance of any 
genera with the depolymerised extract in comparison with the FOS fermentation (Fig. 
4.8). 
 
4.4.7 Sequencing reads at the family level. 
The most prevalent bacterial families present in all fermentation vessels were 
Ruminococcaceae, Lachnospirace, Prevotellaceae, Bacteroidaceae, and 





significant positive influences (P<0.05) on the relative abundance of the Clostridiales 
Family XIII Incertae Sedis (Fig 4.9) and the Lachnospiraceae (Fig. 4.9) and a 
significant reduction of relative abundance for Streptococcace and the Alcaligenaceae 
(Fig. 4.9). Sequencing reads at the family level with the crude extract fermentations 
returned significant positive influences (P<0.05) for Porphyromonadaceae, 
Lachnospiraceae, Erysipelotrichaceae and Gamma Proteobacterium B38 (Fig. 4.9) 
and a significant reduction (p<0.05) in relative abundance for Fibrobacteraceae and 
the Streptococcaceae (Fig 4.9) in comparison with cellulose. 
For the depolymerised extract fermentations, there were significant positive 
influence on relative abundance (P<0.05) Lachnospiraceae and Erysipelotrichaceae 
(Fig 4.9) and decreases for the Bifidobacteriaceae and the Alcaligenaceae (Fig. 4.9), 
in comparison with cellulose. A significant difference was recorded in the level of 
Gamma Proteobacterium B38 between the crude extract and the L digitata 
depolymerised extract. In comparison with the FOS fermentations, the crude extract 
significantly increased (P<0.05) the relative abundance of Porphyromonadaceae, 
Bacteroidales family S24-7, Planococcaceae and Gamma Proteobacterium B38 (Fig. 
4.9) and significant reduction in the relative abundance of Clostridiales (uncultured), 
Clostridiales Family XIII Incertae Sedis, and Xanthomonadaceae. In comparison with 
the FOS fermentations, the depolymerised extract was associated with significant 
increases in relative abundance of Porphyromonadaceae and Bacteroidales families 
S24-7 (Fig. 4.9) and decreases for Clostridiales (uncultured) Peptrostreptococcaceae 
and Clostidales Family XIII Incertae Sedis (Fig. 4.9). 
 
4.4.7 Sequencing reads at the genus level. 
At the genus level, the most prevalent bacteria present were uncultured 
Ruminococcaceae (Firmicutes), Bacteroides (Bacteroidetes), Subdoligranulum 
(Firmicutes), uncultured Lachnospiraceae (Firmicutes), Lachnospiraceae Incertae 
Sedis (Firmicutes) and Faecalibacterium (Firmicutes). The FOS fermentation resulted 
in a significant increase (P<0.05) in the relative abundance of Clostidales Family XIII 
Incertae Sedis (Fig 4.11) and significant decreases in relative abundance of Sutterella 





4.11), Flavonifractor (Fig. 4.11), Butyricimonas (Fig 4.12), and Parabacteroides (Fig 
4.12).  
For the crude extract fermentation, in comparison with cellulose, significant 
increases (P<0.05) were observed in relative abundance of Dialister (Fig. 4.11, note: 
due to the scale of graph, this data is not clearly visible) and Parabacteroides (Fig 
4.12), while there was a significant reduction in relative abundance for 
Peptostreptococcaceae (Fig. 4.11), and Prevotella (Fig. 4.12). With the 
depolymerised extract, in comparison with cellulose, significant increases in relative 
abundance (P<0.05) were observed for Dialister (Fig. 4.11) for an uncultured genus 
of Lachnospiraceae (Fig. 4.11) and Parabacteroides (Fig 4.12), while a significant 
decrease in the relative abundance of Bifidobacterium (Fig. 4.12), was recorded. 
Between the crude and depolymerisation extracts, significant differences in relative 
abundance (P<0.05) of Gammaproteobacteria B38 (Fig. 4.10), Alistipes (Fig. 4.12) 
and Adlercruetzia (Fig. 4.12) were observed. In comparison with the FOS 
fermentations, significant increases with the crude extract in relative abundance were 
observed for Ruminococcus (Fig. 4.11), and uncultured Clostridiales bacterium (Fig. 
4.11), Butyricomonas (Fig 4.12) and Parabacteroides (Fig 4.12). A significant 
decrease (P>0.05) in the relative abundance for Barnsiella ((Fig. 4.12) was observed.  
With the depolymerised extract, in comparison with the FOS fermentations, 
there were significant increases (P<0.05) in the relative abundance of 
Gammaproteobacteria B38 (Fig. 4.10) Flavonifractor (Fig. 4.11), and uncultured 
Lachnospiraceae (Fig. 4.11) with significant decreases in relative abundance of 
uncultured Clostridiales bacterium (Fig. 4.11) and Parabacteroides (Fig 4.12),  
 
4.4.9 Measurement of Alpha (α) and Beta (β) diversity. 
Alpha (α)-diversity was measured using Chao1 richness estimation, Shannon’s index 
of diversity, Simpson index of diversity, observed species and phylogenetic diversity 
metrics (Fig. 4.13). Scatter plot analysis  of alpha diversity revealed that 
supplementation of the fermentation vessels with the extracts had no notable effect on 
diversity. A slight trend towards reduced diversity was observed overall. Beta (β) 





in a principle coordinate analysis plot (Fig. 4.14). At 0 h, a trend was observed for the 
cellulose, FOS, crude extract and depolymerised extract to be clustered close together. 
At 24 h, clustering was still apparent for the cellulose, crude extract and depolymerised 
extract, however, for FOS a slight shift occurred away from the cellulose control and 























Seaweeds are widely regarded for their richness of bioactive components but have 
been overlooked in the main. To date, there have been only a limited number of studies 
regarding the degradation of seaweeds by the gut microbiota. The objective of this 
study was firstly to ascertain the prebiotic potential of two polysaccharide extracts 
prepared from the brown seaweed L. digitata using an ex vivo fermentation system, 
and secondly to determine the effect, if any, that depolymerisation had on measurable 
prebiotic potential.  
 Certain species of seaweeds are common in the diet of consumers in parts of 
South East Asia and in Western cultures where it is used in food as emulsifying agent 
and as thickening agent. Dietary fibre is resistant to digestion and absorption in the 
small intestine, with partial or total fermentation in the large intestine [30]. 
Interestingly, most in vitro and in vivo studies have reported on the low fermentability 
of seaweed fibre by gut microbes. This is because natural seaweed fibres contain 
predominantly high molecular weight polymers which then pass through the gut too 
quickly to be of use as a fermentable substrate by the microbiota [21]. In general, the 
influence of structure and degree of polymerisation on prebiotic effectiveness of 
seaweed polysaccharides is not clearly understood. The carbohydrate content of brown 
seaweeds is high and is estimated to be between 30% and 50%. [31]. Brown seaweeds 
contain carbohydrates such as laminarin, fucoidan and alginic acid and, as such, a 
polysaccharide extract prepared from L. digitata is likely to be a mix of these 
polysaccharides.  
 The extracts used in this study were produced using a dilute hot-acid extraction 
method, with an additional depolymerisation step included to produce the 
depolymerised extract. The same raw material was used for both extracts, and during 
each step of production they were handled and stored in a similar manner. Hydrogen 
peroxide is both an effective and environmentally friendly oxidant, and has been used 
to oxidize many polysaccharides such as chitosan, starch, cellulose and dextran. The 
oxidation method not only depolymerizes the polysaccharide, but also changes the 
structure of the main chain [32] potentially resulting in an altered fermentation profile. 
Hydrogen peroxide generates reactive oxygen species, such as HOO-, HO-, and O2
-. 





The radical method is mild and the structures of the sugar units are not significantly 
changed. While this  method of depolymerisation is a viable alternative to acid 
hydrolysis and enzyme treatment for the preparation of low-molecular weight 
polysaccharides, the issue of radical hydrolysis on the antioxidant activities of 
sulphated polysaccharides remains [9]. The treatment with hydrogen peroxide results 
in a depolymerised extract differing from the crude extract in the length of its 
constituent polysaccharides which were degraded in the depolymerisation process. 
 Prebiotics selectively stimulate the growth and/or activity of specific bacteria, 
mainly Bifidobacterium and Lactobacillus, and thus facilitate a microbiota mediated 
health effect. The best known prebiotics currently include inulin-type fructans (short-
chain FOS (DP 2 - 9) and long-chain inulin (DP 10 - 60); galactooligosaccharides 
(GOS) and xylooligosaccharides (XOS)), sugar alcohols, resistant starch and complex 
polysaccharides such as acacia gum [33] Traditionally, the fermentation potential of 
reputed prebiotics by the microbiota has been evaluated through observing bacterial 
growth and the production of fermentation end products when pure cultures of 
intestinal bacteria (in particular bifidobacteria and lactobacilli) are grown on selective 
media in their presence. Most of these prebiotics have resulted in increased numbers 
of bifidobacteria recovered in faeces [34]. The chemical structure of laminarin consists 
mainly of a linear β-(1→3)-linked glucan with some random β-(1→6)-linked side 
chains, depending on the type of seaweed. β-Glucans have been shown to exhibit 
prebiotic properties by increasing the number of Bifidobacterium and Lactobacillus in 
the pig colon [35] 
The major microbial fermentation products stemming from prebiotic 
metabolism in the large colon are SCFAs [36]. Laminarin and fucoidan, as well as 
other polysaccharides, undergo microbial fermentation in the cecum resulting in the 
production of multiple groups of metabolites, with SCFA being the foremost group 
[37]. Changes in SCFA production patterns are a strong indication of stimulation of 
growth and/or activity of the microbiota. This is one of the central tenents of the 
prebiotic concept. The known prebiotic FOS is resistant to degradation by human 
enzymes in the small intestine, but is extensively fermented in the large bowel  to 
SCFAs, which are absorbed and further metabolised by the host [36] and members of 





polymerisation demonstrated that the shorter-chain FOS were more rapidly fermented 
than long-chain inulin which were more steadily fermented [38]. The dietary 
supplementation of porcine diet with laminarin/fucoidan has been reported to induce 
increased SCFA production[37]. As expected, the addition of FOS, the crude extract 
and the depolymerised extract to their respective fermentation vessels in the current 
study resulted in rapid and significant increases in both the total concentration of 
SCFAs and the rate of their production in comparison with the negative control. The 
FOS achieved the highest absolute concentration of SCFAs. The final absolute 
concentration of SCFA produced by both L. digitata extracts was comparable to that 
of FOS, however SCFA concentration with the crude extract was significantly 
(P<0.05) lower than the FOS at every previous timepoint studied. There was no 
significant difference observed in SCFA concentrations between the depolymerised 
extract and the FOS control except at 5 h. Both L. digitata extracts underwent a lag 
phase in SCFA production at the beginning of the fermentation. It has been reported 
that such a delay is required by the microbiota to synthesise the enzymes necessary to 
hydrolyse and metabolise the polysaccharides present in the extracts [11]. FOS 
consists of mixtures of fructose moieties linked by β-(2→1)-glycosidic bonds to a 
terminal glucose unit [39]. Bonds of this configuration are easily cleaved by enzymes 
produced by the microbiota. The FOS positive control used in this body of work has 
an average dp of less than 10 
All fermentations produced significantly more SCFA than the poorly 
fermentable cellulose control. The timeline of SCFA production indicates that both L. 
digitata extracts and FOS were readily fermented by the microbiota with most SCFA 
production taking place during the first 10 hours. For the FOS fermentation, SCFA 
production was observed to peak during the initial five hours of the fermentation while 
SCFA production for both extracts reached its zenith between 5 h and 10 h. The 
production profile for the FOS agreed with previous data, which had shown significant 
increases in production of the three biologically significant SCFAs, acetate, butyrate 
and propionate. Importantly, both the crude L. digitata and the depolymerised extract 
also gave rise to significant increases in production of these SCFAs. The production 
of acetate, propionate and butyrate in the human colon is highly dynamic. For 
example, both butyrate and propionate can be degraded to acetate (in the absence of 





nitrate-reducing or sulphate reducing bacteria [40].  Acetate was the major SCFA 
produced in each of the fermentation runs, accounting for approx. 50% of all SCFAs 
produced. A significant increase in acetate concentration was observed for all 
fermentation conditions in comparison with the cellulose control. Acetate production 
with the FOS fermentation occurred quickly following inoculation of the vessels with 
more than 70% being produced in the first 5 hours. Acetate production for both L. 
digital extracts was slower and showed rather a steady level of production during the 
first 24 h of the fermentation, with approx. 75% of acetate in the crude extract 
fermentation and 85% of the acetate by the depolymerised extract being produced by 
24 h. The depolymerisation of L. digitata had no significant effect on the production 
of acetate. Both L. digitata extracts exhibited a similar acetate profile and there were 
no significant differences in either rate of production or in final concentration. Acetate 
serves as an energy source for the liver and peripheral tissues and also acts as a 
signaling molecule in metabolic pathways of gluconeogenesis and lipogenesis [19]. 
The second major SCFA of biological important produced during the fermentations 
was propionate. As with acetate, anaerobic microbial fermentation of the FOS control 
and both seaweed extracts generated significant increases in propionate concentration 
and production. Propionate production in the presence of the depolymerised extract, 
during the initial hours of the fermentation, was significantly (P<0.05) increased over 
that observed for the crude extract. Polysaccharide chain length is an important factor 
in microbial fermentation patterns and in this study the depolymerisation of L. digitata 
had a significant positive impact on the production of propionate. The shorter chain 
polysaccharides present in the depolymerised extract favoured the production of 
propionate by the representative microbial community. Butyrate was the third most 
abundant SCFA produced during the fermentations. For all experimental conditions, 
butyrate concentration and rate of production was significantly increased over that of 
the cellulose control. An increased level of butyrate production was observed during 
the fermentation of both L. digitata extracts and would suggest that both extracts were 
successful in stimulating butyrate producers in the representative microbiota. The total 
production of butyrate was significantly (P<0.05) greater for the crude extract than the 
depolymerised extract. The native polysaccharides of the crude extract favoured the 
production of butyrate over the shorter-chained polysaccharides found of the 





chain inulin enhances the production of butyrate by the microbiota. Bifidobacteria, 
however, do not produce butyrate leaving the question of how this comes about 
somewhat unclear. It is likely that bacterial cross feeding plays a part of this 
enhancement of butyrate production [34]. The production of butyrate by mixed human 
faecal microbiota in vitro is strongly influenced by the growth substance. Starch is an 
example of a strongly butyrogenic molecule whereas pectin is relatively less so and 
leads more to acetate and propionate production [41] 
The prebiotic definition states that the stimulation of the gut microbiota is a 
key aspect of any putative prebiotic. As SCFAs are the main fermentation products of 
the microbiota, an increase in their production would be an indicative sign that the 
fermentation substrate has prebiotic potential.  Of the three biologically significant 
SCFAs (acetate, propionate and butyrate) butyrate and propionate are of most interest, 
however butyrate production attracts the most attention due to its antineoplastic 
properties and other beneficial biological functions in the colon [21, 36]. Butyrate has 
been shown to downregulate innate responses in various biological systems [42]; 
Butyrate is proposed to play a key role in maintaining gut homeostasis and epithelial 
integrity as it directly influences host genome expression by inhibiting histone 
deacetylases, and interferes with proinflammatory signals such as NF-κβ. Butyrate is 
synthesised via pyruvate and acetyl-coenzyme A (CoA), mostly by the breakdown of 
complex polysaccharides that reach the colon intact after passing through the upper 
GIT. Alternative substrates can be derived from cross-feeding with other primary 
degraders and lactate-synthesizing bacteria. Acetyl-CoA is then converted to the 
intermediary butyryl CoA in a manner closely related to β-oxidation of fatty acids 
[43]. Butyrate is a major energy source for colonocytes and is taken up either by 
passive diffusion or via apical uptake transporters such as monocarboxylate 
transporter 1 (MCT1) and sodium coupled monocarboxylate transporter 1 (SMCT1). 
Butyric acid is reported to reduce the risk of colon cancer, protect the mucosa through 
stimulation of mucus secretion and tight junction integrity, and acts as an anti-
inflammatory agent. It also increases the expression of MCT1 and its chaperone 
CD147 [44]. The ability to produce butyrate is widely distributed among Gram-
positive anaerobic bacteria that colonize the human gut [45]. Several species within 
families belonging to the phylum Firmicutes have been identified as butyrate 





related to Roseburia spp. (family Lachnospiraceae), Eubacterium rectale (family 
Lachnospiraceae) and Faecalibacterium prausnitzii-related bacteria (family 
Clostridaceae) [40]. 
SCFA concentration at each timepoint during the depolymerised extract 
fermentation was on average higher than that of the crude extract at all timepoint 
except at 48 h; however, there was no significant (P<0.05) difference in their 
respective concentrations at any timepoint. One key influence that fermentable 
substrates can have on SCFA production is on the relative ratio of individual fatty 
acids produced. Substrates that shift the balance to beneficial SCFA are favoured over 
those that lead to the increased fermentation of proteins and which produce toxic 
substances. The ratio and extent of SCFA production is a complex interplay between 
substrate type, microbiome diversity and activity. Acetate, propionate and butyrate, 
taking evidence from available human studies, are present in the approximate molar 
ratio of 60:20:18 [46].  The other principal end products of colonic fermentation are 
the gases hydrogen, carbon dioxide and methane with small quantities of branched 
chain fatty acid (iso-butyrate, valerate, iso-valerate and hexanoate), which are formed 
from protein and amino degradation [47]. Molar ratios of the primary SCFA in this 
study further indicate that fermentation of the crude extract resulted in a shift towards 
the production of butyrate at the expense of acetate and propionate. 
DNA sequencing making use of 16s rRNA gene is the gold standard for 
microbial identification. Of the 52 currently recognised bacterial phyla, approximately 
five to seven phyla are known to be resident in the mammalian GIT. Generally, the 
phyla Firmicutes and Bacteroidetes dominate the gut microbial community while 
members of the Proteobacteria, Actinobacteria, Verrucomicrobia and the new 
candidate phylum TM7 are less abundant. Despite this relatively small representation 
of dominant phyla, the number of bacterial species is estimated to be over a thousand, 
and the number of the genes is more than 150-fold greater than the number of genes 
in their hosts [48]. Clearly, the modulation of the gut microbiota towards a desirable 
composition is of great importance in terms of prebiotic studies. Phylogenetic data 
obtained during this study broadly agreed with data reported in other studies in terms 
of the composition of the dominant phyla, families and genera of the representative 





numbers of Actinobacteria and Proteobacteria also present. The effect of FOS on the 
microbial community was a non-significant increase in the relative abundance of 
Actinobacteria and Proteobacteria and a decrease in the relative abundance of 
Bacteroidetes and Firmicutes. The relative increase in Proteobacteria was small and 
significantly lower than that of both the cellulose control and the crude extract, which 
both recorded relatively large increases in Proteobacteria abundance. The 
Proteobacteria comprise a large grouping of Gram-negative bacteria including many 
pathogens, whose growth would ideally be inhibited to promote a good GIT 
environment. Based on results obtained for bacteria at the phylum level of 
organisation, depolymerisation had no influence on the relative abundance of any 
bacterial phylum. 
Neither of the L. digitata extracts had any significant effect on the relative 
abundance of Bifidobacterium (phylum Firmicutes, family Bifidobacteriaceae) or 
Lactobacillus (phylum Firmicutes, family Lactobacillaceae). Both bifidobacteria and 
lactobacilli are known to be beneficial bacteria of the human microbiota [11] and 
positive changes in their relative abundance would have been expected for a putative 
prebiotic. Previous studies have reported increased numbers of bifidobacteria and 
lactobacilli in the presence of inulin and other non-digestible oligosaccharides [21]. 
Bifidobacterial enumeration on selective media also indicated that there was no 
stimulation of growth by either extract. This would indicate that the L. digitata extracts 
are not bifidogenic in their current form.  There could be two reasons for this. Firstly, 
bifidobacteria and lactobacilli are unable to metabolise polysaccharides from L. 
digitata through carbohydrate utilisation pathways such as the fructose-6-phosphate 
phosphoketolase (F6PPK) pathway and, secondly, the extracts contain some 
biologically active component that inhibits the growth of bifidobacteria and 
lactobacilli. Further, the depolymerisation of L. digitata had no significant bearing on 
the relative abundance of bifidobacteria and lactobacilli or on the recovery of 
culturable Bifidobacterium or Lactobacillus.  This agrees with the observations of a 
recent animal trial where the supplementary addition of laminarin to porcine  diet also 
had no effect on the recovered faecal Bifidobacterium populations [49]. Another study 
reported that laminarin exhibits antimicrobial properties and has been reported to 
reduce populations of Enterobacterium, Bifidobacterium and Lactobacillus in the 





Diversity within the adult faecal microbiota was visualised using scatter plot 
analysis of α-diversity and unweighted PCoA (Principle co-ordinate Analysis) plots 
of β-diversity. Fermentation of both L. digitata extract had limited impact on the 
diversity within the microbial community. The PCoA of β-diversity indicated a clear 
separation between microbial communities based on fermentation run rather than 
treatment condition. A similar effect was also previously seen (Chapter 3) involving 
the fermentation of a Fucus serratus polysaccharide extract. The FOS fermentation 
had a notable effect on diversity compared with the cellulose control and both L. 
digitata extracts.  
Sequencing data for the FOS control also failed to detect any bifidogenic 
activity at 24 h; however, plate counts on selective agar indicated that FOS 
supplementation significantly (P<0.005) increased culturable Bifidobacterium 
numbers by more than 0.5 log in comparison with the cellulose control, and both L. 
digitata extracts at 10 h but not at 5 h or 24 h. Each fermentation system is a closed 
system, that is, there was no addition of extra fermentable material over the course of 
the fermentation run nor was there a removal of bacterial by-products. Plate count data 
suggest that after 10 h, Bifidobacterium become starved of nutrients and/or were 
outcompeted by other surviving bacteria resulting in a reduction in their number by 24 
h.  The crude extract and the depolymerised extract exhibited similar effects during 
their respective fermentations. At the family level, both extracts promoted the growth 
of Lachnospiraceae (phylum Firmicutes, class Clostridia) and Erysipelotrichaceae 
(phylum Firmicutes) in comparison with the cellulose control. Lachnospiraceae is an 
abundant family of anaerobic bacteria found in the mammalian digestive tract and 
relatively rare elsewhere. Members of this family have been linked to obesity and the 
protection of humans from colon cancer mainly owing to an association of several 
members of the family with the production of butyrate [50]. The family 
Erysipelotrichaceae is reported to have a potential role in host physiology and/or 
disease. These organisms appear to be highly immunogenic and can potentially 
flourish following treatment with broad spectrum antibiotics; however, studies 
examining the direct impact of changes in their abundance on host health are required 
[51]. At the genus level, both extracts promoted the growth of Parabacteroides 
(phylum Bacteroidetes, family Porphyromonadaceae), Gram-negative, obligately 





succinate [52],  and Dialister (phylum Firmicutes, family Veillonellaceae) which are 
anaerobic or microaerophilic Gram-negative cocci [53]. One difference of note 
between the two extracts was that the crude extract did significantly impact upon the 
abundance of the genus Alistipes (phylum Bacteroidetes, family Rikenellaceae) in 
comparison with the depolymerised extract. This genus of bacteria is Gram-negative, 
strictly anaerobic, rod shaped bacteria that produce succinate as their principle 
metabolic end-product of glucose fermentation [54]. Based on the results obtained 
from direct enumeration of culturable bacteria and 16s rDNA sequencing, the 
depolymerisation of L. digitata by hydrogen peroxide was seen to have a negligible 
overall impact on faecal microbiota composition underlying their common origin.  
This study has shown that polysaccharides from the brown seaweed L. digitata 
can survive a simulated gastric challenge and are readily fermentable by intestinal 
bacteria. The fermentation of both L. digitata extracts resulted in significant increases 
in production of the biologically significant SCFAs butyrate, propionate and acetate. 
However, plate count data and DNA sequencing results yielded no evidence to suggest 
that L. digitata polysaccharides have any stimulatory effect on Bifidobacterium or 
Lactobacillus. These genera represent the main targets of prebiotic and probiotic 
studies and because of this we cannot confirm prebiotic activity of either extract in 
their current form or under the current definition of a prebiotic. Here, we have 
demonstrated L. digitata to be an excellent source of dietary fibre that can modulate 
the activity of human gut bacteria. The crude L. digitata extract, possessing the parent 
polysaccharides, generated a significantly increased amount of butyrate, compared to 
the depolymerised extract. Butyrate is a preferred energy source for colonic epithelial 
cells and is thought to play an important role in maintaining colonic health in humans 
while also exhibiting anti-tumour activity. Increased production of butyrate by the 
colonic microbiota is a desirable result of anaerobic fermentation. Importantly, it was 
found that depolymerisation of L. digitata polysaccharides had a significant impact on 
fermentation outcomes. Fermentation of the shorter chain polysaccharide of the 
depolymerised extract resulted in a shift in SCFA production to favour propionate over 
butyrate. Propionate has been heavily linked with satiety and an increase in its 







In conclusion, through modulation of polysaccharide chain length by 
depolymerisation processes, different fermentation profiles can be obtained from the 
same seaweed raw material and starting faecal microbiota. This could potentially 
allow ‘designer’ extracts to be produced, whose impact on the gut microbiota can be 
predicted beforehand.  The definitive test of the prebiotic potential of a substrate is to 
transition from ex vivo to in vivo animal trials in small animals and subsequently in 
large animals/humans. However, several challenges exist in the upscaling of prebiotic 
studies. As the yield of polysaccharides can be very low following acid hydrolysis, 
large quantities of seaweed would need to be collected, stored and processed to 
produce sufficient extracts for further investigation. Additionally, the concentration 
and type of seaweed polysaccharide can vary greatly depending on the season of 
collection and the species of seaweed and must be taken into consideration in the 
production of the product. Fermentation of L. digitata polysaccharides did not result 
in confirmation of prebiotic activity, however, positive changes in SCFA production 
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Figure 4.1. Enumeration of a) Bifidobacterium and (b) Lactobacillus. Data represent the mean (±SE). 















































Figure 4.2. The effect of fermentation on (a) Total SCFA concentration and (b) SCFA production per 
timepoint. Data represent the mean (±SE). (a = P<0.05), b = P<0.005, c = P<0.0005 relative to cellulose, 
d = P<0.05, e = P<0.005, f = P<0.005 relative to FOS, un-paired t-test). Red denotes significance for 
FOS, Blue denotes significance for L. digitata crude extract, and Green significance for denotes L. 
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Figure 4.3. The percentage breakdown of total SCFA production. Breakdown of SCFA production 
(a) Total and (b) between 0 – 24 h.  
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(b) Production between 0 – 24 h 
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Figure 4.4. The effect of fermentation on (a) Acetate concentration and (b) Acetate production per 
timepoint. Data represent the mean (±SE). (a = P<0.05), b = P<0.005, c = P<0.0005 relative to cellulose, 
d = P<0.05, e = P<0.005, f = P<0.005 relative to FOS, un-paired t-test). Red denotes significance for 
FOS, Blue denotes significance for L. digitata crude extract, and Green significance for denotes L. 
















C e llu lose
F O S
C ru d e


















































C e llu lose
F O S
C ru d e













Figure 4.5. The effect of fermentation on (a) Butyrate concentration and (b) Butyrate production per 
timepoint. Data represent the mean (±SE). (a = P<0.05), b = P<0.005, c = P<0.0005 relative to cellulose, 
d = P<0.05, e = P<0.005, f = P<0.005 relative to FOS, un-paired t-test). Red denotes significance for 
FOS, Blue denotes significance for L. digitata crude extract, and Green significance for denotes L. 
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Figure 4.6. The effect of fermentation on (a) Propionate concentration and (b) Propionate production 
per timepoint. Data represent the mean (±SE). (a = P<0.05), b = P<0.005, c = P<0.0005 relative to 
cellulose, d = P<0.05, e = P<0.005, f = P<0.005 relative to FOS, un-paired t-test). Red denotes 
significance for FOS, Blue denotes significance for L. digitata crude extract, and Green significance 
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Figure 4.7. The effect of fermentation on (a) BCFA concentration and (b) BCFA production per 
timepoint. Data represent the mean (±SE). (a = P<0.05), b = P<0.005, c = P<0.0005 relative to cellulose, 
d = P<0.05, e = P<0.005, f = P<0.005 relative to FOS, un-paired t-test). Red denotes significance for 
FOS, Blue denotes significance for L. digitata crude extract, and Green significance for denotes L. 
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Figure 4.8 (a) Increase/decrease in relative abundance at the phylum level. (b) Percentage change in 
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Figure 4.9 (a) Increase/decrease in relative abundance at the family level. (b) Percentage change in the 
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Figure 4.10 (a) Increase/decrease in relative abundance of genera in the phylum Proteobacteria. (b) 
Percentage change in the relative abundance of genera in the phylum Proteobacteria. Values represent 
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Figure 4.11 (a) Increase/decrease in relative abundance of genera in the phylum Firmicutes. (b) 
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Figure 4.12 (a) Increase/decrease in relative abundance of genera in the phyla Actinobacteria, 
Fibroacteres, Lentisphaerae, Tenericutes, and Verrocomicrobia. (b) Percentage change in the relative 
abundance of genera in the phyla Actinobacteria, Fibroacteres, Lentisphaerae, Proteobacteria, 
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Figure 4.13 The effect of fermentation of L. digitata extracts on alpha diversity was measured by 
several different methods, (a) Chao1 Richness Estimation, (b) Shannon’s index of Diversity, (c) 
Simpson Index of Diversity, (d) Observed species, and (e) PD Whole Tree. 
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Figure 4.14 Beta diversity. Principle coordinate analysis of unweighted Unifrac reveals separation by 
fermentation run. Red (light) - run 1 0 h, Blue (light) - Run 2 0 h, Green (light) R3 0 h, Red (dark) - 
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A study of the prebiotic potential of the economically 
























Chondrus crispus is an economically and ecologically important red seaweed with a 
long tradition of usage on the island of Ireland. Historically known as Irish moss, C. 
crispus was extensively used in cooking as well as in herbal medicines. As a member 
of the rhodophyta grouping of seaweeds, C. crispus contains large quantities of 
complex polysaccharides such as agarans, xylans and carrageenans which resist 
degradation in the gastrointestinal tract and reach the colon intact. As such they can 
be considered a source of dietary fibre and a possible new source of prebiotics. Here, 
a depolymerised polysaccharide-rich extract from C. crispus was investigated for 
prebiotic potential using in vitro batch faecal fermentations. Some significant 
increases (p<0.05) were recorded in the production of total short-chain fatty acids, 
particularly the biologically important SCFAs propionate. However, there was no 
significant alteration in the molar ratio of SCFA production or impact on the 
production of butyrate. High-throughput DNA sequencing revealed that there was no 
notable impact on the relative abundance of the major probiotic genera, the 
bifidobacteria and lactobacilli. The results of this study revealed that fermentation of 
depolymerised polysaccharides from C. crispus have only a minimal stimulatory 
effect on the ex vivo microbial population and would not be considered prebiotic by 








Seaweeds are a very visible part of the global marine landscape. They are a 
commercially valuable resource that are used for  food, fodder, agricultural fertilizers 
and in the pharmaceutical industry [1]. Worldwide, 96% of the harvested seaweeds 
are produced by aquaculture which in 2013 had an economic value of $6.4 billion. In 
2014 the combined annual seaweed harvest from wild and cultivated crops was 28.4 
million tonnes, an increase of 43% since 2010. Some 75% of the global seaweed 
harvest in 2014 was used for food, with 40% alone being used in traditional Japanese 
cuisine. The production of hydrocolloids (polysaccharides) such as carrageenan, agar 
and alginate, accounted for 13% of the global harvest with the remaining 12% used 
for agriculture [2]. There are essentially two ways of obtaining a economical supply 
of seaweed material-harvesting natural seaweed stocks or through cultivation. 
Numerous options for the mechanical harvesting of stocks exist. However, serious 
concerns exist regarding environmental damage. At present, the mechanical 
harvesting of seaweeds is banned in the UK and Ireland and all harvesting is carried 
out by hand [3]. The use of seaweed in biorefinery started in the 17th century with the 
production of industrial soda and alginate in France and Ireland, and then later in 1893, 
by Edward Curtis, for iodine extraction with light provided by seaweed derived biogas. 
During the First World War, because of a shortage of potash, [4] kelps (brown 
seaweeds) were used to produce the acetone needed for cordite-based guns and 
artillery shells. The minerals from the seaweed were then recycled and used as 
fertilizer. Seaweeds contain high levels of proteins and a variety of different 
polysaccharide molecules. There are thousands of as-yet-undiscovered species of 
seaweed which promises new unique varieties of polysaccharides with different 
biochemical properties. As the components of seaweed undergo seasonal fluctuations, 
the maximum levels of components seldom coincide with each other [5]. Seasonal 
variation in the amount of carbohydrates in seaweeds is quite large and has 
necessitated the seasonal harvesting of seaweeds and the development of proper 
storage technologies, as seaweeds are known to decompose very quickly. A variation 
of between 5 and 32% for mannitol, for example, in Laminaria digitata over a whole 





The seaweed C. crispus is historically important on the island of Ireland. 
Alternatively known as Irish Moss, it has been used since the 19th century in folk 
medicine to treat respiratory ailments such as colds, influenza and tuberculosis. During 
the great Irish famine of 1845 – 1849 the usage of C. crispus was brought to the North-
Eastern corner of the United States of America by an Irish emigrant population fleeing 
starvation. Small quantities are still collected in Ireland for use in cooking and in health 
drinks [7, 8]. C. crispus  is a member of the rhodophyta (red seaweeds) which, along 
with the phaeophyta (brown seaweeds) and the chlorophyta (green seaweeds), is one 
of the main divisions of macroalgae based on colouration of the thallus [9]. The 
colouring of the red seaweeds comes from the dominance of the two pigments 
phycoerythrin and phycothcyanin that mask the effect of other pigments [10]. Red 
seaweeds in general are particularly rich in bioactive proteins, carbohydrates 
(including sulphated polysaccharides, agarans, xylans and carrageenans), vitamins and 
minerals, and pigments [11]. C. crispus contains good quantities of micro and macro 
elements, fatty acids (> 80% unsaturated fatty acids) such as palmitic, palmitoleic, 
oleic, arachidonic and eicosapentanoic acids, and sterols which are potentially be 
beneficial to human health [11]. C. crispus is also an economically and ecologically 
important seaweed species [12]. It grows plentifully in the intertidal zone of the 
Northern to mid-Atlantic region and has been harvested for decades for carrageenans 
(cell wall polysaccharides) which are used extensively as a thickener in the food 
industry [13]. The traditional harvesting of C. crispus was by local fisherman or 
farmers by means of drag rakes, hand rakes or by the collection of plants tossed on the 
shore. The plant was then dried, baled and exported for the extraction of the 
carrageenans [14]. The carrageenans are a family of high molecular weight (200-800 
kDa) sulphated polysaccharides found in red seaweeds and are of a great industrial 
importance [15, 16]. Sulphated polysaccharides can interact with matrix and cellular 
proteins owning to their chemical structures which are rich in polyanions [17]. 
Carrageenans consist of repeated alternating units of α - (1, 3) - galactose and β - (1, 
4, 3, 6) - anhydro - D - galactose. Carrageenans are classified into three industrially 
relevant types, kappa (κ) , lambda (λ) - and iota (ι) – carrageenans (Supplementary 
Fig. 5.1), which differ in the amount and position of their ester sulphate substitutes 
and their (3, 6) - anhydrogalactose content [18]. Variations in these components 





κ- and ι-carrageenan contain the (3, 6) - anhydro-galactose unit and are the gel forming 
types of carrageenan [15]. Typically, κ-carrageenan forms hard, strong and brittle gels, 
while ι-carrageenan forms elastic, soft and weak gels [20]. λ-carrageenan is a very 
high-sulphated type of carrageenan that lacks the (3, 6) - anhydro-galactose unit and 
does not gel.  It is mainly used for its ability to provide a mouth feeling and a creamy 
impact to dairy products [16]. Carrageenans have shown several potential 
pharmaceutical applications including anti-coagulant, anti-cancer, anti-
hyperlipidemic, and immune-modulatory activities. Along with C. crispus other major 
raw sources for carrageenan extraction include Gigartina stella, Eucheuma spp., 
Iridaea spp., and Kappaphycus spp [21]. Seaweed derived hydrocolloids, as of 2015, 
have a global value of approximately US$ 1.1 billion, which is projected to increase 
in the future. While agars have the highest retail price per kg (18 US$/kg), 
carrageenans currently have the highest commercial production (60,000 ton/year) and 
have the highest total value of US$ 626 million per year [22]. Originally, carrageenans 
were first isolated in 1862 by a British pharmacist named Stanford who extracted them 
from Irish Moss [23]. The modern carrageenan industry dates to the 1940s when they 
were used in the dairy industry as the perfect stabilizer for the suspension of cocoa in 
chocolate milk. They are also widely used in ice cream, paints, water gels and 
pharmaceuticals. Carrageenans are extracted from seaweeds by two distinct processes. 
In the refined process, the carrageenan is dissolved completely out of the cellulose 
matrix of the seaweed leaving a very clean and clear product. The semi refined process 
leaves the cellulose intact, thus enhancing the gel strength of the carrageenan within 
the seaweed itself. The final semi-refined product has excellent gelling and binding 
properties at a reduced cost, but the gel formed is less clear than the refined version 
[20].  
Complex seaweed polysaccharides may also give rise to a new and novel 
source of prebiotic compounds.  [24]. A prebiotic is “a selectively fermented food 
ingredient that results in specific changes in the composition and/or activity of the 
gastrointestinal microbiota, thus conferring benefit(s) upon host health” [25]. The 
rising concern among individuals, regarding maintaining good levels of overall health 
and with a growing emphasis on digestive health, is driving growth in the prebiotic 
market. High demands from the food and beverage sectors are also boosting the 





according to research by Transparency Market Research [26]. The inclusion of 
prebiotic food ingredients in the diet may facilitate changes in the GIT environment 
that favour the proliferation of probiotic bacteria such as Bifidobacterium and 
Lactobacillus. In general, the aim of prebiotic administration is to increase the 
saccharolytic activity of the colonic bacteria and promote carbohydrate fermentation, 
the end products of which (SCFAs) have beneficial effects. Concomitantly, the 
fermentation of undigested proteins, which results in the production of potentially 
toxic metabolites, would be expected to be reduced owning to a change in the 
fermentation profile of the GIT [27]. The main SCFAs produced by the microbiota are 
acetic acid (acetate), propionic acid (propionate) and N-butyric acid (butyrate). SCFAs 
are believed to provide an energy source for colonic cells and act as anti-proliferation 
agents [28]. The aim of this investigation was to assess the prebiotic potential of the 
economically important red seaweed C. crispus.  
Here, a polysaccharide-rich extract (the Cc extract) was prepared from the 
commercially valuable red seaweed C. crispus. Prebiotic potential was measured by 
subjecting the Cc extract to an ex vivo faecal batch fermentation. Samples of 
fermentate were taken at various time points for short-chain fatty acid production, 
DNA sequencing, enumeration of Bifidobacterium and Lactobacillus and the 







 5.3 Material and methods 
 
5.3.1 Materials  
All laboratory materials were obtained from Sigma-Aldrich, Dublin, Ireland unless 
otherwise stated. All plastic consumables were obtained from Sarstedt Ltd, Wexford, 
Ireland. 
 
5.3.2 Seaweed origin. 
The seaweed used in this study was the red seaweed species Chondrus crispus 
ISGC0439. This specimen of C. crispus was collected from the Galway bay region of 
Ireland.  
 
5.3.3 Preparation of depolymerized C. crispus polysaccharide rich extract.  
The C. crispus (ISCG0439) sample was washed with cold water and subsequently 
stored at - 20 °C until required for extraction. The extraction method chosen for this 
work was a hot-acid extraction using hydrochloric acid (37% v/v).  Prior to the primary 
extraction, the C. crispus sample was removed from cold storage, blended to a fine 
powder and added to a large reaction vessel along with deionised water in a ratio of 
1:10 (w/v) seaweed/deionised water. HCl was added (8.25 ml/L) to the reaction vessel 
to give a final concentration of 0.1 M.  The reaction vessel was then placed in an orbital 
shaker and allowed to shake at 75 rpm for 3 h at a temperature of 70 °C, after which 
the reaction vessel was removed from the shaker and allowed to cool. The contents of 
the vessel were filtered through a muslin bag with the filtrate being retained and 
transferred to a separate, clean storage vessel. The remaining seaweed mass was 
placed back into the original reaction vessel with fresh reagents and treated as 
previously described. The combined filtrates were neutralised using 1M NaOH (pH 6-
8) prior to storage and were subsequently centrifuged at 5000 g for 5 min to remove 






5.3.4 Post primary extraction processing of the C. crispus extract. 
The evident gelling properties of the C. crispus polysaccharides necessitated that the 
primary extract was subjected to a depolymerisation step. The extract was dissolved 
in 0.04% FeSO4 (1:5 w/v) solution to which hydrogen peroxide (30% puriss grade) 
was added (1:40 v/v) using a ratio of extract to hydrogen peroxide of 1:25. The mixture 
was allowed to shake at 150 rpm in a water bath at 80 °C for 15 min. Following the 
depolymerisation process, the mixture was blast-frozen and freeze-dried prior to 
storage. Ethanol precipitation was employed to separate the seaweed polysaccharides 
from the non-polysaccharide content and to remove impurities. The crude extract 
powder was resuspended in minimal deionised water and reacted with 100% ethanol 
in a ratio of seaweed: ethanol of 1:5. The resulting mixture was centrifuged for 5 min 
at 5000 g. The collected pellet was resuspended in fresh deionised water and blast-
frozen and freeze-dried prior to storage. Size exclusion dialysis with a molecular cut 
off point of 1 kDa was employed to remove simple sugars from the extract. The freeze-
dried powder was resuspended in minimum deionized water prior to dialysis. The 
dialysis tubing was prepared by cutting it into strips of appropriate length (~15cm) and 
rinsing each strip gently in deionised water to remove traces of the sodium azide 
storage solution. Each strip of dialysis tubing was filled with C. crispus extract and 
sealed using plastic clips. The tubing was carefully positioned in a washed container 
filled with deionised water, covered with tinfoil and placed in an orbital shaker and 
allowed to shake at 40 rpm at 25 °C. Each container had its water replaced every 
morning with fresh deionized water. On the third day, the dialysis, the tubes were 
removed from their respective containers and opened. Following dialysis, the collected 
dialysate underwent a simulated gastric digest. First, α-amylase (200 U) was prepared 
in 6.25 ml filter sterilized CaCl2 (1mM, pH7) and added to the seaweed mix, which 
was allowed to shake for 30 min at 37 °C. The pH was adjusted to pH 2 with HCl. 
Pepsin (2.7 g) dissolved in 125 ml 0.1M HCl was added to the seaweed mixture and 
incubated at the same conditions as before for 2 h. The pH was adjusted to pH 7 with 
NaOH. Bile (3.5 g) and pancreatin (560 mg) were dissolved in 0.5 M NaHCO3 and 
added. The seaweed mixture was set shaking for another 3 hours. To produce the final 
extract, the C. crispus digest underwent a further 1 kDa size-exclusion dialysis to 






5.3.5 Preparation of the cellulose negative control. 
The cellulose control for the study was processed in a similar manner to the final C. 
crispus (Cc) extract. Firstly, the cellulose was subjected to a simulated gastric 
digestion followed by size exclusion dialysis as previously outlined. Finally, the 
cellulose (post dialysis) was blast-frozen and freeze-dried to produce the final 
cellulose control. 
 
5.3.6 Carbohydrate analysis. 
The total concentration of carbohydrates in the Cc extract, FOS and cellulose control 
was determined by a resorcinol sulphuric acid method [29] with modifications. 
Briefly, a 75% H2SO4 solution, 6 mg/ml resorcinol stock solution, and a glucose 
control solution of 200 µg/ml were prepared using fresh deionised water. Each sample 
was prepared at a concentration of 1 mg/ml. To each microtube, 200 µl sample, 200 
µl resorcinol solution, and 1 ml of 75% sulphuric were added. Each microtube was 
covered in tinfoil and vortexed for 30 sec. The samples were then incubated at 90 °C 
for 30 min. after which they were placed at room temperature and allowed to cool. 
Readings at an optical density of 430nm and 480nm were taken respectively and an 
average value of total carbohydrates was obtained.  
To evaluate the polysaccharide content of the Cc extract, 2M trifluoroacetic 
acid (TFA) was used to degrade the extract to its component monosaccharides. The 
Cc extract prepared at a concentration of 1 mg/ml in the TFA and was reacted at 80 
°C for 90 minutes with constant stirring. The concentration of glucose and galactose 
in the degraded Cc extract were then determined using a HPLC method with an 
Aminex HPX 87C fixed ion resin column. The column was set at 60 °C and the eluent 
(0.009N H2SO4) was run at 0.5 ml/min. The sugars were detected using a refractive 
index detector attached to the system. The Cc extract was filtered through a 0.22 µm 
microfilter before subjecting to HPLC. Calibration curves for the 3 sugars were 
generated using different concentrations 10, 20, 50, and 100 ug/ml and gave a linear 






5.3.7 Ex vivo faecal fermentation distal colon model. 
The fermentation media used in this experiment was prepared according to Fooks et 
al., [31] with modification. The media consisted of: tryptone water (2 g/l), yeast extract 
(2 g/l), NaCl (0.1 g/l), KH2PO4 (0.04 g/l), K2HPO4 (0.04 g/l), CaCl2.6H20 (0.04 g/l), 
MgSO4.7H2O (0.01 g/l), sodium bicarbonate (2 g/l), tween 80 (2ml/l), hemin (0.05 
g/l), vitamin K1 (10 µl/l), cysteine HCl (1 g/l) and bile salts (0.5 g/l). The medium 
(800ml) was adjusted to pH 6.8 and autoclaved at 121 °C for 15 min. On the morning 
of each experiment, 2 g of either control or seaweed extract were dissolved in 160 ml 
of the fermentation media which in turn were added aseptically to their respective 
vessel in the MultiFors fermentation system (Infors UK). The system and media were 
sparged with N2 for at least 120 min to ensure an oxygen free anaerobic condition was 
established. Faecal samples were obtained from at least three healthy volunteers aged 
between 22 and 50 years. Each volunteer had no history of bowl problems and had not 
taken a course of antibiotics in the previous 6 months. The samples were collected 
roughly 2 h beforehand and were combined in a sterile filter stomacher bag to form a 
composite faecal sample. Immediately prior to the inoculation of the fermenters, the 
composite sample was mixed for 90 sec in the stomacher with an appropriate volume 
of maximum recovery diluent (MRD) containing 0.05% L-cysteine hydrochloride 
adjusted to pH 6.5 (which had been boiled and cooled in the anaerobic cabinet post 
autoclaving) to give a 20% composite faecal solution. Forty millilitres (40 ml) of the 
composite faecal slurry were introduced into each respective fermentation vessel.  The 
final volume for each vessel was 200 ml. Samples (1ml aliquots) were taken at 0 h, 5 
h, 10 h, 24 h, 36 h, and 48 h for total short chain fatty acid analysis, pyrosequencing 
and hydrogen sulphide production analysis. Plate counts were carried out at 0, 5, 10 
and 24 h to enumerate the major probiotic genera, Bifidobacterium and Lactobacillus. 
The negative control used for this experiment was cellulose and the positive control 
used was the known prebiotic fructooligosaccharide (FOS). The faecal fermentation 









5.3.7 Analysis of short-chain fatty acid production. 
Samples of fermentation media were taken in triplicate at all time points for SCFA 
determination. Each sample was centrifuged at 12500 g for 15 min with the 
supernatant being stored at -80 °C prior to further processing. Each sample was later 
thawed on ice and centrifuged at 12500 g for 5 min and filtered using 0.22 µm filters 
to remove bacteria and other solids. Samples were diluted 1:5 with Milli-Q water and 
1 mM 2-ethylbutyric acid, prepared in formic acid, was added to each sample as an 
internal control. SCFA analysis was carried out using a Varian CP-3800 GC system 
with a Flame Ionisation Detector (FID). This was fitted with a Zebron ZB-FFAP 
capillary column (30 m length x 0.32 mm internal diameter x 0.32 µm film thickness). 
Helium was used as the carrier gas and had an initial flow rate of 1.3 ml/min. The oven 
settings were as follows; 1) initial oven temperature was 100 °C - held for 30 sec; 2) 
temperature raised to 180 °C at 8 °C/min - held for 1 min; 3) temperature increased to 
200 °C at 20 °C/min – held at 200 °C for 5 min. The temperatures of the detector and 
the injection port were set at 250 °C and 240 °C respectively. A calibration curve was 
produced using different concentrations of a seven SCFA standard mix (10.0 mM, 8.0 
mM, 4.0 mM, 2.0 mM, 1.0 mM and 0.5 mM). The sample injection volume was 0.5 
μL. Additional vials containing standards were included in each run to maintain 
calibration and a cleaning injection of 1.2% formic acid was used before each analysis. 
The peaks were integrated using the Varian Star Chromatography Workstation version 
6.0 software. The SCFAs investigated in this study were acetic acid (acetate), 
propionic acid (propionate), N-butyric acid (butyrate), isobutyric acid (isobutyrate), 
valeric acid (valerate), isovaleric acid (isovalerate) and hexanoic acid (hexanoate). 
 
5.3.8 Preparation of DNA for high-throughput pyrosequencing. 
Fermentation samples (1 ml) were collected at time points 0 h and for pyrosequencing 
analysis. The MO BIO PowerFecal® DNA Isolation Kit was used to extract total 





The microbiota composition of each sample was established by amplicon 
sequencing of the V4 region using universal 16S rRNA primers predicted to bind to 
94.6% of all 16S rRNA genes [32, 33]. A forward primer (5’- 
AYTGGGYDTAAAGNG) containing a distinct multiple identifier tag (MID) for each 
sample (Table 3.2) and a combination of 4 reverse primers, R1 (5’- 
TACNVGGGTATCTAATCC), R2 (5’- CTACDSRGGTMTCTAATC), R3 (5’- 
TACCAGAGTATCTAATTC) and R4 (5’- TACCRGGGTHTCTAAT.CC) were 
utilised. All primers were synthesised by Eurofins Genomics, Ebersberg, Germany). 
PCRs were carried out using an Applied Biosystems® 2720 Thermo cycler. DNA 
samples were heated to 95 °C for 10 min before all PCRs. The cycling conditions for 
all PCR reactions were as follows: heated lid 110 °C, 94 °C for 2 min followed by 36 
cycles of 94 °C for 1 min, 52° C for 1 min and 72 °C for 1 min. This was followed by 
a final temperature step of 72 °C for 2 min and a holding step at 4 °C. Each PCR 
reaction had a final volume of 50 μl comprising 25 μl of BioMix Red (MSC, Ireland), 
1 μl forward primer (0.15 μM), 1 μl reverse primer (0.15 μM) (mix of 4), 5 μl template 
DNA, and 18 μl sterile PCR water. All PCRs were carried out in triplicate. Negative 
controls were run concurrently for all PCR conditions. PCR products were analysed 
using agarose gel electrophoresis (1.5% in 1 x TAE buffer). Generated amplicons were 
cleaned with Agencourt AMPure XP (Beckman Coulter) and quantified using the 
Quant-iT™ PicoGreen® dsDNA Assay Kit (Invitrogen™). Samples were sequenced 
on a 454 Genome Sequencer FLX platform according to established protocols. 
 
 5.3.9 Enumeration of probiotic bacterial populations by plate count method. 
Samples of fermentation content were taken at each time point between 0 h and 24 h  
for bacterial plate counts. The media used for Bifidobacterium enumeration was 
modified MRS agar plates (0.05% cysteine, 200 µl mupirocin). Lactobacillus selective 
agar (LBS; Difco, Becton-Dickson ltd, Dublin, Ireland) plates with glacial acetic acid 
(1.32 ml/L) were prepared for Lactobacillus enumeration. Appropriate serial dilutions 
of faecal aliquots (1 in 10 dilutions) were carried out using maximum recovery diluent 






5.3.10 Bioinformatic analysis of sequencing data. 
Raw sequences were quality-trimmed using the Qiime Suite of programmes [34]; any 
reads not meeting the quality criteria (a minimum quality score of 25 and a sequence 
length <150 bp for 16S amplicon reads) were discarded. OTUs were aligned using 
PyNAST[35] and taxonomy assigned using BLAST[36] against the SILVA 
SSURef[37] database release 111. α and β diversity indices and rarefaction curves 
were generated using Qiime. A phylogenetic tree was calculated using the FastTree 
[38] software and the resulting principal coordinate analysis was visualised within 
KiNG. 
 
5.3.11 Statistical analysis. 
All results presented as the mean value (± SE). Statistical analysis was carried out 
using GraphPad Prism version 5.0 for windows. Independent t-test were carried out 
on parametric data sets to access whether differences between the treatment groups 












5.4.1 Total carbohydrate concentration and compositional analysis of the Cc 
extract. 
The total concentration of carbohydrates was determined for the Cc extract, FOS and 
cellulose control using a resorcinol sulphuric acid method with modifications. 
Carbohydrate concentration is presented in terms of Glucose equivalent (GE) per 
milligram. Total concentration of carbohydrates for the Cc extract was determined to 
be 52.2 ± 0.3 GE mg-1. Total concentration of carbohydrates for the cellulose control 
was 105.7 ± 6.3 GE mg-1 and for the FOS was 272.1 ± 4.6 GE mg-1.  
The polysaccharide content of the Cc extract was investigated by treatment 
with TFA to degrade the parent polysaccharides to their base monosaccharide 
components. Prior to treatment with TFA, the levels of lactose, glucose and galactose 
in the Cc extract were 0 µg/ml. Following treatment of the Cc extract with TFA, the 
concentration of galactose was 170.5 µg/ml and the concentration of glucose was 6.2 
µg/ml. No lactose was detectable following TFA treatment (Fig. 5.1) 
 
5.4.2 Enumeration of bifidobacteria and lactobacilli by plate count. 
Serial dilutions of fermentation samples were carried out at 0 h, 5 h, 10 h, and 24 h to 
enumerate Bifidobacterium and Lactobacillus numbers (CFU/ml) (Fig 5.2). Results of 
the plate counts showed that the Cc extract had no significant impact on the recovery 
of Bifidobacterium. No noteworthy effect on Bifidobacterium was observed and 
numbers of recovered bifidobacteria were reduced at every time point. A significant 
increase in Bifidobacterium numbers was overserved with FOS, in comparison with 
the cellulose control, at 10 h. There was also a significant increase at 10 h over the Cc 
extract. The recovery of culturable Lactobacillus was not significantly impacted by 
fermentation of the Cc extract or FOS. A reduction in their numbers was observed at 
every time point during the Cc extract fermentation. Lactobacilli attained their highest 
numbers at 5 h for both the cellulose control and FOS. Reduction in Lactobacillus 





5.4.3 Short-chain fatty acid production. 
Total SCFA production was measured using a Gas Chromatography – Flame Ion 
Detector (GC-FID). All reported values are minus the baseline level of SCFAs taken 
at 0 h and are ± the SEM. The total production of SCFA was significantly increased 
(p>0.05) for the FOS fermentation (+167.8% ± 10.6). A non-significant increase in 
total SCFA production of 13.7% ± 6.1 was observed for the Cc extract (Fig. 5.3). Total 
SCFA concentration was significantly higher (p<0.05) with the Cc fermentation at 24 
h and 36 h respectively, in comparison with cellulose. Fermentation of FOS by the 
representative microbiota resulted in significant increases (P>0.05) in the 
concentration of acetate, butyrate and propionate as well as significant increases in 
total SCFA concentration. Total SCFA concentration with the FOS control was 
significantly higher than that observed with the Cc extract at all time points (Fig. 5.3). 
Acetate was the major SCFA produced for all fermentations, accounting for 45.0% ± 
3.7 (cellulose), 52.0% ± 2.6 (FOS) and 48.6% ± 3.0 (Cc extract) of total SCFA 
production (Fig. 5.4). Total acetate production was increased during the Cc extract 
fermentation by 10.5% ± 4.9. Neither acetate concentration or production were 
significantly affected by supplementation with the Cc extract (Fig. 5.5). The second 
major SCFA produced was butyrate, which accounted for 22.2% ± 1.0 (cellulose), 
23.2% ± 0.2 (FOS) and 19.5% ± 2.2 (Cc extract) for total SCFA production (Fig. 5.4) 
Total butyrate production was reduced by 1.3% ± 8.3 with the Cc extract fermentation. 
There was no significant impact on butyrate concentrations or production at any time 
point during the Cc fermentation (Fig. 5.6). The third major SCFA produced was 
propionate. Propionate production accounted for 16.8% ± 1.0 (cellulose), 19.4% ± 1.3 
(FOS), and 19.7% ± 1.3 (Cc extract) (Fig. 5.4) Total propionate production was 
increased during the Cc extract fermentation by 21.8% ± 2.9. Propionate concentration 
was significantly higher than the cellulose control at 24 h (P=0.008) and at 36 h 
(P=0.011). Propionate production was not significantly affected during the Cc extract 
fermentation (Fig. 5.7). There was no significant impact on the BCFA concentration 
or production with the Cc extract of FOS fermentation (Fig. 5.8) 
The molar ratio of acetate production: propionate production: butyrate 
production after with the Cc extract was approximately 58:24:18. Compared with the 
molar ratio of the control fermentation which was 57:19:24, there was significant 





reduction in the amount of butyrate production. Acetate production was not 
significantly affected. This ratio for the FOS was also not significantly different from 
the cellulose control. After 48 h the Cc extract ratio returned to the same level as the 
cellulose control (Table 5.1) 
 
5.4.4 High throughput DNA sequencing of the 16s rRNA gene variable V4 region. 
Taxonomy based analysis of the high throughput sequencing data revealed a baseline 
(T0) assignment of reads as follows. In the cellulose control community, 54.3% ± 3.8 
of reads corresponded with Firmicutes, Bacteroidetes 41.5% ± 3.6, Proteobacteria 
3.2% ± 0.8, Actinobacteria 0.67% ± 0.2%, with all other phyla accounting for 0.3% ± 
0.32. In the FOS community, 52.9% ± 9.1 of assigned sequence reads corresponded 
with Firmicutes, Bacteroidetes 43.8% ± 9.1, Proteobacteria 2.8% ± 0.1, Actinobacteria 
0.7% ± 0.2, with all other phyla accounting for 0.1% ± 0.1. Finally, the Cc extract 
community had 50.9% ± 5.8 reads assigned to Firmicutes, Bacteroidetes 36.6% ± 3.7, 
Proteobacteria 11.4% ± 2.3, Actinobacteria 0.7% ± 0.2, and other phyla 0.1% ± 0.1. 
In comparison with the cellulose control, a significant (P>0.05) decrease of change in 
relative abundance was observed with the FOS fermentation for the phylum 
Proteobacteria (Fig 5.9). No significant differences were observed between the 
cellulose control and the Cc extract fermentation in terms of change in relative 
abundance (Fig. 5.9) 
Analysis of reads assigned at a family level showed that the most dominant 
families present were Bacteroidaceae, Lachnospiraceae, Ruminococcaceae, 
Porphyromonadaceae and Prevotellaceae. Fermentation of the Cc extract resulted in 
a significant (P<0.05) reduction in change of relative abundance of 
Christensenellaceae (Firmicutes), in comparison with the cellulose control. For the 
FOS fermentation, significant increases (P>0.05) in relative abundance for the family 
Erysipelotrichaceae (Fig. 5.10) and significant decreases in relative abundance for 
uncultured Bacteroidales family S24-7 (Fig. 5.10) and Christensenellaceae (Fig. 5.10). 
In comparison with the FOS control, there were significant increases (P>0.05) with 
the Cc extract in the relative abundance of uncultured Bacteroidales family S24-7 (Fig. 
5.10), Alcaligenaceae (Fig. 5.10), and Pseudomonadaceae (Fig. 5.10) and a significant 





At the genus level, the most abundant genera were found to be Bacteroides, an 
uncultured genus of the family Lachnospiraceae, Prevotella, Faecalibacterium, 
Lachnospiraceae incertae sedis, and an uncultured genus of the family 
Ruminococcaceae. There were no significant increases/decreases observed with the 
Cc extract. At the genus level with the FOS fermentation, in comparison with the 
cellulose control, there were significant increases (P>0.05) in relative abundance of 
Anaerostipes (Fig. 5.12), and an uncultured genus of the family Erysipelotrichaceae 
(Fig. 5.12) with significant decreases in relative abundance being observed for the 
genera Odoribacter (Fig. 5.11) an uncultured member of the family 
Christensenellaceae (Fig. 5.12), Lachnospiraceae incertae sedis (Fig. 5.12), 
Flavonifractor (Fig. 5.12), an uncultured member of the family Ruminococcaceae 
(Fig. 5.12) and for Sutterella (Fig. 5.13). Significant differences were observed 
between the Cc extract and FOS for Lachnospiraceae incertae sedis (Fig. 5.12), 
Flavonifractor (Fig. 5.12), uncultured Ruminococcaceae (Fig. 5.12), uncultured 
Erysipelotrichaceae (Fig 5.12), Sutterella (Fig. 5.13), Comamonas (Fig. 5.13), 
Massilia (Fig. 5.13), Enterobacter (Fig. 5.13), Klebsiella (Fig. 5.13), Pseudomonas 








Seaweeds, in general, are akin to biological metabolite factories. They contain large 
quantities of polysaccharides and simple sugars as well as vitamins and minerals, 
proteins and phenolic compounds. Among seaweeds, C. crispus has one of the highest 
percentages of soluble dietary fibre (15-22%) [39]. The predominant polysaccharides 
found in C. crispus are carrageenans, agars and xylans, and it was of interest to see if 
a polysaccharide extraction of C. crispus would exhibit prebiotic activity. The general 
extraction process for sulphated polysaccharides from red seaweeds is dependent on 
the purity of the product you wish to obtain. For high purity, the polysaccharide is 
dissolved in solution, filtered to remove particular matter and then recovered from the 
solution by precipitation with an organic solvent such as ethanol, a step which also 
removes large amounts of impurities [19]. Briefly here, a dilute hot-acid (0.1 M HCl) 
primary extraction was carried out at 70 °C followed by depolymerisation, ethanol 
precipitation, size exclusion dialysis and a simulated gastric digestion to remove the 
non-polysaccharide content from the extract. Treatment of the biomass with dilute acid 
removes the polyvalent cations[40], as well as interrupting the hydrogen bonds 
between the different cell-wall  polysaccharides facilitating an increase in the 
extraction yield. However care should be taken to prevent the degradation of any acid 
sensitive polysaccharides [40]. Here, the primary acid extraction of C. crispus did not 
dispel the gelling properties of the Chondrus polysaccharides. When the freeze-dried 
extract powder was resuspended in minimum deionised water, a strong gel was seen 
to form. Carrageenans represent one of the main texturizing and gelling agents used 
by the food industry. They are natural ingredients that have been used for decades in 
foods and have generally been regarded as safe (GRAS) status [41]. In general, they 
serve as gelling, stabilising and viscosity-building agents [42]. Any extract for 
prebiotic studies with such properties could not be added to a fermentation vessel 
without causing significant technical issues. While it was understood that 
depolymerisation could greatly degrade the polysaccharides, it was deemed a 
worthwhile risk in terms of producing an extract that could be successfully added to 
an anaerobic fermenter for prebiotic investigation. In order to overcome this issue and 





using hydrogen peroxide [43]. The result of the depolymerisation step was that the 
gelling effect of the polysaccharide was negated and further processing of the C. 
crispus extract was possible. Ethanol precipitation and high-speed centrifugation were 
used to segregate the seaweed polysaccharides from the significant quantities of salts 
and non-polar content present. The next step in processing the extract was to remove 
simple sugars and any other small components that weren’t removed by ethanol 
precipitation. Monosaccharides, such as glucose, are the preferred energy source for 
bacteria as the enzymes needed for their degradation and oxidization are widely found. 
A selective effect on growth would not be seen ex vivo with an extract containing high 
amounts of simple sugars. Size exclusion dialysis is a process used to selectively 
separate molecules by molecular weight (size exclusion). The partial cleavage of 
glycosidic bonds is a useful approach for isolation of oligosaccharide fragments in 
structural analysis of complex polysaccharides [44]. Trifluoroacetic acid was 
discovered in the early 1900s and is widely used as a solvent, catalyst and a reagent 
[45]. Treatment of the Cc extract with the TFA resulted in the liberation of large 
quantities of galactose. In red seaweeds, hydrolysis of carrageenan and agar leads to 
high amounts of galactose and 3,6-anhydro-galactose in the hydrolysate [4]. From this 
we conclude that the Cc extract, following extensive post extraction processing, is 
primarily composed the polysaccharide carrageenan as carrageenan can comprise 50-
65% of the dry weight of C. crispus [46].  
Historically, investigations of the colonic microbiota relied heavily on 
conventional culturing techniques. These techniques, unfortunately, had an inherent 
bias, since roughly 90% of the gut microbiota have not yet been cultured [47].  To 
investigate the prebiotic potential of this extract, an ex vivo faecal fermentation 
approach was taken. Batch fermentation vessels inoculated with faecal slurry are 
useful for comparative evaluation of putative prebiotics as several can be set up 
simultaneously and can be used on a small scale for the screening of novel substrates 
that are only available in small quantities [48]. Here, the MultiFors fermentation 
system (Infors UK Ltd) was used to mimic the conditions found in the distal colon. 
When non-digestible carbohydrates are taken in as part of the diet, they pass through 
the digestive system intact until they reach the colon where the microbiota uses them 
as substrates for fermentation. To carry out a putative prebiotic study, the 





important aspect of the model was to ensure that the environment was completely 
anaerobic. The bifidobacteria are obligate anaerobes and are not tolerant of oxygen in 
their environment. To achieve this, N2 gas was sparged continuously throughout the 
vessels for the duration of each fermentation run beginning two hours before 
inoculation with the composite slurry. The pH of each vessel was automatically 
adjusted so that a constant pH of 6.7 was maintained throughout the fermentation run 
through the appropriate addition of either NaOH or HCl. SCFAs (acetate, butyrate and 
propionate) in vitro don’t accumulate in the colon but instead are absorbed by the 
colonic mucosa. The contents of each of the vessels were mixed by a magnetic stirrer 
to keep the mixture of growth media and bacterial cells as homogenous as possible. In 
a batch fermentation system, SCFAs are not absorbed but remain in the fermentation 
vessel and the resultant drop in pH could inhibit microbial growth [49]. However, 
several problems exist with using a batch fermentation system in fermentation studies. 
Batch fermentations are limited in terms of experimental duration and the amount of 
substrate added to avoid negative feedback mechanisms. Batch cultures are also highly 
dependent on the inoculation density as this directly impacts on microbial growth in 
closed systems. In contrast, continuous culture systems are superior in modelling the 
dynamic nature of the gastrointestinal tract, allowing the adaptation of various 
parameters, including dilution rate, retention time, pH and temperature, to meet and 
maintain optimal growth conditions. Furthermore, substrate replenishment and toxic 
waste removal are continuous and facilitate studies on the modulation of microbial 
composition and activity [50] 
Short-chain fatty acids are produced as the end products of 
polysaccharide/oligosaccharide fermentation [48] by microbiota in the colon [51].  
They are used by host cells as an energy source as well as acting as regulators of energy 
intake and energy metabolism [52]. Here, total SCFA production was taken as 
meaning the accrued production of the short chain fatty acids with between 2 and 6 
carbon atoms namely, acetate, propionate, butyrate, iso-butyrate, valerate, isovalerate 
and hexanoate. There was no significant difference (P <0.05) between the baseline 
levels of SCFA observed in the different fermentation vessels at 0 h indicating that the 
microbial load at the beginning of the fermentations was homologous for all 
fermentation vessels. The main SCFAs of biological importance are acetate, 





molar ratio of 60:20:20, with production being in the order of acetate> propionate> 
butyrate [53, 54]. Carbohydrates differ in the extent that they are fermented by 
microorganisms and in the molar ratio of fatty acids produced, leading to greater or 
lesser proportions of propionate and butyrate produced, both of which have positive 
implications in the prevention of colon cancer. Fermentation is also influenced by 
factors such as the degree of lignification, water solubility, particle size and molecular 
structure [48].  
The approximate molar ratio for the cellulose control after was 58:19:24 which 
broadly conformed to other reported studies. The ratio for the Cc extract fermentation 
was measured as 58:24:18, indicating a significantly increased (p = 0.020) proportion 
of propionate production in comparison with the control fermentation. A significant 
decrease in the ratio of butyrate production was also observed at both 5 h and 10 h 
respectively. Supplementation with FOS had no apparent effect on the ratio of acetate: 
propionate: butyrate production. This indicates that the addition of the Cc extract had 
a propiogenic effect on the ex vivo microbial populations. The results obtained from 
the GC-FID analysis indicate that the depolymerized C. crispus extract was poorly 
metabolised in general by the microbial populations present in the fermentation 
vessels. The polysaccharides present in the extract, mainly carrageenan, only caused 
a moderate increase in the production of short-chains. This is in agreement with a 
study by Ferguson and Jones [54] where the fermentability of  31 carbohydrates 
(measuring total SCFA production) were graded and carrageenan was placed 30 out 
of 31. The amounts and proportions of SCFAs were similar to the controls used in the 
study indicating that carrageenan had undergone little or no fermentation. The 
generation of SCFAs is one the most important metabolic functions of the microbiota 
that benefits the host organism. Their creation is an important indicator of a putative 
prebiotic compound. In contrast with the Cc extract, the FOS was readily fermented 
by the ex vivo bacterial populations resulting in a sharp increase in the total production 
of SCFAs as well as the individual increases in acetate, propionate and butyrate, the 
three most biologically relevant SCFAs. The depolymerisation step in the preparation 
of the Cc extract may have degraded the polysaccharides to such an extent that they 





The human microbiota is a highly complex bacterial community dominated by 
hundreds of species of obligate anaerobes, among which are the bifidobacteria. Many 
studies have focused on measuring their abundance as an indication of prebiotic effect 
[55] as their selective stimulation can have several benefits such as the stabilization of 
the gut mucosal barrier and the prevention of diarrhoea. Bifidobacteria produces both 
lactic and acetic acids that results in a lowering of luminal pH and the inhibition of 
pathogens[56]. Like most intestinal bacterial, bifidobacteria are saccharolytic 
organisms, obtaining their energy through the fermentation of carbohydrates. They 
play an important role in carbohydrate fermentation in the colon as they possess a wide 
array of carbohydrate modifying enzymes. For example, 5% of the whole genome of 
Bifidobacterium longum corresponds to carbohydrate-modifying enzymes. 
Bifidobacteria use a variety of glycolyl hydrolases to degrade a variety of plant 
polysaccharides or host-derived glycoproteins and glycol-conjugates that release a 
variety of mono- and oligosaccharides that are then catabolised [57, 58]. The selective 
stimulation of growth of beneficial members of the gut microflora is a key feature of 
the prebiotic definition coupled with the idea of augmenting their metabolic activity. 
As measured by bacterial plate counts, fermentation of the C. crispus polysaccharides 
had no impact on the growth of Bifidobacteria and a detrimental effect on the growth 
of Lactobacilli. In comparison, the FOS control (a known prebiotic) has a notable, if 
not significant, impact on numbers of Bifidobacteria. FOS is composed of a mixture 
of fucose moieties that are linked by β-(2-1) glycosidic bonds with a terminal glucose 
unit. Bifidobacteria possess a β- fructofuranosidase enzyme that hydrolyses fructose 
moieties from the terminal β-2,1 position and is involved in the hydrolysis of fructans 
and sucrose [57]. By this mechanism, bifidobacteria can utilize FOS and other inulin 
type compounds for growth.  
The classical microbiological approach to the cultivation and study of 
microorganisms began in the 17th century when a Dutch linen merchant constructed 
the first apparatus capable of viewing the microbial world that is all around us. Since 
then advances in technology has allowed scientists to move past culture-dependent 
studies and towards non-culture based technologies such as 16S rRNA sequencing 
which has provided extensive information on the microbial composition of many 
different ecosystems. The 16s rRNA gene is the most common target for sequencing 





for distinction to be made between the different taxa [59].  Here the V4 variable region 
of the 16s rRNA gene was targeted for high throughput DNA sequencing using a 454 
Genome Sequencer FLX platform. The prebiotic concept is centered on the notion that 
the ingestion of non-digestible, fermentable food ingredients can stimulate the growth 
and/or activity of a small number of beneficial members of the gut microbiota. While 
not named specifically, this is taken to mean stimulation of Bifidobacterium and 
Lactobacillus and an increasing number of other beneficial bacteria such as Roseburia.  
 As expected, large increases in the ex vivo populations of Bifidobacteria were 
observed during the FOS fermentation. However, there were no likewise increases of 
Bifidobacteria brought about by the Cc extract. Further, neither the FOS nor the Cc 
extract had any significant effect on the relative abundance of Lactobacillus. These 
observations positively correlate with the data recovered from the major probiotic 
genera plate counts.  It would appear the Cc extract did not stimulate the growth of 
either of the two main probiotic genera. At the genus level, all three fermentation 
conditions (cellulose control, FOS and Cc extract) brought about notable decreases in 
Faecalibacterium, another species often mentioned as being probiotic in nature. A 
substantial reduction in the relative abundance of Klebsiella was observed in the Cc 
supplemented vessels. Klebsiella is an opportunistic pathogen with the majority of 
infections being associated with hospitalization. Those most at risk are 
immunocompromised individuals who have been hospitalized and suffer from a severe 
underlying disease such as diabetes and chronic pulmonary obstruction. Nosocomial 
acquired infections are mainly caused by Klebsiella pneumonia [60]  
Rarefaction curves were calculated at 97% similarity and were saturated for all 
samples, indicating that extra sampling would only yield a limited increase in species 
richness. A scatter plot analysis of alpha diversity indicated that neither the C. crispus 
extract nor the FOS had a substantial influence on species diversity. Beta diversity was 
estimated using principal coordinate analysis (PCA) plots generated using an 
unweighted Unifrac distance matrix. Through PCA, the samples were shown to cluster 
into relatively distinct groupings based on the fermentation run and not treatment type 
indicating that the greatest factor affecting diversity was the initial composition the 
faecal slurry inoculum. A study carried out by Liu et al., [46] looked at the prebiotic 





supplementation with C. crispus (2.5%) resulted in significant increases in the 
population of Bifidobacterium breve and a reduction of the abundance of the 
pathogenic species Clostridium septicum and Streptococcus pneumonia. Also, higher 
concentration of short-chain fatty acids was found in faecal samples of the C. crispus 
group. The C. crispus used in this study was not a refined extract as presented here. 
No processing was carried out to isolate the polysaccharide content and to remove 
non-carbohydrate matter. The study also found that the observed effect was dose 
dependent with a 2.5% concentration being optimal. This is a higher concentration 
than that used in this investigation and suggests that a slightly increased percentage of 







The three groupings of seaweeds, red seaweeds (phylum Rhodophyta), brown 
seaweeds (phylum Ochrophyta, class Phaeophyceae) and green seaweeds (phylum 
Chlorophyta) contain large quantities of polysaccharides that resist digestion in the 
mammalian digestive tract and thus are potential novel sources of prebiotic 
compounds. Seaweeds of the phylum Rhodophyta contain large quantities of 
polysaccharides such as carrageenan, agarans and xylans which differ from the main 
polysaccharides found in the brown seaweed (laminarin, fucoidan, alginate) and the 
green seaweeds (ulvan). The concept of prebiotics is an intriguing one. The delivery 
of non-digestible components to the gut, after surviving gastric transit, and then being 
utilised by certain beneficial members of the microbiota, namely Bifidobacterium and 
Lactobacillus. However, not all putative prebiotics are made equally and they vary 
considerably in their fermentability potential. The conclusion of this study is that a 
polysaccharide-rich extract from C. crispus, prepared as outlined above, does not 
exhibit prebiotic activity when used as the sole source of carbon in an ex vivo 
fermentation model. The results obtained from high throughput DNA sequencing and 
traditional enumeration techniques clearly indicate that the fermentation of C. crispus 
extract failed to selectively stimulate the main probiotic genera of Bifidobacterium and 
Lactobacillus and had a minimum effect on the overall microbial population. The 
production of SCFAs, especially the biologically important acids acetate, butyrate and 
propionate, are an excellent indication of stimulation of microbial activity. Increases 
in propionate concentration, while statistically significant (p<0.05) at certain time 
points, fell short of the levels that would be expected from a putative prebiotic. This 
study concludes that depolymerised C. crispus polysaccharides were poorly fermented 
by the ex vivo microbiota and did not have a significant impact on the microbial 
populations present. It is reasonable to assume that depolymerisation with hydrogen 
peroxide resulted in degradation of the red seaweed polysaccharide. While the C. 
crispus extract, in this form, does not exhibit prebiotic activity it would be of great 
interest to revisit this seaweed using different approaches to overcome the gelling 
properties of carrageenans such as an enzymatic extraction approach rather than hot 
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Figure 5.1. Compositional analysis of the Cc extract. The Cc extract was treated the TFA and the 










































Figure 5.2. Plate count data for (a) culturable Bifidobacterium and (b) culturable Lactobacillus 
populations at 0 h, 5 h, 10 h and 24 h. Data represent the mean (±SE). (a = P<0.05), b = P<0.005, c = 




















































Figure 5.3 Total SCFA production. The effect of the C. crispus extract and FOS on (a) total SCFA 
concentration and (b) SCFA production. Data represent the mean (±SE). (a = P<0.05), b = P<0.005, c 
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 A:P:B A:P:B:BC 
Total SCFA production 
Cellulose 56:19:25 50:17:22:11 
FOS 55:21:25 52:19:23:6 
C. crispus extract 55:22:22 48:20:19:13 
   
Production 0 – 24 h  
Cellulose 57:19:24 52:17:21:10 
FOS 56:21:23 55:20:22:4 
C. crispus extract 58:24:18 52:23:14:8 
   
Production 24 - 48 h  
Cellulose 39:20:41 28:15:29:28 
FOS 42:15:43 33:12:33:22 



















Figure 5.4 Breakdown of SCFA production by time. Percentage breakdown of (a) total SCFA, and (b) 





























































Figure 5.5 Acetate production. The effect of the C. crispus extract and FOS on (a) acetate concentration 
and (b) acetate production. Baseline values obtained at 0 h were subtracted from each time point Data 
represent the mean (±SE). (a = P<0.05), b = P<0.005, c = P<0.0005 relative to cellulose, d = P<0.05, e 
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Figure 5.6 Butyrate production. Effect of the C. crispus extract and FOS on (a) butyrate concentration 
and (b) butyrate production. Baseline values obtained at 0 h were subtracted from each time point. Data 
represent the mean (±SE). (a = P<0.05), b = P<0.005, c = P<0.0005 relative to cellulose, d = P<0.05, e 
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Figure 5.7 Propionate production. The effect of the C. crispus extract and FOS on (a) propionate 
production and (b) propionate production. Baseline values obtained at 0 h were subtracted from each 
time point. Data represent the mean (±SE). (a = P<0.05), b = P<0.005, c = P<0.0005 relative to cellulose, 
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Figure 5.8 Branched-chain fatty acid production. The effect of the C. crispus extract and FOS on (a) 
BCFA concentration (b) BCFA production. Baseline values obtained at 0 h were subtracted from each 
time point. Data represent the mean (±SE). (a = P<0.05), b = P<0.005, c = P<0.0005 relative to cellulose, 
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Figure 5.9 (a) Increase/decrease in relative abundance at the phylum level. (b) Percentage change in 
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Figure 5.10 (a) Notable increases/decreases in relative abundance at the family level. (b) Percentage 
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Figure 5.11 (a) a) Increase/decrease in relative abundance of genera in the phyla Actinobacteria, 
Fibrobacteres, Lentisphaerae, Proteobacteria, Tenericutes, and Verrocomicrobia. (b) Percentage change 
in the relative abundance of genera in the phyla Actinobacteria, Fibrobacteres, Lentisphaerae, 
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Figure 5.12. (a) Increase/decrease in relative abundance of genera in the phylum Firmicutes. (b) 
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Figure 5.13 (a) Increase/decrease in relative abundance of genera in the phylum Proteobacteria. 
Percentage change in the relative abundance of genera in the phylum Proteobacteria. Values represent 
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Figure 5.15 Alpha diversity. (a) Chao1 richness estimation, (b) Shannon’s index of diversity, (c) 
Simpson index of diversity, (d) Observed species and (e) Phylogenetic diversity metrics were used to 
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Figure 5.16 Beta diversity. Principle coordinate analysis of unweighted Unifrac reveals separation by 
fermentation run. Light Blue - Run 1 0 h, Light Green – Run 2 0 h, Light Red – Run 3 0 h, Dark Blue - 










Supplementary Table 5.1 (a) To generate 16s rRNA bacterial gene amplicons (V4), a different version 
of the same forward primer was used for each fermentation sample. Each version contained a unique a 
distinct multiple identifier (MID) barcode allowing for distinction between the different samples. (b) A 
combination of four different reverse primers were used in conjunction with a single forward primer to 









































































































































































































Supplementary Figure 5.3 Rarefaction curve for each group at 97% similarity levels. Amount of 










































Supplementary Table 5.2 Alpha diversity. (a) Chao1 richness estimation, (b) Shannon’s index of 
diversity, (c) Simpson index of diversity, (d) Observed species and (e) Phylogenetic diversity metrics 

















Control run 1 0 h 1,465.43 0.97 6.77 42.74 770.00 
Control run 2 0 h 1,035.98 0.97 6.68 38.14 642.00 
Control run 3 0 h 989.06 0.96 6.40 32.14 556.00 
 
FOS run 1 0 h 1,295.62 0.96 6.54 40.69 688.00 
FOS run 2 0 h 1,348.45 0.97 6.68 42.77 726.00 
FOS run 3 0 h 903.48 0.96 6.31 30.18 505.00 
 
Cc extract run 1 0 h 987.69 0.97 6.86 37.65 620.00 
Cc extract run 2 0 h 990.28 0.96 6.59 39.58 612.00 
Cc extract run 3 0 h 1,165.60 0.96 6.50 38.66 645.00 
 
 
Control run 1 24 h 1,485.28 0.97 6.98 45.99 828.00 
Control run 2 24 h 1,187.42 0.96 6.37 40.07 680.00 
Control run 3 24 h 1,101.78 0.97 6.79 36.14 631.00 
 
FOS run 1 24 h 1,031.50 0.97 6.57 36.09 619.00 
FOS run 2 24 h 852.11 0.95 5.78 32.76 490.00 
FOS run 3 24 h 1,014.92 0.96 6.08 35.91 561.00 
 
Cc extract run 1 24 h 1,249.02 0.96 6.65 44.08 805.00 
Cc extract run 2 24 h 707.57 0.96 6.46 32.49 487.00 
Cc extract run 3 24 h 1,022.99 0.97 6.76 37.06 634.00 






















Foodborne illnesses are a major burden on health services throughout the world. A 
variety of antimicrobial agents have been used to prolong the shelf-life of processed 
goods and inhibit the growth of foodborne pathogens but resistance to traditional 
antimicrobials is spreading quickly. Listeria monocytogenes is among the most 
prevalent foodborne pathogen and is the causative agent of listeriosis. This organism 
can tolerate an extensive range of environmental conditions - such as refrigeration 
temperatures, and survives well under both aerobic and anaerobic conditions. These 
attributes combine to make Listeria monocytogenes a major concern in the production 
of Ready-to-Eat (RTE) foods. In this study, ten ethanol extractions derived from Irish 
brown seaweeds, were examined for their antimicrobial activity against a selection of 
foodborne pathogens including Listeria monocytogenes.  Extracts from the seaweeds 
Fucus vesiculosus, F. serratus F. spiralis, Ascophyllum nodosum and Pelvetia 
canaliculata significantly inhibited (p<0.05) the growth of Listeria monocytogenes 
5788 at 24 h. The F. vesiculosus extract was chosen for further evaluation. Molecular 
weight fractions of F. vesiculosus were tested against several Listeria stains. It was 
found that the anti-listerial activity was concentrated in the 0 - 3.5 kDa and the 3.5-
100 kDa molecular weight subfractions, with the 3.5 - 100 kDa exhibiting the highest 
activity of all. Antimicrobial activity was found to be positively correlated with 
elevated levels of phenolic compounds. F. vesiculosus was found to have the highest 
level of phenolic compounds amongst all the seaweed species tested at 138.3 ± 0.7 µg 
GAE mg-1 and demonstrated the most potent activity against the pathogen L. 
monocytogenes. This is a promising outcome as to the potential of utilising such 
extracts from seaweeds in food products to serve as both biopreservation and 












Food related illness is a common and often preventable malaise [1] that affects 
approximately 30% of individuals living in industrialised countries every year. As 
such, it is a major burden on health services throughout the world [2]. The Centre for 
Disease Control (CDC) in Atlanta projects that each year in the US alone more than 
5,000 people die of foodborne related illnesses. [3]. World-wide, six pathogens alone 
are estimated to account for over 90% of food-related deaths: Salmonella, Listeria, 
Toxoplasma, Norwalk-like viruses, Campylobacter, and Escherichia coli O157:H7 
[3]. Among the most important avenues of treatment of bacterial infection today are 
antibiotics. Antibiotics are organic or synthetic compounds that even at a low level 
have deleterious effects on the growth and/or metabolism of susceptible 
microorganisms. They have been in large scale use since the development of the 
sulphonamides in the 1930’s. However, current antibiotics have been associated with 
several negative traits such as: high-cost, toxicity, residual side effects, allergic 
reactions, hypersensitivity and immunosuppression. The over reliance on antibiotics 
and their misuse by health care workers and the public alike have also resulted in the 
emergence of antibiotic-resistant bacterial strains, leading to a reduction in 
effectiveness of anti-microbial therapy in some instances. The WHO has classified the 
spread of antibiotic resistance among bacteria as one of the biggest threats to public 
health in the 21st century. Because the extensive use of antibiotics can alter the normal 
human gut microbiota, enrichment with antibiotic resistant bacteria which further 
complicates treatment, can occur [4, 5]. Many naturally-occurring compounds found 
in edible and medicinal plants, herbs and spices have been shown to possess 
antimicrobial properties [6] but the search for new antimicrobials to date has mainly 
focused on terrestrial environments. Algae are a proven source of novel bioactive 
compounds [2]. In this respect the long evolution of marine plants, compared with 
their terrestrial counterparts, has resulted in the generation of a huge diversity of genes, 
species etc. This diversity, coupled with the ability of plants to adapt, compete and 
survive in extreme environmental conditions, has made marine organisms potentially 
a very valuable source for novel antimicrobial activities. Moreover, they possess the 





potent bioactive/antimicrobial activity [7]. The rise of resistance to antibiotics makes 
the development of novel strategies to prevent and treat bacterial infections crucial. 
 Seaweeds are multicellular photosynthetic organisms that are found in 
abundance in both shore and offshore areas [8]. Based on the composition of their 
photosynthetic pigments, they are generally classified in to three groupings; the 
Phaeophyta (brown seaweeds), the Chlorophyta (green seaweeds), and the 
Rhodophyta (red seaweeds) [9]. Close to 10,000 different species of seaweed have 
been catalogued so far [10]. Both fresh and dry seaweeds are traditionally consumed 
as vegetables in countries of East Asia most notably Japan, China and Korea. Edible 
species of seaweed have a high nutritional value with proteins and lipids that are of a 
comparatively better quality than other terrestrial vegetables. Seaweeds are also used 
for animal feed applications and in soil cultivation as a fertilizer [4]. Seaweeds are a 
great source of structurally novel secondary metabolites [10] that are postulated to 
play an important role in mediating marine host-microbe interactions in the ocean [11]. 
Secondary metabolites are produced as a chemical defense against the biotic pressure 
placed on them by predators, consumers and epibionts as well as the abiotic pressure 
of the immediate environment (e.g. nutrient deficiency, desiccation, UV) which can 
affect their growth. Potential drugs from seaweeds are now attracting a considerable 
amount of attention from the pharmaceutical sector due to the ever-growing need to 
find new substances with antimicrobial activity against problematic human pathogens. 
The therapeutic benefits of seaweeds in traditional medicines have been known for 
centuries, but it was only at the beginning of the 20th century that antimicrobial 
substances produced by algae were observed. Today it is known that seaweed derived 
compounds have a broad range of biological actions such as, antibiotic, anticoagulant, 
antioxidant, antiviral, antineoplastic, antifouling, anti-inflammatory, anti-mitotic, 
anti-thrombotic, anti-lipemic, anti-cytotoxic, anti-hypotensive, anti-ichthyotoxic and 
anti-mitogenic activities [12]. These beneficial properties are contributed by the 
various types of carotenoids and polyphenols present in seaweeds - among the most 
prominent kinds are catechin, phlorotannins, fucoxanthin, zeaxanthin, β-carotene, and 
lutein [13]. Other compounds synthesized by seaweeds include acetogenins, alkaloids, 
lipids, phenolic compounds, pigments, polysaccharides, proteins, polyunsaturated 
fatty acids, and terpenes [14]. Many seaweed species have also been shown to produce 





bacteriocidal compounds belong to various chemical groups such as terpenoids, 
phlorotannins and other phenolic compounds, acrylic acid, steroids, halogenated 
ketones and alkanes, cyclic polysulphides, amino acids and fatty acids. The production 
of antimicrobial substances by seaweed species can vary for different reasons such as 
environmental factors, season, geographic location, the stage of life cycle as well as 
different parts of the thallus [12, 14]. In general, these compounds can (a) target the 
bacterial cell wall and membrane, which results in an extensive release of intracellular 
substances and/or disruption of the uptake and transportation of substances (e.g. 
phlorotannins) or (b) reduce protein and nucleic acid synthesis or (c) inhibit 
respiration. Phlorotannins may also form complexes with some extracellular bacterial 
enzymes, thus reducing their activity. Bioactive substances from seaweeds, such as, 
furanones, can also interfere with quorum sensing mechanisms in bacteria which can 
affect their virulence [16]. Phenolic compounds possess great structural variations and 
are one of the most diverse groups of secondary metabolites. The hydroxyl groups in 
phenolic compounds are thought to interfere with membrane structure causing leakage 
of cellular components [17]. Interestingly, extracts from seaweeds have been found to 
be more active against Gram-positive bacteria than Gram-negative bacteria which may 
be related to the other membrane functioning as an extra barrier [35]. 
 A major concern in the production of ready-to-eat (RTE) foods is the 
contamination of goods by the Gram-positive, facultative anaerobic bacterium Listeria 
monocytogenes [18]. L. monocytogenes is a pathogen of both humans and animals, 
and has also been isolated from a variety of raw dairy, meat, and meat products, sea 
foods and fresh products [19]. It is also the etiologic agent of listeriosis which is an 
extremely serious foodborne disease that can be life threatening to individuals in high 
risk categories such as: the elderly, pregnant women, neonates and immune-
compromised individuals [20]. Listeriosis is primarily acquired through the 
consumption of contaminated food. The first identified foodborne outbreak of 
Listeriosis occurred in the early 1980s and since then L. monocytogenes has become 
increasingly important as a foodborne pathogen and also a model system for infection 
biology [21]. The pathogenicity of L. monocytogenes is due to its capacity to adhere 
to, invade and multiply within a great variety of normally nonphagocytic cells 
(enterocytes, hepatocytes, fibroblasts, endothelial cells and dendritic cells)[22]. L. 





having the capability to grow at refrigeration temperatures (2 - 4 °C), at pH ranging 
from 4.0 to 9.6 (optimum pH 6-8) and at water activity levels of 0.90 [23]. 
Additionally, L. monocytogenes can adhere to a variety of food contact surfaces such 
as stainless steel and polystyrene, and can persevere in food processing facilities for 
several months or even years as biofilms. Protected in biofilms, this organism can 
tolerate high concentrations of many environmental agents such as sanitizers, 
disinfectants and antimicrobial compounds, making it very difficult to eliminate 
effectively. The fact that Listeria can survive so many environmental challenges 
makes it a major concern for the food industry and public health services. RTE foods 
such as fish products, heat-treated meat products and cheese are often cited as sources 
of Listeria infection [23]. Antibiotic treatment of listeriosis has proven to be 
successful, with treatment usually encompassing the use of β-lactam antibiotics such 
as ampicillin or penicillin alone or in combination with an aminoglycoside 
(gentamicin). For those allergic to β-lactams, trimethoprim and sulphonamides have 
been successfully used as alternatives [19]. Listeria were considered relatively 
susceptible to a wide range of antibiotics until the discovery of an antibiotic resistant 
strain of L. monocytogenes in 1988 [24]. 
  Current antibiotic treatments are often accompanied with undesirable aspects 
such as high expense, and toxicity; and residual side effects such as allergic reactions, 
hypersensitivity and immunosuppression. Researchers are now increasingly 
investigating alternative antimicrobial compounds from terrestrial plants and marine 
organisms such as seaweed [4]. The aim of this study was to access the antimicrobial 
activity of ten ethanol extracts prepared from ten brown seaweeds collected from along 
the Irish coast against a selection of pathogenic bacteria. Emphasis was given to the 
activity of different fractions of Fucus vesiculosus (Phaeophyceae) against the major 





6.3 Materials and methods 
 
6.3.1 Media. 
All media used in this study was obtained from Sigma-Aldrich, Dublin, Ireland, unless 
otherwise stated. All plastic consumables were obtained from Sarstedt, Wexford, 
Ireland  
 
6.3.2 Bacterial strains. 
The bacterial strains used in this study were obtained from the Teagasc Research 
Facility, Moorepark culture collection and were as follows: Listeria monocytogenes 
5788, L. monocytogenes EGDe, L. monocytogenes DPC 4590 ATC 19112 and L. 
monocytogenes DPC 4608 SLCC 1694; Staphylococcus aureus 5246; Escherichia coli 
O157:H7, E. coli 6235; and Salmonella enterica serovar Typhimurium DT104 (104-
25). Strains were grown overnight on BHI agar (Merck, Darmstadt, Germany), or in 
BHI broth at 37 °C. Stocks of all strains were kept at - 80 °C with working stocks 
being stored at - 20 °C. 
 
6.3.3 Seaweed collection. 
The seaweed samples used in this study were sourced from four collection points along 
the western coast of Ireland; Finnavara, Co. Clare (F), Mweenish, Co. Galway (M), 
New Quay, Co. Clare (NQ) and Spiddal, Co. Galway (S). Harvesting took place 
between April 2009 and February 2011. The species of seaweed used in the study were 
as follows;  Alaria esculenta (Phaeophyceae) (S), Laminaria digitata (Phaeophyceae) 
(S) (May 2009), Himanthalia elongata (Phaeophyceae) (F) (April 2010), Saccharina 
latissima, (Phaeophyceae) (S) (September 2010), Fucus serratus (Phaeophyceae) (S), 
Fucus vesiculosus (Phaeophyceae) (S) and Ascophyllum nodosum (Phaeophyceae) 
(NQ) (October 2010), Pelvetia canaliculata (Phaeophyceae) (S), Chondrus crispus 
(Rhodophyta) (F), Fucus spiralis (Phaeophyceae) (S), and Laminaria hyperborea 






6.3.4 Preparation of ethanol 80% extracts and fractions for antimicrobial study. 
 
Following collection, the seaweeds were washed with cold water to remove particulate 
matter. Samples were freeze-dried, ground to a fine powder, vacuum packed and 
stored at -80 °C prior to extraction. A solvent liquid extraction using ethanol/water 
(80:20) as the solvent was then carried out. Dried seaweed matter was mixed in a ratio 
of 1:10 (w/v) with the extraction solvent in a large reaction vessel and placed in an 
orbital shaker (MaxQ 6000 shaker, Thermo Fisher Scientific, Ireland) at 175 rpm. 
After 3 h, the reaction vessel was removed from the orbital shaker and its contents 
were filtered through a Buchner funnel. The seaweed material was then returned to the 
reaction vessel with fresh extraction solvent and the process repeated. The extraction 
was repeated a third time overnight to ensure complete extraction from the seaweed 
material. The collected solvents were then combined, and the ethanol removed using 
a rotary evaporator with the water bath set at 60 °C. The extracts were then blast-
frozen and freeze-dried and stored at -80 °C as a fine powder.  The sugar fraction was 
obtained by ethanol precipitation using 100% ethanol at a ratio of seaweed: ethanol of 
1:5. The mixture was then centrifuged for 5 min at 5000 g and the precipitate pellet 
was collected. Fresh deionised water was finally used to resuspend the pellet prior to 
being blast and freeze-dried.  
 Fractions of F. vesiculosus (0 - 3.5 kDa, 3.5 - 100 kDa, and > 100 kDa) were 
prepared as follows: the crude ethanol extract was dissolved in a minimal volume of 
deionised water and transferred to 3.5 kDa cut-off dialysis tubing (Spectrum labs, 
Breda, The Netherlands). The tubing was clamped at both ends and submerged in 
deionised water. The container was then moderately shaken (50 rpm) at room 
temperature for 72 h. The water in the container was routinely replaced with fresh 
deionised water until the dialysate ran colourless. Both the higher molecular weight 
retentate (> 3.5 kDa) and the low molecular weight dialysate (0 - 3.5 kDa) were 
collected and subsequently freeze-dried. The retentate greater than 3.5 kDa was further 
dissolved in a minimal volume of deionised water and added to 100 kDa dialysis 







6.3.5 Microtitre plate-based dilution method for antimicrobial activity. 
 
Each seaweed extract was prepared in 10 mM sodium phosphate buffer with 2% 
vol/vol DMSO being added in to aid in solubility. The stock concentration of extract 
was 2 mg/ml with a working concentration of 1 mg/ml. The extract was filter sterilized 
using a 0.45 µm filter. Bacterial strains were grown in triplicate overnight in 5 ml BHI 
broth at 37 °C and subcultured (1 ml of culture added to 5 ml BHI broth) the following 
morning in fresh media to an OD 600nm of 0.3. Cells were harvested from 1 ml samples 
of subcultured cells by centrifugation at 15000 g for 5 min. The supernatant was 
aspirated and the bacterial pellets were washed twice and resuspended in 1 ml of 
sodium phosphate buffer. Serial dilutions were then carried out in sodium phosphate 
buffer for plate counting. Fifty microliters of the stock seaweed extract were added to 
50 µl of cells (1:100 dilutions) in a 96-well microtitre plate. The plate was incubated 
at 37 °C for 2 h without media as some media components can inhibit the activity of 
antimicrobial peptides Following the incubation step, 100 µl of double strength BHI 
broth was added to each well to allow the outgrowth of surviving bacteria. The plate 
was then transferred to a microplate reader where readings of OD 600nm were taken 
every hour for 24 h. Percentage inhibition was calculated according to the equation. 
 
Inhibition (%) =  
𝑂 − 𝐸
0
 X 100  
 
Where O is (OD600nm of the organism at 24 h - OD600nm of the organism at 0 h) and E 
is (OD600nm of the organism in the presence of the seaweed extract at 24 h – blank at 
24 h) – (OD600nm of the organism in the presence of the extract at 0 h – the blank at 0 
h) [25].  
 
6.3.6 Total phenolic content analysis of seaweed extracts. 
 
The total phenolic content (TPC) of the seaweed extracts was assessed using 





external standard for the quantification of phenolic compounds in the seaweed 
samples. A stock solution of gallic acid (120 µg/mL) was serially diluted with water 
(120, 90, 60, 30, and 0 µg/mL) to generate a standard curve. To analyse each sample 
for TPC, the following were added to a microtube: 100 µl of seaweed sample (1 
mg/mL) or standard solution, 100 µl of methanol, 100 µl of Folin-Ciolalteu reagent 
(Sigma – Aldrich) and 700 µl of 20% (m/v) sodium carbonate. The tubes were then 
vortexed vigorously and incubated in the dark for 20 min at room temperature. 
Following incubation, all samples were centrifuged for 3 min at 12500 g. The 
absorbance of the supernatant taken from each sample was measured in triplicate at 
735 nm using a spectrophotometer. The standard curve generated using the gallic acid 
standards was used to obtain the TPC values for the seaweed samples which are 
expressed as micrograms of gallic acid equivalents (GAE) per milligram of sample 
(μg GAE mg−1) [26]. 
 
6.3.7 Statistical analysis. 
 
Statistical analysis was carried out on experimental results using GraphPad Prism 
version 5 for windows. Percentage inhibition data was subjected to a one-way 
ANOVA followed by Dunnett’s Multiple Comparison test. All experiments were 
carried out in duplicate with at least three biological repeats. A p-value of <0.05 was 
















6.4.1 Antimicrobial activity of ten seaweed extracts against a selection of 
foodborne pathogenic bacteria. 
Extracts derived from ten brown seaweeds were screened for antimicrobial activity 
against strains of Gram-positive (L. monocytogenes and S. aureus) and Gram-negative 
(E. coli and S. enterica serovar Typhimurium) pathogens. The positive controls used 
were Nisin from Lactococcus lactis (2.5% w/w) for Gram-positive organisms and 
Tetracycline for Gram-negative organisms. At a working concentration of 1 mg/ml, 
three seaweeds of the genus Fucus (F. vesiculosus, F. serratus and F. spiralis) (Fig. 
6.1) and the seaweeds A. nodosum, H. elongata, P. canaliculata significantly inhibited 
(p<0.05) growth of L. monocytogenes 5788 at 24 h (Fig. 6.2,). The percentage 
inhibition of Listeria monocytogenes 5788 growth as measured by optical density was 
for A. nodosum (91.5% ± 12.4), F. serratus (91.8% ± 1.2), F. spiralis (94.0% ± 8.9), 
F. vesiculosus (complete inhibition), H. elongata (45.5% ± 10.8) and P. canaliculata 
(82.8% ± 16.5) (Fig. 6.3). No viable colony forming units were recovered at a 100 
dilution on BHI agar plates for A. nodosum, P. canaliculata and all three Fucus 
species. The F. vesiculosus extract also significantly inhibited (p>0.05) the growth of 
E. coli 6235 after 24 h (Fig. 6.1) with a percentage inhibition (as measured by optical 
density readings) of 36.0% ± 5.9 (Fig. 6.3) Significant inhibition (p<0.05) of S. aureus 
5246 at 24 h by A. nodosum, H. elongata and P. canaliculata extracts and E. coli 6236 
by A. nodosum (Fig. 6.2) and F. vesiculosus extracts was also observed (Fig 6.1). 
 
6.4.2 Strain specificity of the F. vesiculosus ethanol extract. 
 
The ETOH 80% extract of F. vesiculosus (Fv extract) was chosen for further 
evaluation. The Fv extract was tested for antimicrobial activity against three further 
strains of L. monocytogenes (4590, 4608 and EDGe) for antimicrobial activity (Fig. 
6.4). At a concentration of 1000 µg/ml and 250 µg/ml, the Fv extract showed 
significant inhibitory (p<0.05) activity against all strains following at 24 h. At 1000 





At a dilution of 100 no viable CFUs were recovered from any of the tested strains on 
BHI agar plates after 24 h.  
 
6.4.3 Anti-listeria activity of F. vesiculosus ethanol subfractions. 
 
Different molecular weight fraction of the F. vesiculosus ethanol extract were 
evaluated for antimicrobial activity against two Listeria strains (L. monocytogenes 
5788 and L. monocytogenes EGDe) as outlined previously (Fig. 6.7). The subfractions 
were 0 - 3.5 kDa, 3.5 - 100 kDa, 100 + kDa, tannins and sugars. The most potent and 
consistent anti-listerial activity was observed with the 0 - 3.5 kDa and the 3.5 - 100 
kDa fractions. Both subfractions significantly inhibited (p>0.0001) the growth of L. 
monocytogenes 5788 and L. monocytogenes EGDe after 24 h. Plate counts at 24 h 
yielded no viable CFUs on BHI plates after 24 h with either test strain. The sugar 
fraction from F. vesiculosus had no inhibitory effect on the growth of any strain tested. 
Both fractions (0 – 3.5 kDa and 3.5 – 100 kDa) were further tested against L. 
monocytogenes 5788 (Fig. 6.8) at working concentrations of 1000 µg/ml, 100 µg/ml 
and 10 µg/ml. The 0 - 3.5 kDa and 3.5 - 100 kDa subfractions significantly inhibited 
(p>0.05) growth of L monocytogenes 5788 at 100 µg/ml, however, only the 3.5 - 100 
kDa subfraction significantly inhibited growth at 10 µg/ml.  
 The 3.5 – 100 kDa extract was subsequently tested against a range of Listeria 
strains (5788, 4590, 4606 and EDGe) (Fig. 6.9) at working concentrations of 1000 
µg/ml, 100 µg/ml and 10 µg/ml. Percentage inhibition of growth was about 80% for 
strains 4590, 4608 and EDGe at 100 µg/ml (Fig. 6.10). There was no recovery of viable 
CFUs at 24 h for any 100 µg/ml for strains 5788, 4608, EDGe. The complete inhibition 
of bacterial growth was observed for the nisin control at 1 mg/ml for all strains. Below 








6.4.4 Antimicrobial activity of the F. vesiculosus ethanol extracts against S. 
aureus. 
 
The crude Fv extract and the 3.5 - 100 kDa fraction were tested for antimicrobial 
activity against two additional strains of the Gram-positive bacteria S. aureus (S. 
aureus strains FRI913 and Sa45). After 16 h, Staphylococcus aureus FRI913 growth 
was significantly reduced (p<0.05) by the Fv 3.5 - 100 kDa fraction with a percentage 
inhibition of 83.6% ± 2.7. The Fv crude extract had a minimal effect on growth after 
16 h. The growth of S. aureus Sa45 after 1 h was significantly reduced (p<0.05) by 
the Fv crude extract with a percentage inhibition of 82.9% ± 20.1. The Fv 3.5 - 100 
kDa fraction inhibited growth by 66.0% ± 46.7 Plate counts for surviving bacteria 
recorded no recovery of viable CFUs of either strain at a 100  dilution following testing 
of the 3.5 - 100kDa fraction.  
 
6.4.5 Total phenolic content analysis of seaweed extract and Fv fractions 
 
Given that phenolic compounds generally have potent antimicrobial activity, the total 
phenolic content of each seaweed extract and fraction was determined. Total phenolic 
content (TPC) values are reported in terms of micrograms of gallic acid equivalents 
(GAE) per milligram of sample (µg GAE mg-1). The highest levels of phenolic 
compounds in unfiltered extracts were observed in the F. vesiculosus extract with 
138.4 ± 0.7 μg GAE mg−1 and the P. canaliculata 101.2 ± 2.5 followed by A. nodosum 
(87.9 ± 2.0 µg GAE mg-1) and F. spiralis (80.1 ± 1.3 µg GAE mg-1) (Fig. 6.11). The 
lowest phenolic content in unfiltered ethanol extracts was found in L. digitata (3.5 ± 
0.2 µg GAE mg-1). Following filtration, highest levels of phenolic compounds were 
F. vesiculosus at 103.9 ± 1.5 µg GAE mg-1 and P. canaliculata at 65.85 ± 1.7 µg GAE 
mg-1 followed by A. nodosum (49.2 ± 0.2 µg GAE mg-1) and F. serratus (43.4 ± 0.1). 
Again, the lowest level of phenolic compounds in filtered extracts was L. digitata (3.9 
± 0.1 µg GAE mg-1) (Fig. 6.11) 
 
 In a similar way, the subfractions of the F. vesiculosus extract were examined 





fractions of F. vesiculosus were in the tannin fraction with 515.7 ± 5.0 µg GAE mg-1 
and the 3.5 - 100 kDa fraction with 419.7 ± 4.9 The lowest levels of phenolic 
compounds were found in the sugars’ fraction with 16.9 ± 0.5 µg GAE mg-1). The 
highest TPC levels in (0.45 µm) filtered sub-fractions were in the tannin fraction with 
446.3 ± 9.9 µg GAE mg-1 and the 3.5-100 kDa fraction with 360.7 ± 4.73 followed by 
the 100 + kDa fraction (229.91 ± 5.55 µg GAE mg-1) and the 0-3.5 kDa fraction (30.9 
± 0.3 µg GAE mg-1). The lowest recorded level of total phenolic compounds in the 








 Despite improvements in the way our food is prepared, cooked and stored, the 
number of reported cases of food-related illnesses is on the rise. In addition, there has 
been a growing incidence of resistance to conventional antimicrobials that are used to 
treat food borne infections [27]. The contamination of RTE foods most often occurs 
during the post-processing stage of preparation. The thermal treatment of RTE food, 
that contains cooked meat, during processing is sufficient to eliminate L. 
monocytogenes but recontamination can occur during the handling, slicing and 
packaging phases of food production through cross-contamination [28]. RTE foods 
contain salts (sodium chloride, nitrite and nitrate) that have antimicrobial activity but 
these do not inhibit the growth of L. monocytogenes when food is refrigerated at 4 °C 
[29]. Chemical and natural preservatives, such as nisin and pediocin, are often used to 
inhibit Listeria in dairy and meat products, but Listeria can become highly resistant to 
these measures. For this reason, the development of new biopreservatives to protect 
against listeria and to prolong the shelf-life food is both desirable and necessary. Algae 
are known to produce a great multitude of biologically active secondary metabolites 
that have been shown to have anti-microbial activity. These bioactives have primarily 
been discovered in brown and red seaweeds and accordingly the screening of seaweed 
extracts for antimicrobial activity is a subject that has been frequently addressed in 
scientific literature. Here, ethanol extracts from ten brown seaweeds were screened for 
activity against a panel of both Gram-positive and Gram-negative pathogens using a 
microtitre plate-based dilution method. The pathogens L. monocytogenes, S. aureus, 
E. coli and S. enterica serovar Typhimurium were chosen because they are among the 
most prevalent foodborne organisms, that not only affect the quality of food but also 
cause severe illness if contaminated food is ingested [2]. An in vitro antibacterial assay 
that is simple, reproducible, rapid, sensitive, and cost effective was required for 
screening seaweed fractions. Often the amount of purified compounds or fractions 
which are available for antimicrobial screening can be a limiting factor in any 
workable screening programme [30]. In this assay, bacterial cells were grown to early 
log phase (OD 600nm of 0.3) as actively growing cells are more sensitive to 
antimicrobials than stationary cells from an overnight culture. The growing cells and 





of any media, as the components of growth media such as NaCl, carbohydrates etc., 
have been shown to inhibit the activity of certain antimicrobial peptides. The addition 
of double strength BHI broth to each experimental well was to facilitate the growth of 
any surviving bacteria in the presence of the extract. 
 The initial screening demonstrated that several of the ethanol extracts 
demonstrated moderate activity against the Gram-positive bacteria S. aureus, against 
the Gram-negative bacteria E. coli, and against S. enterica serovar Typhimurium at 24 
h. An extended lag phase was observed for S. aureus (F. serratus, F. vesiculosus, F. 
spiralis, and L. digitata), S. enterica serovar Typhimurium (F. vesiculosus, Fucus 
serratus, L. hyperborea, and F. spiralis), E. coli O157:H7 (F. spiralis and L. digitata) 
and E. coli 6235 (F. vesiculosus). A definite inhibition of growth was evident, 
however, each strain was able to overcome the inhibitory effect in time. Several 
extracts did, however, demonstrate potent inhibitory activity against the Gram-
positive pathogen L. monocytogenes. According to the Food Safety Authority of 
Ireland (FSAI) L. monocytogenes poses a most challenging threat to the safety of food 
products in Ireland [25] making it a pertinent target of antimicrobial screening studies. 
The ethanol extracts from the seaweeds A. nodosum, F. vesiculosus, F. serratus, F. 
spiralis, H. elongata and P. canaliculata all significantly inhibited (p<0.05) the 
growth of L. monocytogenes 5788 measured after 24 h. The percentage inhibition for 
the three Fucus species as well as for A. nodosum was more than 90% with the most 
potent activity observed with the F. vesiculosus extract. No viable colony forming 
units (CFUs) were recovered at any dilution for these extracts indicating a complete 
inhibition of the L. monocytogenes. Based on the results of this initial screen, the 
ethanol 80% extract of F. vesiculosus was selected for further evaluation of its 
antimicrobial activity against Listeria monocytogenes. As different strains of the same 
bacterial species can vary greatly in their sensitivity to a given antimicrobial substance 
[5] the crude F. vesiculosus (Fv) extract was tested against three further strains of 
Listeria to access the specificity of the anti-listerial activity. At a working 
concentration of 1 mg/ml, percentage inhibition against all additional strains (L. 
monocytogenes 4590, L. monocytogenes 4608 and L. monocytogenes EGDe) exceeded 
90% demonstrating that the crude Fv extract has potent antimicrobial activity against 
a range of L. monocytogenes strains and activity was not limited to a particular strain. 





food preservation as a biopreservatives. It was also shown that Fv extract retained its 
potent antimicrobial activity at a concentration of 100 µg/ml but only displayed weak 
inhibition at 10 µg/ml. The positive control used in this study for Gram-positive 
bacteria was Nisin from Lactococcus lactis (2.5% w/w). Interestingly, at a 
concentration of 100 µg/ml the percentage inhibition of L. monocytogenes 5788 
growth by the crude extract after 24 h was significantly higher than that of the positive 
control. Plate counts performed after 24 h revealed that no viable CFU was recovered 
from Fv extract (100 µg/ml) plates, while a count of listerial cells on the nisin (100 
µg/ml) plates was comparable to control numbers. This indicates that at an extract 
concentration of 100 µg/ml, the crude Fv extract had a greater inhibitory effect on 
listerial growth than the positive control.  However, it must be clearly stated that the 
working concentration for the nisin control was only 2.5 µg/ml. 
 Size exclusion dialysis is a valuable technique with which compounds can be 
fractionated by molecular weight through selective diffusion of molecules across a 
semipermeable membrane. The resulting fractions can then be tested individually or 
in combination for observed biological activities found in the crude sample. Anti-
listerial activity was concentrated in the low (0 - 3.5 kDa) and medium (3.5 - 100 kDa) 
molecular weight fractions. Both fractions were active against every strain of L. 
monocytogenes tested with the 3.5 - 100 kDa fraction being active in some cases below 
10 µg/ml. Again, during the analysis of subfraction activity, the nisin control was only 
consistently active against strains of L. monocytogenes at 1 mg/ml and failed to 
significantly inhibit growth at concentrations less than 100 µg/ml. Significant anti-
listerial activity was also observed for the Tannin fraction and the high (100 + kDa) 
molecular weight fractions. Highly potent anti-listerial activity was observed with the 
100 + kDa fraction but owing to the excessive amounts of pigmentation within the 
extract, consistent results were difficult to obtain by readings of optical density. The 
only subfraction not to demonstrate antimicrobial activity was the sugar subfraction. 
Higher levels of antimicrobial activity from seaweed extracts have been 
reported in literature against Gram-positive bacteria [25] in agreement with data 
obtained in this study for the Gram-positive bacterium L. monocytogenes. As such it 
was decided to further test the crude F. vesiculosus extract and the Fv 3.5 - 100 kDa 
subfraction against the Gram-positive S. aureus. At 1 mg/ml, the Fv 3.5 - 100 kDa 





strain (S. aureus FRI913) had its growth greatly attenuated for the first 1 h. The effect 
of the crude Fv extract on these strains was mixed. The growth S. aureus Sa45 was 
arrested by the Fv crude extract for the initial 10 h while S. aureus FRI913 had its log 
phase delayed by approximately 4 h. Without doubt, Fv extracts have an inhibitory 
effect on the growth of S. aureus. However, the effect seems to be varying between 
the different strains and not as potent as the effect observed with Listeria 
monocytogenes. Potent antimicrobial activity against S. aureus has also been reported 
by [31] using methanol extracts of Haligra spp. This extract possessed significantly 
higher concentrations of total phenolic content than other seaweeds in the study. Also, 
significant inhibition of growth (p>0.05) by the crude Fv ethanol extract at 1 mg/ml 
was also observed for the Gram-negative bacterium E. coli 6235. Although the E. coli 
cells were not completely inhibited, growth was arrested for several hours before the 
cells entered log phase. Gram-negative pathogens tend to be more resistant to 
antimicrobials, in general, than Gram-positives owing to their additional outer 
membrane. The activity of seaweed extracts against Gram-negative pathogenic 
bacteria warrants further investigation as the problem of increasing bacterial resistance 
to antimicrobials becomes more pressing.  
 The term phenolic compound describes several hundred molecules found in 
edible plants that have in their structure a benzene ring substituted by at least one 
hydroxyl group  [32]. Seaweeds are an excellent source of polyphenols which play an 
important role in preventing the degradation of lipids by free radicals. Phlorotannins 
are a group of phenolic compounds that are composed entirely of polymers of 
phloroglucinol. They have been identified in several brown seaweed families such as 
Fucaceae, Sargassaceae and Cystoseiraceae [33].  It had been reported that they are 
the only phenolic group detected in brown seaweeds. However, the presence of other 
phenolic compounds such as catechins, flavonols and flavonol glycosides have been 
described in methanol extracts of red and brown algae [34]. Phlorotannins are derived 
from the oligomerising decoupling of the phloroglucinol monomer. They are essential 
for early cell-wall development in members of the Fucaceae family and for reducing 
oxidative damage that occurs from UV radiation and fluctuations in nutrient 
availability. Phlorotannins are difficult to characterise, isolate and purify because of 
their polymeric structure and similar polarity [26]. The total phenolic content of 80% 





method. This method measures the total concentration of phenolic hydroxyl groups 
present in a sample. Phenolic compounds in the seaweed extract react with the Folin-
Ciocalteu reagent to form a blue complex that can be detected and quantified by 
reading absorbance at 735 nm [35]. The highest levels of phenolic compounds in 
filtered seaweed extracts were found in the F. vesiculosus extract (103.9 ± 1.5 μg GAE 
mg−1) followed by P. canaliculata, A. nodosum, F. spiralis and F. serratus. The level 
of phenolic compounds in seaweed is directly affected by the climate in which they 
grow and the amount of sunlight that they are subjected to. As such, the same seaweed 
species harvested in different countries at different times of the year can have differing 
concentrations of phenolic compounds. An extension of this is that the levels of 
phenols in seaweeds are also affected by their location along the shoreline. Those 
seaweeds that are located higher up on the shore are exposed more often to 
sunlight/UV radiation and suffer more from desiccation than those species found 
lower down the intertidal zone and that spend more of their time submerged in the 
water. This results in those species found lower down requiring reduced levels of 
phenols for protection [24], while those located in the upper regions of the shore 
contain comparatively increased concentrations of phenols. The highest 
concentrations of phenolic compounds were consistently observed in those extracts 
from seaweed species inhabiting the upper to mid region of the shoreline (P. 
canaliculata, A. nodosum F. vesiculosus, F. spiralis and F. serratus). Filtered extracts 
from seaweeds found in the lower or subtidal zone of the shoreline were found to 
contain very low levels of phenols (< 20 μg GAE mg−1). High levels of phenolic 
compounds correlated strongly with the observed antimicrobial activity of the ethanol 
extracts against several strains of Listeria monocytogenes. All seaweed extracts that 
demonstrated significant inhibition of Listeria (p<0.05) at 24 h and, whose percentage 
inhibition of growth was < 90%, contained high levels of phenolic compounds. All 
fractions of F. vesiculosus which were investigated for antimicrobial activity were also 
found to be rich in phenolic compounds. The highest concentration of phenolic 
compounds among the F. vesiculosus subfractions was found in the tannin fraction.  
In contrast, seaweed extracts with low levels of phenol compounds had no significant 
impact on the growth of Listeria monocytogenes.  
Phlorotannins have been reported to occur commonly in the 10 - 100 kDa size 





be found in F. vesiculosus, and in other related species. It has been reported that F. 
vesiculosus contains an array of phlorotannins less than 1.2 kDa in size [26]. The 
higher molecular weight fractions of F. vesiculosus (3.5 - 100 kDa and 100 + kDa) 
were found to contain between 3 and 4 times the polyphenol concentration of the crude 
Fv extract. The low molecular weight fraction (0 - 3.5 kDa) exhibited levels of 
polyphenol comparable with the crude F. vesiculosus ethanol extract. This is 
consistent with observed levels of activity. Polyphenols in brown algae are thought to 
provide a low level defense against bacteria. As high-molecular weight phlorotannins 
appear to be, at best only weakly antibacterial and antifungal, intermediate- and low-
molecular weight fractions are presumably responsibly for these bioactivities [36]. 
From the results obtained here, we conclude that the antimicrobial activity of the crude 
F. vesiculosus extract and F. vesiculosus subfraction against L. monocytogenes is 
because of the presence of large quantities of low molecular weight polyphenolic 
compounds. This is agreement with several in vitro studies that have demonstrated 
that algal derived polyphenols and flavonoids exhibit antimicrobial activity [37]. 
Phenolic compounds can also act as antioxidants by chelating metal ions preventing 
radical formation and improving the endogenous antioxidant system [38]. Numerous 
studies have described a correlation between phenolic content, the inhibition of α-
amylase and α-glucosidase, and antioxidant activity. For example, a study carried out 
by Lordan et al., [39] demonstrated that total phenolic content of extracts from  F. 













In conclusion, the results of this study indicate that the Irish seaweeds, F. vesiculosus, 
F. serratus, F. spiralis, A. nodosum, P. canaliculata and H. elongata successfully 
display antimicrobial activity which is correlated to the presence of large 
concentration of phenolic compounds. F. vesiculosus had the highest levels of 
phenolic compounds of all the seaweeds investigated and demonstrated the most 
potent antimicrobial activity against the pathogen L. monocytogenes. This is a 
promising outcome as to the potential of utilising such extracts from seaweeds in food 
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Figure 6.1. Antimicrobial activity of ethanol extracts of Fucus serratus, F. spiralis, F. vesiculosus, 
Laminaria digitata and L. hyperborea against (a) Listeria monocytegenes 5788, (b) Staphylococcus 
aureus 5236, (c) Salmonella enterica serovar Typhimurium 6236, (d) Escherichia coli O157H7, and 
(e) E. coli 6235 at a concentration of 1mg/ml. The control for the experiment was 2.5% Nisin from 
Lactococcus lactis at a concentration of 1 mg/ml. 
 
(a) L. monocytogenes 5788 
 
 































































(c) S. enterica serovar Typhimurium 6236 
 
(d) E. coli O157H7 
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Figure 6.2. Antimicrobial activity of EtOH extracts of A. esculenta, A. nodosum, H. elongata, P. 
canaliculata, and S latissima against (a) Listeria monocytogenes 5788, (b) Staphylococcus aureus 5236, 
(c) Salmonella enterica serovar Typhimurium 6236, (d) Escherichia coli O157H7, and (e) E. coli 6235. 
at a concentration of 1mg/ml. The control for the experiment was 2.5% Nisin from Lactococcus lactis 




(a) L. monocytogenes 5788 
 
 






























































(c)  S. enterica serovar Typhimurium 6236 
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Figure 6.3 Percentage inhibition at 24 h of (a) Listeria monocytogenes 5788, (b) Staphylococcus aureus 
5236, (c) Salmonella enterica serovar Typhimurium 6236, (d) Escherichia coli O157H7 and (e) E. coli 
6235 in the presence of ethanol extracts derived from Irish brown seaweeds at a concentration of 1 

































































































































 Figure 6.4. Strain specificity of the anti-listerial activity of the crude F.  vesiculosus extract at 1000 
µg/ml and 250 µg/ml against (a) L. monocytogenes 4590 (b) L. monocytogenes 4608 and (c) L. 
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Figure 6.5 Strain specificity of the anti-listerial activity of the crude F.  vesiculosus 0 – 3.5 kDa fraction 
at 1000 µg/ml and 250 µg/ml against (a) L. monocytogenes 4590 (b) L. monocytogenes 4608 and (c) L. 
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Figure 6.6 Percentage inhibition at 24 h (a) L. monocytogenes 4590 (b) L. monocytogenes 4608 and (c) 
L. monocytogenes EGDe, by the F. vesiculosus crude ethanol extract and the 0 – 3.5 kDa fraction. The 
positive control for the experiment was Nisin (2.5%) from Lactococcus lactis. (a = P<0.05), b = 


























































































































































Figure 6.7 Different fractions of F. vesiculosus were tested for activity against (a) L. monocytogenes 
5788 and (b) L. monocytogenes EDGe. The positive control for the experiment was Nisin (2.5%) from 




(a) L. monocytogenes 5788 
 
 









































Figure 6.8 The F. vesiculosus fractions 0 – 3.5 kDa and 3.5 – 100 kDa were tested against a 
representative L. monocytogenes strain (5788) at 1000, 100 and 10 µg/ml. The positive control for the 
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Figure 6.9 The effect of the F. vesiculosus 3.5 - 100 kDa subfraction had on the viability of (a) L. 
monocytogenes 5788, (b) L. monocytogenes 4590, (c) L. monocytogenes 4608, and (d) L. 
monocytogenes EGDe at concentrations of 1000, 100 and 10 µg/ml. The positive control for the 
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Figure 6.10. Percentage inhibition at 24 h by the F. vesiculosus 3.5 – 100 kDa fraction (a) L. 
monocytogenes 5788, (b) L. monocytogenes 4590 (c) L. monocytogenes 4608 and (d) L. monocytogenes 
EGDe. The positive control for the experiment was Nisin (2.5%) from Lactococcus lactis. (a = P<0.05), 
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(c) L. monocytogenes 4608 
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Figure 6.11. Total phenolic content of (a) unfiltered and filtered ethanol extracts from ten brown 




























Figure 6.12 Total phenolic content of unfiltered and filtered subfractions of F. vesiculosus. Values represent the 








































7.1 General Discussion. 
Seaweeds are multicellular marine algae that belong to three distinct evolutionary groups: 
brown seaweeds (phylum Ochrophyta, class Phaeophyceae), red seaweeds (phylum 
Rhodophyta) and the green seaweeds (phylum Chlorophyta). Each grouping varies 
considerably in their morphology, physiology and biochemistry. The chemical composition of 
seaweeds depending greatly on factors like species, time of harvesting, light availability and 
water temperature. Seaweeds are a common sight along the coastal regions of the world and 
have enjoyed a long tradition of diverse use by mankind, having been used for centuries in food 
preparation and in traditional medicine. Some seaweeds are rich in protein, while other species 
produce secondary metabolites with various biological activities. [1]. An immense variety of 
activities are attributed to seaweed components and are well documented in the literature. 
Among the most common uses of seaweeds today are their use in the drugs, cosmetics and the 
food industries [2]. Ireland is an island off the west coast of Europe, with a temperate climate 
and a very significant coastline (7500 km), allowing access to a large source of seaweed [3]. 
In the literature review presented in this thesis, the potential of using seaweed-derived 
components to treat a variety of serious non-communicable diseases (NCDs) such as cancer, 
cardiovascular disease and diabetes was discussed. NCDs are becoming much more prevalent 
as society become increasingly sedentary and loving longer and some being less health 
conscience. Whole generations of people are exercising less, eating more and consuming 
alcohol and tobacco to a dangerous extent. These risk factors are the driving force behind the 
development of new cases of NCDs, which are becoming an enormous burden on global health 
services. Edible seaweeds are natural superfoods, containing copious amounts of complex 
carbohydrates, vitamins, minerals and oils. They produce biologically active secondary 
metabolites that exhibit a plethora of activities which can help alleviate and treat NCDs. 
Recently, NCDs have replaced infectious diseases as the number one cause of human mortality. 
Current medical treatments for NCDs rely mainly on drugs that have been obtained from the 
terrestrial regions of the world, with the oceans and seas remaining largely an untapped 
reservoir for exploration. Seaweed bioactive compounds have demonstrated such activities as 
anti-cancer, anti-oxidant, anti-inflammatory, and anti-diabetic [4]. It is only in relatively recent 
times that the scientific community has developed the capabilities to better understand the 
health benefits of seaweeds that our ancestors knew of anecdotally. Indeed, the literature 





much of the research heralds the therapeutic effects from in vitro studies, the way has been laid 
to assess their efficacy in vivo through appropriate animal and human clinical trials. 
 
The main organic components of seaweed are polysaccharides, proteins and lipids [5]. 
Most of the polysaccharide content of seaweeds contain complex bonds which cannot be 
broken down by human digestive enzymes [6, 7]. In brown seaweeds, the soluble dietary fibre 
polysaccharides are alginates, fucans and laminarins, while the insoluble fibres are essentially 
made of cellulose. In red seaweeds, the major polysaccharides include carrageenan, xylan and 
agarans [8], while in green seaweeds among the major polysaccharides is ulvan [9]. 
Bifidobacteria are a major grouping of beneficial bacteria that colonise the intestinal mucosa 
of healthy individuals. They exhibit several health-promoting effects such as antimicrobial 
activity against enteric pathogens, immunomodulation and reduced incidences of gut disorders. 
Bifidobacteria can metabolise many of the complex dietary carbohydrates that escape 
hydrolysis by mammalian digestive enzymes in the gut and reach the colon intact. Many non-
digestible carbohydrates in the gut act as prebiotics and enhance the growth of the 
bifidobacteria [10]. As such, bifidobacteria are often targeted for prebiotic intervention [11]. A 
prebiotic is a substrate that is selectively utilized by host microorganisms conferring a health 
benefit  [12]. As a first step in the study of the prebiotic properties of Irish seaweeds (Chapter 
2) it was of great interest to see if the carbohydrates found in seaweeds could be successfully 
utilised by different strains of bifidobacteria, and, therefore, demonstrate a bifidogenic effect. 
Fifteen Irish seaweeds (ten brown seaweeds, three red seaweeds and two green seaweeds) were 
accessed for bifidogenic activity using an anaerobic ex vivo approach. The media used in study 
was a specially designed minimal media for bifidobacteria, containing all the nutrients required 
for growth except a major carbon source. By supplementing the media with each seaweed 
extract, any observed growth would be as a direct result of Bifidobacterium utilising seaweed 
carbohydrates contained within the extract. At an extract concentration of 2.5 mg/ml, 
significant stimulation of bifidobacterial growth was observed for several of the extracts, most 
notably the brown seaweeds Fucus serratus and Pelvetia canaliculata. The results of the initial 
screen showed that F. serratus was the most promising candidate for further bifidogenic 
investigation as it had the greatest overall effect on Bifidobacterium. A dose-response study 
was carried out, and it was found that a F serratus concentration of 1.25 mg/ml demonstrated 
the greatest bifidogenic stimulatory effect, and significantly outperformed the positive control 





observed with the F. serratus, extract at a concentration of 2.5 mg/ml. It was found that several 
of the brown seaweeds, including F. serratus, contained large concentration of phenolic 
compounds. Phenolic compounds such as phlorotannins are commonly produced in brown 
seaweeds and their presence at a high concentration is the likely explanation for the inhibitory 
effect observed. A limitation of this study was the nature of the cold-water extracts. Solid-
liquid extractions, using cold water as the solvent, is a cheap and quick way of obtaining 
biologically active substances from raw materials such as seaweed. However, the method lacks 
appropriate post-extraction processing, which allows for the presence of unwanted compounds 
such as phenols and monosaccharides to remain in the extractions. For reliable prebiotic 
investigations, an extraction method solely designed for the isolation of polysaccharides and 
the removal of unwanted materials is required. Also, the choice of solvent (in this case cold-
water) must be carefully considered. For example, sulphated polysaccharides from seaweeds 
are generally extracted using hot water or dilute acid/alkali [13]. The conclusion of this study 
was that different Bifidobacterium strain can use cold-water seaweed extracts as their sole 
carbon source and that the bifidogenic effect is greatest amongst brown seaweed species. The 
brown seaweed F. serratus proved to be the best candidate for further prebiotic investigation, 
which would require the creation of a new type of seaweed extract.  A refined extraction 
process, with appropriate post extraction processing to remove monosaccharides, phenolic 
compounds and other biologically active compounds found in seaweeds is recommended.  
To further evaluate the prebiotic potential of F. serratus a polysaccharide-rich extract (Fse 
extract) was produced (Chapter 3) using an appropriately designed extraction process. Dilute 
hot-acid was used as the extraction solvent to aid the extraction of F. serratus structural 
polysaccharides with the extraction being repeated twice to maximise recovery. Following the 
primary extraction, several processing steps were used to address the issues encountered while 
using the cold-water extracts previously. Ethanol precipitation was used to isolate and separate 
the algal sugars from the remaining bulk. Monosaccharides and other small sugars were then 
removed from the extract by size exclusion dialysis, using 1 kDa cut-off dialysis tubing. 
Finally, a simulated gastric digestion was carried out to simulate passage from the mouth to the 
colon. The effects of prebiotics can be evaluated on the basis of the growth of probiotic bacteria 
such as bifidobacteria and lactobacilli, a decrease in intestinal pathogens, and a change in the  
production of health-related bacterial metabolites such as short-chain fatty acids (SCFAs), with 
the gold standard of prebiotic comparison studies being fructooligosaccharides (FOS) [14, 15]. 





only a minority can grow on inulin. Interestingly, both FOS and inulin have been proved to be 
bifidogenic, likely as a result of cross-feeding in faecal cultures [11]. The prebiotic potential of 
the Fse extract was assessed by an ex vivo anaerobic batch fermentation, using freshly voided 
faecal matter from healthy volunteers, allowing for observations to be made about changes in 
the main bacterial groups present within. Because of the inhibitory effect observed with cold-
water extract of F. serratus in Chapter 2, a reduced concentration of 1% (w/v) was used. This 
concentration is in agreement with a study carried out by Ramnani et al.  [16], which also used 
a batch fermentation approach to access prebiotic potential. Samples were taken for SCFA 
analysis, DNA sequencing, enumeration of Bifidobacterium and Lactobacillus, and the 
production of hydrogen sulphide (T = 0 h, 5 h, 10 h, 24 h, 36 h, and 48 h). The results from the 
fermentation of F. serratus polysaccharides were mixed. While significant increases in the 
production of SCFAs was observed, particularly the production of propionate and acetate, the 
fermentation of F. serratus polysaccharides had no measurable impact on bifidobacteria or 
lactobacilli. SCFAs are the major end-product of bacterial fermentation of undigested 
carbohydrates in the colon, and consist mainly of propionate, acetate and butyrate [17]. SCFAs 
mediate their influence by activating cells via cell surface G-protein-coupled receptors such as 
FFAR 2 (GPR44) and FFAR 3 (GPR41), which are differentially expressed by epithelial cells, 
adipocytes and phagocytes [18]. The production of SCFAs indicate that the polysaccharides 
contained in the Fse extract survived the simulated gastric digest intact and were fermentable 
by the representative microbiota. DNA sequencing of the 16s rRNA gene variable V4 region 
indicated a marked increase in the relative abundance of the propionate-producing superfamily 
Veillonellaceae, the genus Parabacteroides that is known to produce both propionate and 
acetate and the family Erysipelotrichaceae which is peripherally related to the butyrate-
producing superfamily Lachnospiraceae. A significant shift (p<0.05) was observed in favour 
of the production of propionate. Non-significant increases in butyrate production were also 
observed. SCFAs have been shown to stimulate the release of the anorectic gut hormones 
peptide YY (PYY) and glucagon like peptide-1 (GLP-1) from rodent enteroendocrine L cells. 
These hormones are involved in the short-term signalling of satiation and satiety to the appetite 
centres of the brain. It is believed that SCFAs stimulate the release of GLP-1 in rodents by 
stimulating FFAR2. Propionate has the highest affinity for this receptor amongst the SCFAs 
[19]. Fermentation of the FOS control, a known prebiotic, resulted in a significant increase 
(p<0.05) of all three biologically significant SCFAs, acetate, butyrate and propionate. 





from DNA sequencing results or direct plate count enumeration. A notable non-significant 
increase in bifidobacteria numbers was observed at 10 h on MRScys plates. Hydrogen sulphide 
is a toxic substance produced by several genera of colonic bacteria [20] by the action of 
sulphate-reducing bacteria on inorganic sulphur or through the fermentation of sulphur 
containing proteins and amino acids such as methionine, cysteine, cysteine and taurine [21].  A 
reduction in the production of hydrogen sulphide is indicative of prebiotic action as 
carbohydrate fermentation would be seen to predominate over protein fermentation. No 
hydrogen sulphide was detectable in fermentate samples collected, precluding an assessment 
on the effect on hydrogen sulphide production. A major limitation of the study was that the 
amount of Fse extract, obtained from the extraction process, only allowed for the batch 
fermentation to be carried out three times. This reduced the statistical power of the data but, 
nonetheless, a clear insight into the prebiotic potential of F. serratus polysaccharides was 
obtained. A re-examination the prebiotic potential of F. serratus using a higher concentration 
of extract and an increased number of technical and biological repeats could yield a more robust 
result, leading to an in vitro animal trial focusing on the effect on the model microbiota and the 
release of satiety-related hormones (PYY, GLP-1). Further, the effect of F. serratus 
polysaccharides on bifidobacteria would be better evaluated using a qPCR approach using 
bifidobacteria specific primers targeting housekeeping genes such as groEL, recA, and dnak 
[22] and rpoB. This would also allow for species and strain diversity to be analysed [23]. The 
conclusion of this study was that polysaccharides from F. serratus do not exhibit prebiotic 
activity in agreement with the current definition. However, a shift in fermentation patterns 
towards the production of propionate can have a positive effect in relation to improving satiety 
and protecting against obesity. Further research into the prebiotic potential of F. serratus 
polysaccharides is recommended culminating in animal trials. 
The biological function of polysaccharides is greatly dependent on their molecular weight. 
High molecular weight polysaccharides have more complex structures and conformations than 
lower molecular weight polysaccharides, and have a higher viscosity and poorer water-
solubility. This makes it difficult for them to enter the interior of the cell or attach to receptors 
[24]. To date, there have been a limit number of studies regarding the degradation of seaweeds 
by the gut microbiota. Seaweed polysaccharides tend to be high molecular weight, resulting in 
a quick passage through the gut, reducing the time that they are available as fermentable 
substrate to the microbiota. Evidence is now emerging that low molecular weight 





prebiotics [16]. In nature, polysaccharides are often transformed into lower molecular weight 
oligosaccharides by a variety depolymerisation processes. To access the effect of 
depolymerisation on prebiotic potential two similarly processed polysaccharide rich extracts 
were created from the Irish seaweed Laminaria digitata (Chapter 4). One extract (the crude 
extract) was processed in an identical manner as the previous F. serratus extract, while the 
other (the depolymerised extract) was depolymerised using hydrogen peroxide. The effect of 
depolymerisation would be to lower the molecular weight of the parent L. digitata 
polysaccharide. Again, an anaerobic batch faecal fermentation was used to access prebiotic 
potential, with samples being taken for SCFA analysis, DNA sequencing, Bifidobacterium and 
Lactobacillus enumeration and hydrogen sulphide formation (T = 0, 5, 10, 24, 36, and 48 
hours). The fermentation of both extracts resulted in significant increases in the production of 
all three biologically important SCFAs, butyrate, propionate and acetate. This indicates that L. 
digitata polysaccharides can survive a simulated gastric digestion, satisfying an important 
aspect of the prebiotic definition. Depolymerisation of L. digitata resulted in significant 
difference in SCFA production. The depolymerised extract exhibited significantly increased 
propionate production and decreased production of butyrate in comparison with the non-
depolymerised extract. The most obvious reason for the stimulation of butyrate production ex 
vivo is the direct selection of members of the representative microbiota capable of using the 
substrate [25], in this case L. digitata derived polysaccharides. Genes for butyrate production 
are widely spread among anaerobic Gram-positive members of the microbiota including 
several families belonging to the phylum Firmicutes, Roseburia spp. family Lachnospiraceae), 
Eubacterium rectale (family Lachnospiraceae) and Faecalibacterium prausnitzii-related 
bacteria (family Clostridaceae) [26]. An increase in butyrate production is of great interest to 
researchers and health professionals. Butyrate is the preferred energy source for epithelial cells 
of the colon and also has been implicated in the prevention of colitis and colorectal cancer [27]. 
As with the F. serratus fermentation, no noticeable impact was recorded for either extract on 
bifidobacteria or lactobacilli. The selective stimulation of beneficial members of the gut 
microbiota underlines the prebiotic concept as currently defined and precludes the labelling of 
L. digitata polysaccharides as prebiotic at this time. 
Previous fermentation studies of seaweed prebiotic potential mainly focused on the 
brown seaweeds, (F. serratus and L. digitata). It was of great interest to examine the potential 
of another grouping of seaweeds, the red seaweeds. The polysaccharide content of red 





mainly of carrageenan, xylans and agarose. Chondrus crispus was chosen as the model red 
seaweed as it is both an economical and historically important seaweed in Ireland (Chapter 5). 
The C. crispus extract (Cc extract) was prepared using a dilute hot-acid extraction and 
appropriate post-extraction processing. Owing to the gelling nature of the C. crispus 
polysaccharides, depolymerisation, using hydrogen peroxide, was required. The compositional 
analysis of the Cc extract, following treatment with TFA, revealed the presence of large 
quantities of galactose. The hydrolysis of carrageenan and agar is known to liberate galactose 
and 3, 6-anhydro-galactose [28]. This indicates the presence of large quantities of carrageenan 
in the extract as carrageenan can comprise 50-65% of the dry weight of C. crispus [29]. SCFA 
analyse of the Cc extract fermentation revealed that the extract was poorly fermented by the 
representative microbiota. Overall, only moderate increases in SCFA production was observed, 
albeit still significantly increased over the cellulose negative control. As with the fermentation 
of F. serratus and L. digitata, there was no effect on recovered Bifidobacterium and 
Lactobacillus populations. The poor prebiotic performance of the Cc extract could be because 
of the depolymerisation process itself degrading the polysaccharides beyond the point of been 
utilised by the representative microbiota. It would have been of interest to compare prebiotic 
activity between the depolymerised C. crispus extract and a C. crispus extract not having been 
subjected to a depolymerisation process. It was concluded that red seaweed polysaccharides 
are not suitable as candidates for further prebiotic investigation.  
Foodborne illnesses are a major drain on public health services throughout the world. 
Such illnesses are common and often preventable, and affect approximately 30% of individuals 
in industrialised countries each year [30] [31]. In Chapter 6, the antimicrobial activity of ten 
Irish brown seaweed species were investigated. Extracts from brown seaweeds were selected 
because these are reported to contain more biologically active substance than red seaweeds 
(which are rich in protein) and green seaweeds. The pathogens L. monocytogenes, S. aureus, 
E. coli and S. enterica serovar Typhimurium were chosen because they are among the most 
prevalent foodborne organisms, which not only affect the quality of food but also cause severe 
illness if contaminated food is ingested [2]. The initial antimicrobial screen was carried out at 
a working concentration of 1 mg/ml and demonstrated that several of the ethanol extracts 
harboured potent activity against the food pathogen Listeria monocytogenes. The extracts that 
demonstrated the strongest effect were by F. vesiculosus, F. spiralis, F. serratus, A. nodosum 
and P. canaliculata. The greatest anti-listerial effect was observed with F. vesiculosus. Plate 





at any dilutions. Fucus vesiculosus was subsequently chosen for further investigation. Several 
different sub-fractions of F. vesiculosus were prepared. It was found that anti-listerial activity 
was concentrated in the 0 – 3.5 kDa and 3.5 – 100 kDa. Both fractions and the crude ethanol 
extract of F. vesiculosus inhibited the growth of all L. monocytogenes strains tested. Activity 
with the 3.5 – 100 kDa extract was observed against Listeria at a concentration of 10 µg/ml. 
Anti-listerial activity was positively correlated with phenolic content, with all extracts and 
fractions containing highest concentrations of phenolic compounds also demonstrating highest 
levels of antimicrobial activity. Phenolic compounds are a group of hundreds of different 
molecules that have a benzene ring in their structure substituted by at least one hydroxyl group 
[32]. As high-molecular weight phlorotannins appear to be, at best only weakly antibacterial 
and antifungal, intermediate- and low-molecular weight fractions are presumably responsible 
for the observed levels of activity against Listeria [33]. The highest observed levels of phenolic 
compounds were observed for F. vesiculosus, F. spiralis, F. serratus, A. nodosum and P. 
canaliculata, all of which displayed potent anti-listeria activity. Apart from activity against 
Listeria, several of the other seaweed extracts demonstrated moderate activity against the 
Gram-positive bacteria S. aureus, against the Gram-negative bacteria E. coli, and S. enterica 
serovar Typhimurium at 24 h. The observed activity of phenol-rich seaweed rich extracts and 
fractions is not surprising as the presence of large quantities of phenolic compounds were 
inferred to have caused the inhibitory effect observed in Chapter 2 with the cold-water 
extraction from F. serratus. Despite efforts to eliminate L. monocytogenes from ready-to-eat 
(RTE) foods, contamination still occurs. It has been estimated that as much as 5% of RTE 
foods, such as sliced luncheon meats and prepared deli-style salads, contain L. monocytogenes 
[34]. In many respects, L. monocytogenes differs from most known foodborne pathogens in 
that it is ubiquitous, resistance to diverse environmental conditions, and is microaerophilic and 
psychrophilic [35]. The ability of Listeria to persist in RTE meat processing plants is in part 
because of their ability to form biofilms that aids in resistance to sanitation efforts and allows 
the organism to be a persistent contaminant [36]. The conclusion of the antimicrobial screening 
of ethanol extract from brown seaweeds is that they can be potentially used to great effect as 
biopreservatives in the food industry, especially phenolic-rich F. vesiculosus derived agents 
against L. monocytogenes.  
In conclusion, the potential of seaweeds to positively impact on the health of individuals 
is enormous. Through the modification of SCFA production, it can be expected that seaweed 





propionate and acetate either by direct consumption or by their incorporation into other food 
stuffs. Butyrate is a major source of energy for colonocytes and well regarded as a protectant 
against colorectal cancer and other gut disorders, while propionate is positively associated with 
satiety and glucose regulations. To qualify as a prebiotic, several criteria must be met by the 
substrate being investigated, namely the ability to resist gastric acidity and hydrolysis in the 
upper regions of the gastrointestinal tract and to be fermentable upon reaching the colon, 
leading to the selective growth and/or stimulation of a limited number of beneficial microbes. 
Observed increases in the production of SCFAs indicate that a multitude of seaweed 
polysaccharides can survive gastric digestion and reach the colon intact and be fermented on 
by colonic bacteria. None of the seaweed fermentations carried out resulted in a positive effect 
on Bifidobacterium and Lactobacillus. Seeing that positive impacts on SCFA production were 
observed for both the F. serratus and L. digitata fermentations, this could be a failure of the 
methods used to quantify the effect on beneficial members of the microbiota. FOS is a well-
known and established prebiotic and is often cited in literature as a control in prebiotic studies. 
For all FOS fermentations (F. serratus study, L. digitata study, and C. crispus study) as 
expected, significant increases in acetate, butyrate and propionate were recorded, however, no 
clear stimulation of Bifidobacterium or Lactobacillus was evident. Alternatives to traditional 
culturing methods would add greatly to prebiotic investigations. Methods such as the plating 
of serial dilutions on the selective media is both laborious, time consuming and prone to large 
degrees of error. Replacement with molecular technologies, such as qPCR, and through 
utilising primers designer to target specific members of the microbiota, would allow for the 
collection of unequivocal data about the effect of putative prebiotics. Time constraints 
precluded a more extensive use of molecular techniques in this thesis. Seaweeds are clearly an 
excellent source of dietary fibre, the benefits of which are well documented in literature. Based 
on the results present here further investigation of brown seaweed as a source of prebiotics is 
recommended.  Seaweeds components have clearly been established to have a wide range of 
biologically active components. They contain a multitude of non-digestible polysaccharides 
that can reach the colon intact and be fermented by colonic bacteria while also contain 
compounds such as polyphenols that are proposed to possess potent antimicrobial activity. This 
underlines the importance of a properly designed extraction methodology to more efficiently 
isolate these compounds with opposing activities. The development of new biopreservative 
agents utilising phenolic compounds isolated from seaweeds such as F. vesiculosus, and other 





RTE foods, especially as a protectant against Listeria contamination. Once the safety of ethanol 
and phenolic extractions from seaweeds is proven, using mammalian cell culture models 
followed by animal and human trials, incorporation of seaweed extracts into food matrices for 
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